
<html lang="en"     class="pb-page"  data-request-id="1de78089-9bc6-4070-b4d6-861928413bf4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01671;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2018.61.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="High in Vivo Stability of 64Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates" /></meta><meta name="dc.Creator" content="Swarbhanu  Sarkar" /></meta><meta name="dc.Creator" content="Nikunj  Bhatt" /></meta><meta name="dc.Creator" content="Yeong Su  Ha" /></meta><meta name="dc.Creator" content="Phuong Tu  Huynh" /></meta><meta name="dc.Creator" content="Nisarg  Soni" /></meta><meta name="dc.Creator" content="Woonghee  Lee" /></meta><meta name="dc.Creator" content="Yong Jin  Lee" /></meta><meta name="dc.Creator" content="Jung Young  Kim" /></meta><meta name="dc.Creator" content="Darpan N.  Pandya" /></meta><meta name="dc.Creator" content="Gwang Il  An" /></meta><meta name="dc.Creator" content="Kyo Chul  Lee" /></meta><meta name="dc.Creator" content="Yongmin  Chang" /></meta><meta name="dc.Creator" content="Jeongsoo  Yoo" /></meta><meta name="dc.Description" content="Although the importance of bifunctional chelators (BFCs) is well recognized, the chemophysical parameters of chelators that govern the biological behavior of the corresponding bioconjugates have no..." /></meta><meta name="Description" content="Although the importance of bifunctional chelators (BFCs) is well recognized, the chemophysical parameters of chelators that govern the biological behavior of the corresponding bioconjugates have no..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01671" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01671" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01671" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01671" /></link>
        
    
    

<title>High in Vivo Stability of 64Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01671" /></meta><meta property="og:title" content="High in Vivo Stability of 64Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0007.jpeg" /></meta><meta property="og:description" content="Although the importance of bifunctional chelators (BFCs) is well recognized, the chemophysical parameters of chelators that govern the biological behavior of the corresponding bioconjugates have not been clearly elucidated. Here, five BFCs closely related in structure were conjugated with a cyclic RGD peptide and radiolabeled with Cu-64 ions. Various biophysical and chemical properties of the Cu(II) complexes were analyzed with the aim of identifying correlations between individual factors and the biological behavior of the conjugates. Tumor uptake and body clearance of the 64Cu-labeled bioconjugates were directly compared by animal PET imaging in animal models, which was further supported by biodistribution studies. Conjugates containing propylene cross-bridged chelators showed higher tumor uptake, while a closely related ethylene cross-bridged analogue exhibited rapid body clearance. High in vivo stability of the copper–chelator complex was strongly correlated with high tumor uptake, while the overall lipophilicity of the bioconjugate affected both tumor uptake and body clearance." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01671"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01671">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01671&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01671&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01671&amp;href=/doi/10.1021/acs.jmedchem.7b01671" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 385-395</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01584" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00844" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">High in Vivo Stability of <sup>64</sup>Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swarbhanu++Sarkar">Swarbhanu Sarkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikunj++Bhatt">Nikunj Bhatt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yeong+Su++Ha">Yeong Su Ha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phuong+Tu++Huynh">Phuong Tu Huynh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nisarg++Soni">Nisarg Soni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Woonghee++Lee">Woonghee Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong+Jin++Lee">Yong Jin Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jung+Young++Kim">Jung Young Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darpan+N.++Pandya">Darpan N. Pandya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gwang+Il++An">Gwang Il An</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyo+Chul++Lee">Kyo Chul Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongmin++Chang">Yongmin Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0585-8714" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeongsoo++Yoo">Jeongsoo Yoo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0752-5745" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea</span></div><div class="corresp-info"><strong>*</strong>Phone: +82-53-420-4947. Fax: +82-53-426-4944. E-mail: <a href="/cdn-cgi/l/email-protection#5b223434311b30352e753a38753029"><span class="__cf_email__" data-cfemail="5e273131341e35302b703f3d70352c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01671&amp;href=/doi/10.1021%2Facs.jmedchem.7b01671" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 385–395</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 14, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2017</li><li><span class="item_label"><b>Published</b> online</span>3 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01671" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01671</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D385%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSwarbhanu%2BSarkar%252C%2BNikunj%2BBhatt%252C%2BYeong%2BSu%2BHa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D1%26contentID%3Dacs.jmedchem.7b01671%26title%3DHigh%2Bin%2BVivo%2BStability%2Bof%2B64Cu-Labeled%2BCross-Bridged%2BChelators%2BIs%2Ba%2BCrucial%2BFactor%2Bin%2BImproved%2BTumor%2BImaging%2Bof%2BRGD%2BPeptide%2BConjugates%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D395%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01671"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1137</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01671" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;High in Vivo Stability of 64Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Swarbhanu&quot;,&quot;last_name&quot;:&quot;Sarkar&quot;},{&quot;first_name&quot;:&quot;Nikunj&quot;,&quot;last_name&quot;:&quot;Bhatt&quot;},{&quot;first_name&quot;:&quot;Yeong&quot;,&quot;last_name&quot;:&quot;Su Ha&quot;},{&quot;first_name&quot;:&quot;Phuong&quot;,&quot;last_name&quot;:&quot;Tu Huynh&quot;},{&quot;first_name&quot;:&quot;Nisarg&quot;,&quot;last_name&quot;:&quot;Soni&quot;},{&quot;first_name&quot;:&quot;Woonghee&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Jin Lee&quot;},{&quot;first_name&quot;:&quot;Jung&quot;,&quot;last_name&quot;:&quot;Young Kim&quot;},{&quot;first_name&quot;:&quot;Darpan&quot;,&quot;last_name&quot;:&quot;N. Pandya&quot;},{&quot;first_name&quot;:&quot;Gwang&quot;,&quot;last_name&quot;:&quot;Il An&quot;},{&quot;first_name&quot;:&quot;Kyo&quot;,&quot;last_name&quot;:&quot;Chul Lee&quot;},{&quot;first_name&quot;:&quot;Yongmin&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Jeongsoo&quot;,&quot;last_name&quot;:&quot;Yoo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;385-395&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01671&quot;},&quot;abstract&quot;:&quot;Although the importance of bifunctional chelators (BFCs) is well recognized, the chemophysical parameters of chelators that govern the biological behavior of the corresponding bioconjugates have not been clearly elucidated. Here, five BFCs closely related in structure were conjugated with a cyclic RGD peptide and radiolabeled with Cu-64 ions. Various biophysical and chemical properties of the Cu(II) complexes were analyzed with the aim of identifying correlations between individual factors and the biological behavior of the conjugates. Tumor uptake and body clearance of the 64Cu-labeled bioconjugates were directly compared by animal PET imaging in animal models, which was further supported by biodistribution studies. Conjugates containing propylene cross-bridged chelators showed higher tumor uptake, while a closely related ethylene cross-bridged analogue exhibited rapid body clearance. High in vivo stability of the copper–chelator complex was strongly correlated with high tumor uptake, while the overall lipop&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01671&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01671" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01671&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01671" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01671&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01671" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01671&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01671&amp;href=/doi/10.1021/acs.jmedchem.7b01671" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01671" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01671" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01671%26sid%3Dliteratum%253Aachs%26pmid%3D29240422%26genre%3Darticle%26aulast%3DSarkar%26date%3D2018%26atitle%3DHigh%2Bin%2BVivo%2BStability%2Bof%2B64Cu-Labeled%2BCross-Bridged%2BChelators%2BIs%2Ba%2BCrucial%2BFactor%2Bin%2BImproved%2BTumor%2BImaging%2Bof%2BRGD%2BPeptide%2BConjugates%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D1%26spage%3D385%26epage%3D395%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=290879" title="Chemical biology">Chemical biology</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a>,</li><li><a href="/action/doSearch?ConceptID=290715" title="Mechanisms of action">Mechanisms of action</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/jmcmar.2018.61.issue-1/20180111/jmcmar.2018.61.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0007.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Although the importance of bifunctional chelators (BFCs) is well recognized, the chemophysical parameters of chelators that govern the biological behavior of the corresponding bioconjugates have not been clearly elucidated. Here, five BFCs closely related in structure were conjugated with a cyclic RGD peptide and radiolabeled with Cu-64 ions. Various biophysical and chemical properties of the Cu(II) complexes were analyzed with the aim of identifying correlations between individual factors and the biological behavior of the conjugates. Tumor uptake and body clearance of the <sup>64</sup>Cu-labeled bioconjugates were directly compared by animal PET imaging in animal models, which was further supported by biodistribution studies. Conjugates containing propylene cross-bridged chelators showed higher tumor uptake, while a closely related ethylene cross-bridged analogue exhibited rapid body clearance. High in vivo stability of the copper–chelator complex was strongly correlated with high tumor uptake, while the overall lipophilicity of the bioconjugate affected both tumor uptake and body clearance.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Radioactive copper is one of most actively studied radionuclides. It comprises several radioisotopes (<sup>60</sup>Cu, <sup>61</sup>Cu, <sup>62</sup>Cu, <sup>64</sup>Cu, or <sup>67</sup>Cu) having different decay modes, which are utilized for a wide range of applications from nuclear imaging to radiotherapy.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Among these, Cu-64 is most commonly used for the preparation of radiopharmaceuticals because of its attractive physical properties (β<sup>+</sup> 19%, β<sup>–</sup> 38%, <i>t</i><sub>1/2</sub> = 12.7 h) and good availability.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Some <sup>64</sup>Cu-labeled imaging probes are already used in humans, and more are in clinical trials.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recently, the use of radioactive copper for radiotherapy has gained more interest because of progress made in the production of the therapeutic nuclide Cu-67 (β<sup>–</sup> 100%, <i>t</i><sub>1/2</sub> = 61.8 h).<a onclick="showRef(event, 'ref1 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref6">(1, 6)</a></div><div class="NLM_p">Even though several small copper complexes such as <sup>64</sup>Cu-ATSM and <sup>64</sup>Cu-PTSM have shown great potential as PET (positron emission tomography) imaging probes in the clinic,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> most applications are as biomolecule conjugates, in which peptides or antibodies are radiolabeled with radioactive copper ions using bifunctional chelators (BFCs).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Ideally, BFCs will easily form robust copper complexes and should not lose copper ions under physiological conditions.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> They also need to undergo straightforward conjugation with biomolecules, after which the intrinsic targeting properties of these compounds should not deteriorate.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> For this, great efforts have been made worldwide to develop better chelators for copper ions.<a onclick="showRef(event, 'ref10 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref10 ref14 ref15 ref16 ref17 ref18">(10, 14-18)</a> In particular, the observation that the widely employed chelator DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) loses copper ions in vivo accelerated the development of cross-bridged chelators that form ultrastable copper complexes. Initially, Wong and Anderson developed the cross-bridged chelator ECB-TE2A (ethylene cross-bridged 1,8-<i>N</i>,<i>N</i>′-bis(carboxymethyl)-1,4,8,11-tetraazacyclotetradecane),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and recently propylene cross-bridged TE2A (PCB-TE2A) was added by our group.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">However, traditional BFCs such as DOTA, TETA, and DTPA derivatives are still most commonly chosen as chelators for the radiolabeling of biomolecules with Cu-64.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Although several studies have directly compared the effects of different chelators on radiolabeled bioconjugates, it remains unclear what properties of chelators are the most important determinants of the biological properties of bioconjugates, especially regarding tumor uptake, because of the small number of chelators compared and the nonsystematic structural variations between them.<a onclick="showRef(event, 'ref10 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref23">(10, 23)</a></div><div class="NLM_p last">In this work, we carefully chose five BFCs with systematic variations in structure, focusing particularly on cross-bridged chelators. Five chelators were conjugated with the same RGD peptide and used for both in vitro and in vivo studies, including PET imaging. Various factors, including in vivo stability, lipophilicity, mode of conjugation, overall charge, linker, and specific activity, were directly compared and correlations between these parameters and tumor targeting efficacy were closely examined.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Conjugation of BFCs with RGD Peptides</h3><div class="NLM_p">Five BFCs were carefully selected for side-by-side comparison studies (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). First, three cross-bridged chelators were selected. The original cross-bridged chelator, ECB-TE2A, was directly compared with its propylene analogue PCB-TE2A. Another PCB-TE2A derivative, PCB-TE2A-Bn-NCS, was also examined to assess the effect of the additional functionality on the chelator backbone. The noncross-bridged chelator TE2A-Bn-NCS was chosen for direct comparison with cross-bridged PCB-TE2A-Bn-NCS. Finally, a NOTA derivative (NOTA-Bn-NCS), which is known to form a more stable copper complex than DOTA in vivo,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> was compared with the others.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of BFC-c(RGDyK) conjugates, NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>), ECB-TE2A-c(RGDyK) (<b>4</b>), and PCB-TE2A-c(RGDyK) (<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These chelators can be also categorized into two groups depending on their conjugation mode with biomolecules. Three chelators having an extra isothiocyanate group (−NCS) conjugate with cyclic RGDyK peptides (c(RGDyK)) via thiourea bonding, whereas ECB-TE2A and PCB-TE2A are linked to the peptide through amide bond formation using an acetate pendant arm (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Specifically, NOTA-Bn-NCS and TE2A-Bn-NCS, the chelators bearing NCS functionality, were allowed to react with the free amine group on the lysine of the c(RGDyK) peptide in the presence of diisopropylethylamine (DIEA) and then purified by semipreparative HPLC. The formation of the both bioconjugates was confirmed by ESI-MS. We used standard dicyclohexylcarbodiimide (DCC) coupling for the synthesis of PCB-TE2A-c(RGDyK) (<b>5</b>). In this protocol, the carboxylic group of PCB-TE2A was first activated by DCC/DIEA in dry DMSO, and the subsequent addition of the peptide allowed the amino group of lysine to react with the activated carboxylic acid group of PCB-TE2A; the bioconjugate was formed via an amide linkage. This compound was then purified and confirmed by ESI-MS as described above for the NCS-bearing chelators. The other two bioconjugates, PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>) and ECB-TE2A-c(RGDyK) (<b>4</b>), were prepared according to the literature.<a onclick="showRef(event, 'ref20 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref20 ref25 ref26">(20, 25, 26)</a> The yields of the isolated conjugated products were 13%, 7%, and 9% for NOTA (<b>1</b>), TE2A (<b>2</b>), and PCB-TE2A (<b>5</b>), respectively.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthetic procedures for the <sup>64</sup>Cu bioconjugates. (A) Conjugation strategies for noncross-bridged chelators, TE2A-Bn-NCS and NOTA-Bn-NCS, to c(RGDyK), and radiolabeling with Cu-64. (B) Conjugation of PCB-TE2A to c(RGDyK) and radiolabeling with Cu-64. Reaction conditions: (i) diisopropylethylamine (DIEA), dimethylformamide (DMF), room temperature, 16 h; (ii) <sup>64</sup>CuCl<sub>2</sub>, water, 50 °C, 15 min; (iii) dicyclohexylcarbodiimide (DCC), DIEA, DMSO, room temperature, 16 h; (iv) <sup>64</sup>CuCl<sub>2</sub>, 0.1 M NH<sub>4</sub>OAc buffer (pH 8), 80 °C, 60 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Radiochemistry</h3><div class="NLM_p">Next, all bioconjugates were labeled with [<sup>64</sup>Cu]CuCl<sub>2</sub> (37–370 MBq) at a concentration of 1 μg/20 μL (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), which was followed by HPLC purification to separate traces of free copper and minor impurities (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A–C, Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S10">Figure S10</a>). Although the radiochemical purity of all isolated <sup>64</sup>Cu bioconjugates was determined to be >95%, the radiolabeling conditions varied depending on the presence of cross-bridges on the chelators. For the noncross-bridged chelates, NOTA (<b>1</b>) and TE2A (<b>2</b>), quantitative radiolabeling was feasible at 50 °C within 15 min in simple water. However, the cross-bridged macrocycles, PCB-TE2A-Bn-NCS (<b>3</b>), ECB-TE2A (<b>4</b>), and PCB-TE2A (<b>5</b>), were radiolabeled at 80 °C in buffer (pH 8.0) with an extended incubation time of 60 min (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The radiolabeling yields of all three cross-bridged chelates were greater than 95%. Typical radiochemical yields were ∼80% after HPLC purification from the start of radiolabeling. Total radiolabeling time including HPLC purification was less than 2 h.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–C) UV-HPLC (230 nm, black) and radio-HPLC (red) chromatogram of bioconjugates. (A) UV/radio HPLC chromatogram of <sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>1</b>). (B) UV/radio HPLC chromatogram of <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>). (C) UV/radio HPLC chromatogram of <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>). (D) Measurement of the biophysical properties of the bioconjugates. (E) In vitro inhibition of <sup>125</sup>I-echistain binding to integrin on U87MG cells by c(RGDyK) and bioconjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The  specific activities of all <sup>64</sup>Cu bioconjugates was measured to be in the range of 15–40 GBq/μmol (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). The cross-bridged chelates showed slightly higher specific activities than the noncross-bridged chelates. Any meaningful correlation between specific activities and tumor uptakes was not observed.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Effect of BFCs on Overall Lipophilicity of Bioconjugates</h3><div class="NLM_p last">The Log <i>D</i> values at pH 7.4 of all radiolabeled bioconjugates are summarized in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D. As expected, the ECB-TE2A chelate (<sup>64</sup>Cu-<b>4</b>), which conjugates amides directly with peptide via an acetate arm, showed the highest hydrophilicity (Log <i>D</i> −3.73). The PCB-TE2A chelate (<sup>64</sup>Cu-<b>5</b>), which has an additional methylene bridging carbon compared with ECB-TE2A, had the next highest hydrophilicity (Log <i>D</i> −3.49). The overall charge of these two chelates after Cu(II) complexation is +1. The other three chelates, which contain an additional lipophilic benzyl isothiocyanate group (Bn-NCS), showed more lipophilic characteristics. Among these three chelates, NOTA-Bn-NCS (<sup>64</sup>Cu-<b>1</b>), which has an overall charge of −1 after complexation, showed higher hydrophilicity (Log <i>D</i> −3.19), while PCB-TE2A-Bn-NCS (<sup>64</sup>Cu-<b>3</b>), which contains a propylene cross-bridge and forms a neutral Cu(II) complex, was determined to be the most lipophilic (Log <i>D</i> −1.92). Another neutral complex, <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>), showed much higher hydrophilicity than the PCB-TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>3</b>) (Log <i>D</i> −3.38). Several factors, such as the overall charge of the copper complex, the presence of an additional benzyl group, and the conjugation mode, thus seem to contribute to the overall lipophilic behavior of the peptide conjugates.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Affinity Assay</h3><div class="NLM_p last">We then examined the α<sub>v</sub>β<sub>3</sub> integrin affinity of the five RGD conjugates (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>E). Surface receptor binding assays, using α<sub>v</sub>β<sub>3</sub> integrin-positive U87MG cells and <sup>125</sup>I-echistatin as a radioligand, indicated that all bioconjugates selectively bind to the cell surface integrin receptor. The 50% inhibitory concentrations (IC<sub>50</sub>) of the bioconjugates were all comparable and in the narrow range of 28–60 nM, which are similar to that of unconjugated c(RGDyK) peptide itself (22.6 ± 4.77 nM). It is interesting to note that the direct conjugation of cross-bridged chelators with c(RGDyK) via an acetate group, resulted in minimal disturbance to its affinity toward α<sub>v</sub>β<sub>3</sub> integrin. It has been reported previously that the conjugation mode of the chelator has minimal impact on the integrin binding affinity of RGD conjugates.<a onclick="showRef(event, 'ref25 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29">(25, 28, 29)</a> The ECB-TE2A (<b>4</b>) and PCB-TE2A (<b>5</b>) conjugates showed even lower IC<sub>50</sub> values than the other three chelators with slightly long spacers between the chelator and the RGD moiety, although the differences were not large (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro and in Vivo Stability Studies</h3><div class="NLM_p">First, we measured the serum stability of the <sup>64</sup>Cu bioconjugates; no significant demetalation was observed for any chelator. For the least stable conjugate, the NOTA conjugate (<sup>64</sup>Cu-<b>1</b>), 95% of the complex remained intact after 24 h incubation with fetal bovine serum at 37 °C, while the three cross-bridged chelators showed less than 1% decomplexation (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S1">Figure S1</a>).</div><div class="NLM_p">The plasma protein binding of <sup>64</sup>Cu-BFCs-c(RGDyK) was measured to be 17.5%, 12.9%, 12.5%, 15.8%, and 9.6% for NOTA (<sup>64</sup>Cu-<b>1</b>), TE2A (<sup>64</sup>Cu-<b>2</b>), PCB-TE2A-Bn-NCS (<sup>64</sup>Cu-<b>3</b>), ECB-TE2A (<sup>64</sup>Cu-<b>4</b>), and PCB-TE2A (<sup>64</sup>Cu-<b>5</b>), respectively (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S2">Figure S2</a>). No correlation between protein binding and stability or lipophilicity was observed.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Next, we directly analyzed the in vivo stability of the <sup>64</sup>Cu-labeled bioconjugates in blood, liver, and kidney 1 h postinjection into Sprague–Dawley (SD) rats. In contrast to the in vitro serum stability data, there were large differences in in vivo stability between the different chelators (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). In general, the three cross-bridged chelators showed much higher robustness compared with the two noncross-bridged chelators. In particular, PCB-TE2A-Bn-NCS (<sup>64</sup>Cu-<b>3</b>) showed exceptionally high stability in all three tissues. The blood demetalation of PCB-TE2A-Bn-NCS (<sup>64</sup>Cu-<b>3</b>) was only 5.8%, whereas the blood demetalation of NOTA (<sup>64</sup>Cu-<b>1</b>) and TE2A (<sup>64</sup>Cu-<b>2</b>) was five times higher (30% and 40%, respectively), as determined by quantification of the demetalated free <sup>64</sup>Cu ion peak (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S3">Figure S3</a>). The other cross-bridged chelators, which use one acetate group for peptide conjugation, showed intermediate inertness in blood (24% and 20% for ECB-TE2A (<sup>64</sup>Cu-<b>4</b>) and PCB-TE2A (<sup>64</sup>Cu-<b>5</b>), respectively). In liver, the stability differences between the cross-bridged and noncross-bridged chelators were even more pronounced. All three cross-bridged chelators showed approximately 10% demetalation, which was only one-quarter of that observed for the noncross-bridged chelators (40% and 45% for NOTA (<sup>64</sup>Cu-<b>1</b>) and TE2A (<sup>64</sup>Cu-<b>2</b>), respectively). A very similar pattern was observed in the kidneys; demetalation was in the range of 8–12% for the cross-bridged chelators, whereas NOTA and TE2A showed approximately 4-fold higher demetalation (34% and 45%, respectively). The ultrahigh robustness of PCB-TE2A-Bn-NCS can be explained by its tight clam shell-like holding of the copper ion with two acetate arms;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in contrast, the other two cross-bridged chelators use only one acetate arm for coordination to Cu(II) ions.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo stability of radiotracers in rat tissues at 1 h postinjection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Animal PET Imaging Studies</h3><div class="NLM_p">A full comparative study to evaluate the in vivo behavior and tumor targeting efficacy of all <sup>64</sup>Cu-labeled bioconjugates was performed using animal PET imaging studies in U87MG tumor-bearing nude mice (<i>n</i> = 3 per bioconjugate). Representative maximum intensity projection (MIP) PET images collected 1, 4, and 24 h postinjection are displayed in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. At first glance, most activity was found in clearance organs such as the liver, kidneys, intestine, and bladder at 1 and 4 h postinjection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A–J). After 24 h, most of the abdominal activity had been cleared from the body, and tumors became more easily distinguishable from the background for all five <sup>64</sup>Cu bioconjugates (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>K–O). However, upon closer inspection, all five conjugates showed distinct clearance and tumor uptake patterns. Tumors could be clearly identified from the background as early as 1 h postinjection in the case of the three cross-bridged chelators (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C–E), while the tumors could not be clearly identified until 24 h postinjection using the two noncross-bridged chelators (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>K,L). With respect to absolute tumor uptake, the two PCB-TE2A conjugates exhibited distinctively higher tumor uptake compared with the other three chelators (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C,H,M and E,J,O). The clearance patterns of the five conjugates were also different. The ECB-TE2A conjugate (<sup>64</sup>Cu-<b>4</b>) exhibited the fastest body clearance via the urinary route,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> while the two propylene cross-bridged chelators showed higher liver and kidney uptake at all time points compared with the other chelators. In particular, the PCB-TE2A-Bn-NCS bioconjugate (<sup>64</sup>Cu-<b>3</b>) showed significant activity in the liver and intestine until 24 h postinjection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>M).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative PET (A–J) and PET/CT (K–O) images of bioconjugates in U87MG tumor-bearing mice at 1, 4, and 24 h postinjection (<i>n</i> = 3 for each group). PET images are shown in maximum intensity projection mode. All images are decay-corrected and adjusted to the same maximum value. (A,F,K) <sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>1</b>), (B,G,L) <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>), (C,H,M) <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>3</b>), (D,I,N) <sup>64</sup>Cu-ECB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>4</b>), and (E,J,O) <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>). White arrowhead indicates tumor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The detailed pharmacokinetic behavior of the <sup>64</sup>Cu-labeled conjugates was analyzed by PET image-based quantification. Regions of interest (ROIs) were drawn on liver, kidney, and muscle, as well as tumor tissue. The resulting quantitative data along with the tumor-to-organ ratios are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. One of the strongest distinctions among the five <sup>64</sup>Cu-labeled peptides was the higher concentration of activity in tumors for two propylene cross-bridged chelators. The PCB-TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>3</b>) exhibited the highest tumor uptakes at all time points (3.76 ± 0.21, 3.89 ± 0.07, 3.49 ± 0.10 %ID/g at 1, 4, 24 h, respectively), which was followed by the PCB-TE2A conjugate (<sup>64</sup>Cu-<b>5</b>) (3.45 ± 0.16, 3.10 ± 0.10, 2.34 ± 0.32 %ID/g). The ethylene cross-bridged chelator (<sup>64</sup>Cu-<b>4</b>) showed the third highest tumor uptake until 4 h (2.23 ± 0.11, 1.99 ± 0.21 %ID/g at 1 and 4 h, respectively). In contrast to the noncross-bridged chelators, which showed maximum uptake of less than 2%ID/g in tumors at all time points, tumors could be visualized clearly using peptide conjugates of the three cross-bridged chelators. Even though the absolute tumor uptake of the ECB-TE2A conjugate (<sup>64</sup>Cu-<b>4</b>) was lower than that of the PCB-TE2A conjugates (<sup>64</sup>Cu-<b>5</b>), the tumors were more unambiguously visualized using the ECB-TE2A-conjugated peptide at 1 and 4 h because uptake of this conjugate in the neighboring liver and intestine was considerably lower than uptake of the other conjugates. Liver uptake of the ECB-TE2A conjugate (<sup>64</sup>Cu-<b>4</b>) was less than half that of the PCB-TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>3</b>) (1.97 ± 0.38 vs 3.91 ± 0.16 at 1 h, 1.66 ± 0.25 vs 3.15 ± 0.57 at 4 h, 0.79 ± 0.13 vs 2.73 ± 0.11 %ID/g at 24 h, respectively), resulting in the highest tumor-to-liver ratios at all time points (1.13, 1.20, 1.41 at 1, 4, and 24 h, respectively). In contrast to all other chelators, the ECB-TE2A conjugate (<sup>64</sup>Cu-<b>4</b>) was rapidly excreted, mostly via the urinary route rather than the hepatobiliary route, which has also been observed by other groups.<a onclick="showRef(event, 'ref25 ref32'); return false;" href="javascript:void(0);" class="ref ref25 ref32">(25, 32)</a> However, the PCB-TE2A conjugate (<sup>64</sup>Cu-<b>5</b>), which has only one extra methylene carbon in the cross-bridge compared with the ECB-TE2A conjugate, resembled the PCB-TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>3</b>) more closely than the ECB-TE2A conjugate in tumor uptake and clearance patterns. The PCB-TE2A conjugate (<sup>64</sup>Cu-<b>5</b>) showed preferential excretion through the liver and intestine rather than the kidneys (3.91 ± 0.22 vs 2.97 ± 0.45 at 1 h, 3.13 ± 0.10 vs 2.25 ± 0.46 at 4 h, 1.83 ± 0.10 vs 1.60 ± 0.38 %ID/g at 24 h for liver and kidney, respectively). Considering that the chelators differ in their linker (the presence of the additional benzyl NCS group), the overall charge after Cu(II) complexation (neutral vs +1), and conjugation mode (thiourea vs amide), the closer resemblance of the PCB-TE2A conjugate (<sup>64</sup>Cu-<b>5</b>) to the PCB-TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>3</b>) than the ECB-TE2A conjugate (<sup>64</sup>Cu-<b>4</b>) is striking and could be considered a good example of the importance of the bifunctional chelator in <sup>64</sup>Cu-labeled peptide conjugates.<a onclick="showRef(event, 'ref25 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref28">(25, 28)</a> The only plausible explanation of this observation is that the high hydrophilicity of the ECB-TE2A conjugate (log <i>D</i> −3.73) facilitates urinary excretion.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Tumor, Liver, Kidney, And Muscle Uptakes of <sup>64</sup>Cu Bioconjugates at 1 h (A), 4 h (B), and 24 h (C) Post-Injection<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">(A)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">organ uptake (% ID/g), 1 h</th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">tumor-to-organ ratio</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bioconjugates</th><th class="colsep0 rowsep0" align="center" char="±">tumor (T)</th><th class="colsep0 rowsep0" align="center" char="±">liver (L)</th><th class="colsep0 rowsep0" align="center" char="±">kidney (K)</th><th class="colsep0 rowsep0" align="center" char="±">muscle (M)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>L</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>K</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>M</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.90 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">2.49 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.78 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.76 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.07 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">4.63 ± 0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.79 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">2.56 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">2.87 ± 0.40</td><td class="colsep0 rowsep0" align="char" char="±">0.38 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">4.71 ± 1.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">3.76 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">3.91 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">3.67 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">0.38 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.96 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">1.02 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">9.89 ± 0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-ECB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">2.23 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.97 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±">3.24 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.13 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.69 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">6.97 ± 0.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">3.45 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">3.91 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">2.97 ± 0.45</td><td class="colsep0 rowsep0" align="char" char="±">0.48 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.16 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">7.18 ± 0.69</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">(B)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">organ uptake (% ID/g), 4 h</th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">tumor-to-organ ratio</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bioconjugates</th><th class="colsep0 rowsep0" align="center" char="±">tumor (T)</th><th class="colsep0 rowsep0" align="center" char="±">liver (L)</th><th class="colsep0 rowsep0" align="center" char="±">kidney (K)</th><th class="colsep0 rowsep0" align="center" char="±">muscle (M)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>L</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>K</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>M</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.99 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">2.20 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">1.42 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.36 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">1.40 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">5.53 ± 0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.86 ± 0.37</td><td class="colsep0 rowsep0" align="char" char="±">2.14 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.61 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">1.16 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">6.41 ± 1.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">3.89 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">3.15 ± 0.57</td><td class="colsep0 rowsep0" align="char" char="±">3.31 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">0.36 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.20 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">1.18 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">10.81 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-ECB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.99 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.66 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">2.49 ± 0.64</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.20 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">6.86 ± 0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">3.10 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">3.13 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">2.25 ± 0.46</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.99 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">1.38 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">7.75 ± 1.00</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">(C)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">organ uptake (% ID/g), 24 h</th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">tumor-to-organ ratio</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bioconjugates</th><th class="colsep0 rowsep0" align="center" char="±">tumor (T)</th><th class="colsep0 rowsep0" align="center" char="±">liver (L)</th><th class="colsep0 rowsep0" align="center" char="±">kidney (K)</th><th class="colsep0 rowsep0" align="center" char="±">muscle (M)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>L</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>K</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i>/<i>M</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.49 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.45 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.22 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.03 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.25 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">6.77 ± 0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">1.00 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">1.12 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">6.10 ± 0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">3.49 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">2.73 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.28 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">2.30 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">10.91 ± 0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-ECB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">1.11 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.79 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">1.37 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.41 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">6.17 ± 0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>64</sup>Cu-PCB-TE2A-c(RGDyK)</td><td class="colsep0 rowsep0" align="char" char="±">2.34 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">1.83 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">1.60 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.28 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">1.46 ± 0.40</td><td class="colsep0 rowsep0" align="char" char="±">7.55 ± 1.14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Organ uptakes are presented as %ID/g. Quantification was calculated based on the PET/CT images depicted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>.</p></div></div></div><div class="NLM_p last">The improved tumor targeting efficacy, in terms of absolute tumor uptake and high tumor-to-background ratios, associated with the three cross-bridged chelators can be mostly attributed to the high in vivo stability of the corresponding Cu(II)–chelator complexes. As seen in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, the copper complexes of the three cross-bridged chelators showed much higher in vivo stability than the complexes of the noncross-bridged chelators. Among the three cross-bridged chelators, <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>3</b>), which exhibited the highest tumor uptake and prolonged tumor retention (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), showed approximately 4-fold lower demetalation in blood compared with the other two chelators. Ultrastable <sup>64</sup>Cu-labeled chelators could be delivered to the tumor region, minimizing the release of free <sup>64</sup>Cu(II) ions, which increases background activity and results in lower tumor-to-organ ratios.<a onclick="showRef(event, 'ref25 ref34'); return false;" href="javascript:void(0);" class="ref ref25 ref34">(25, 34)</a> The lipophilicity of chelators also seems to have some effect on tumor uptake of <sup>64</sup>Cu-labeled bioconjugates.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Even though the in vivo stability of <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) was comparable with that of the ECB-TE2A analogue (<sup>64</sup>Cu-<b>4</b>), the PCB-TE2A conjugate, which had higher lipophilicity than the ECB-TE2A conjugate (Log <i>D</i> −3.49 vs −3.73), exhibited >1.5-fold higher tumor uptake at all three time points.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biodistribution Studies</h3><div class="NLM_p">Biodistribution studies of <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>) and <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) were performed for the first time in the current study (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>); biodistribution data for the other radiotracers have been reported previously.<a onclick="showRef(event, 'ref20 ref24 ref32'); return false;" href="javascript:void(0);" class="ref ref20 ref24 ref32">(20, 24, 32)</a> Both of the <sup>64</sup>Cu bioconjugates showed α<sub>v</sub>β<sub>3</sub> integrin-mediated specific tumor uptake. In agreement with the PET imaging data, tumor uptake of <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) was 2-fold higher than that of the TE2A-Bn-NCS conjugate (<sup>64</sup>Cu-<b>2</b>) 1 and 24 h postinjection (4.70 ± 0.35 vs 2.36 ± 0.41 at 1 h, 3.82 ± 0.23 vs 1.78 ± 0.04 %ID/g at 24 h). The PCB-TE2A conjugate (<sup>64</sup>Cu-<b>5</b>) exhibited prolonged activity in tumors, and more than 80% of the activity observed 1 h postinjection remained after 24 h (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). The activity in the other organs cleared gradually over time, resulting in high tumor-to-organ ratios at 24 h (22.6, 6.5, and 4.9 for blood, muscle, and liver, respectively). The relatively low tumor-to-kidney ratio of the PCB-TE2A conjugate (1.8) can be attributed to its preference for renal excretion, presumably because of its high hydrophilicity<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (Log <i>D</i> −3.49) and the net positive charge of the tracer.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> In contrast to the PCB-TE2A analogue (<sup>64</sup>Cu-<b>5</b>), the more lipophilic neutral <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) conjugate (<sup>64</sup>Cu-<b>2</b>) was excreted via both the liver and kidneys (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A), resulting in a lower tumor-to-liver ratio at all time points (0.71 vs 2.1, 0.75 vs 1.8, and 1.8 vs 4.9, respectively). Prolonged retention in tumor and fast blood clearance also resulted in an increase in the tumor-to-blood ratio for <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) compared with <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>) at all time points (6.8 vs 4.4, 30.9 vs 7.7, and 22.6 vs 15.7 at 1, 4, and 24 h, respectively). In blocking studies, tumor uptake of TE2A-Bn-NCS (<sup>64</sup>Cu-<b>2</b>) and PCB-TE2A (<sup>64</sup>Cu-<b>5</b>) conjugates was reduced by 54% (1.09 ± 0.16%ID/g) and 77% (1.08 ± 0.15%ID/g), respectively, by coinjection of c(RGDyK) peptide, which clearly indicates that tumor uptake was mediated by specific binding of radiotracers to the α<sub>v</sub>β<sub>3</sub> integrin receptor (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Biodistribution data of (A) <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>) and (B) <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) at 1 h, 1 h with blocking, and 4 and 24 h postinjection in U87MG tumor-bearing nude mice (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the current study, the effects of bifunctional chelators on the pharmacokinetic behavior of <sup>64</sup>Cu-radiolabeled peptides were evaluated. Five closely related chelators, including three cross-bridged macrocycles, were conjugated with cyclic RGD peptides and radiolabeled with Cu-64 ions in high yield. Various properties, such as in vitro and in vivo stability, Log <i>D</i>, specific activity, selective binding affinity, and protein binding, were measured. For biological evaluation, direct comparison of tumor uptake and body clearance among the five bioconjugates was achieved by animal PET imaging studies. Biodistribution studies further supported the imaging data.</div><div class="NLM_p">Significant differences in tissue uptake and clearance patterns were observed depending on the chelator utilized in the peptide conjugate. The three cross-bridged chelators resulted in higher tumor visibility compared with the noncross-bridged chelators. In particular, propylene cross-bridged chelators, which exhibited ultrahigh in vivo stability, showed higher tumor uptake, while the analogous ethylene cross-bridged chelator, which had the highest hydrophilicity, showed rapid body clearance. In our study, the in vivo stability of copper complexes was strongly correlated with tumor uptake of bioconjugates. Tumor targeting and body clearance, and therefore tumor-to-background ratios, also showed strong correlations with the overall lipophilicity of the <sup>64</sup>Cu bioconjugates. No significant correlation between other factors (i.e., overall charge of the Cu(II) complex, linker, or conjugation mode of the chelator) and biological behavior was observed, although these factors might together contribute to the overall lipophilicity of the <sup>64</sup>Cu bioconjugates. The effect of the chelator on the specific activity, selective binding affinity, and protein binding of the peptide conjugates was also minimal.</div><div class="NLM_p last">In conclusion, propylene cross-bridged TE2A derivatives show potential as promising bifunctional chelators for the radiolabeling of short peptides with radioactive copper ions, at least for RGD peptides. Further studies using PCB-TE2A chelators for radiolabeling of other disease-specific peptides for radioactive copper-based imaging and therapeutic applications are highly anticipated.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Materials and Methods</h3><div class="NLM_p last">All chemicals or solvents used in the study were purchased from Sigma-Aldrich (St. Louis, USA) unless otherwise stated. c(RGDyK) was purchased from FutureChem (Seoul, Korea). Cu-64 was produced at KIRAMS (Seoul, Korea) by the <sup>64</sup>Ni(p,n)<sup>64</sup>Cu nuclear reaction using an MC50 Cyclotron (Scanditronix, Sweden). All radio-TLC measurements were performed using a Bioscan 2000 imaging scanner (Bioscan, Washington, DC. USA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Conjugation of BFCs to c(RGDyK)</h3><div class="NLM_p">The BFCs used in the study had two different functional groups (−NCS or −COOH), and two different coupling reactions were employed to conjugate the chelators to c(RGDyK) peptide depending on the functionality. For the synthesis of TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), <i>N</i>,<i>N</i>-diisopropylethylamine (20 mmol) was added to a solution containing TE2A-Bn-NCS (10 μmol, 4.8 mg) and c(RGDyK) (10 μmol, 6.2 mg) in dimethylformamide (DMF; 1 mL), and the resulting mixture was stirred at room temperature for 16 h. A similar method was followed for the synthesis of NOTA-Bn-NCS-c(RGDyK) (<b>1</b>). Here NOTA-Bn-NCS (11 μmol, 5 mg) and c(RGDyK) (32 μmol, 10 mg) were used and the reaction was continued with <i>N</i>,<i>N</i>-diisopropylethylamine (40 mmol, 5 mg). Subsequently, the bioconjugates were purified by semipreparative HPLC. HPLC conditions for TE2A-Bn-NCS-c(RGDyK) (<b>2</b>) and NOTA-Bn-NCS-c(RGDyK) (<b>1</b>) were as follows. For TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), an Agilent preparative C18 column (5 μm, 21.2 mm × 100 mm) with the mobile phase (flow rate 3 mL/min) starting from 95% solvent A [0.1% TFA in water] and 5% solvent B [0.1% TFA in acetonitrile] [0–2 min] to 35% solvent A and 65% solvent B at 32 min was used. The peak containing the TE2A-Bn-NCS-c(RGDyK) (<b>2</b>) conjugate was collected at a retention time of 21.7 min, and it showed a retention time of 12.8 min through analytical HPLC (Vydac TP C18, 3 μm, 4.6 mm × 100 mm; flow rate 1 mL/min, the mobile phase consisting of 0.1% TFA/H<sub>2</sub>O (solvent A) and 0.1% TFA/acetonitrile (solvent B) with a gradient consisting of 1% B to 70% B in 20 min). For NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), a Waters μbondapak C18 column (10 μm, 7.8 mm × 300 mm) with the mobile phase (flow rate 3 mL/min) starting from 95% solvent A (0.1% TFA in water) and 5% solvent B (0.1% TFA in acetonitrile) (0–2 min) to 35% solvent A and 65% solvent B at 32 min was used. The peak containing NOTA-Bn-NCS-c(RGDyK) conjugate (<b>1</b>) was collected at a retention time of 17.5 min. All fractions containing the product were combined and lyophilized to provide the final product as a white powder (isolated yield 7.3% and 13% for TE2A-Bn-NCS-c(RGDyK) (<b>2</b>) and NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), respectively).</div><div class="NLM_p">For the conjugation of PCB-TE2A to c(RGDyK), a typical amide coupling reaction was applied. <i>N,N</i>′-Dicyclohexylcarbodiimides (10 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (20 mmol) were added to a solution of PCB-TE2A (20 μmol, 7.2 mg) and c(RGDyK) (10 μmol, 6.2 mg) in DMSO (1 mL), and the reaction was allowed to continue at room temperature for 16 h. Finally, the pure PCB-TE2A-c(RGDyK) (<b>5</b>) was isolated as a white solid by HPLC purification [Zorbax Agilent Prep-C18; 21.2 mm × 100 mm; mobile phase starting from 95% solvent A (0.1% TFA in water) and 5% solvent B (0.1% TFA in acetonitrile) (0–2 min) to 35% solvent A and 65% solvent B at 32 min; flow rate 3 mL/min], which was followed by lyophilization (9.4% yield). Analytical HPLC identified the retention time of PCB-TE2A-c(RGDyK) (<b>5</b>) to be 12.2 min (Vydac TP C18, 3 μm, 4.6 mm × 100 mm; flow rate 1 mL/min, with the mobile phase consisting of 0.1% TFA/H<sub>2</sub>O (solvent A) and 0.1% TFA/acetonitrile (solvent B) with a gradient consisting of 1% B to 70% B in 20 min). The other bioconjugates, ECB-TE2A-c(RGDyK) (<b>4</b>) and PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>), were prepared according to the published literature.<a onclick="showRef(event, 'ref20 ref26'); return false;" href="javascript:void(0);" class="ref ref20 ref26">(20, 26)</a></div><div class="NLM_p">The formation of all bioconjugates was confirmed by ESI-MS. For TE2A-Bn-NCS-c(RGDyK), the calculated and identified <i>m</i>/<i>z</i> values for C<sub>50</sub>H<sub>76</sub>N<sub>14</sub>O<sub>12</sub>S [M + H]<sup>+</sup> were 1097.56 and 1097.54, respectively (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S4">Figure S4</a>). For NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), the calculated and identified <i>m</i>/<i>z</i> values for C<sub>47</sub>H<sub>67</sub>N<sub>13</sub>O<sub>14</sub>S [M + H]<sup>+</sup> were 1070.47 and 1070.5, respectively (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S5">Figure S5</a>). For PCB-TE2A-c(RGDyK) (<b>5</b>), the calculated and identified <i>m</i>/<i>z</i> values for C<sub>44</sub>H<sub>71</sub>N<sub>13</sub>O<sub>11</sub> [M + H]<sup>+</sup> were 958.5 and 958.2, respectively (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S6">Figure S6</a>).</div><div class="NLM_p last">The chemical purities of the five isolated BFC-c(RGDyK) peptides were characterized by employing the second HPLC conditions. More than 95% chemical purity were obtained in all five peptide conjugates (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S9">Figure S9</a>).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Radiolabeling with <sup>64</sup>Cu</h3><div class="NLM_p">Two different strategies were used for the radiolabeling of BFCs-c(RGDyK). For noncross bridged macrocycles NOTA-Bn-NCS-c(RGDyK) (<b>1</b>) and TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), <sup>64</sup>CuCl<sub>2</sub> (18.5–148 MBq) in 100 μL of Milli-Q water (with no carrier added) was first mixed with 10 μg of BFCs-c(RGDyK) in 100 μL of Milli-Q water followed by incubation at 50 °C for 15 min using a ThermoMixer (800 rpm, Eppendorf). The radiolabeling progress was monitored by radio-TLC using Whatman MKC18F TLC plates developed with 10% NH<sub>4</sub>OAc/methanol (3:7). Under this condition, <sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>1</b>) and <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>) gave <i>R</i><sub>f</sub> values in the range of 0.9–1.0. For the cross bridged macrocycles, PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>), ECB-TE2A-c(RGDyK) (<b>4</b>), and PCB-TE2A-c(RGDyK) (<b>5</b>), the radiolabeling was performed in 0.1 M NH<sub>4</sub>OAc buffer (pH 8.0) with an elongated incubation time of 60 min at 80 °C. Cross-bridged macrocycles gave <i>R</i><sub>f</sub> values of 0.8–0.9 under the same TLC condition. The <sup>64</sup>Cu-labeled peptide was then purified by reverse-phase HPLC (RP-HPLC) using a Waters Grace smart RP C18 column (4.6 mm × 250 mm, 5 μm), with the mobile phase consisting of 0.1% TFA/H<sub>2</sub>O or pure H<sub>2</sub>O (solvent A, 0.1% TFA/H<sub>2</sub>O and H<sub>2</sub>O was used for cross-bridged and noncross-bridged macrocycles, respectively) and 0.1% TFA/acetonitrile or acetonitrile (solvent B, 0.1% TFA/acetonitrile and acetonitrile was used for cross-bridged and noncross-bridged macrocycles, respectively) and a gradient consisting of 1% B to 70% B in 20 min with a 1 mL/min flow rate. The radiotracers were collected in a fraction collector in 1–2 mL of HPLC eluent. The solvents were then evaporated at 37 °C, and the activity was reconstituted in saline or 10% DMSO/saline, followed by passage through a 0.22 μm Millipore filter into a sterile dose vial for use in animal experiments. The radiochemical purities of <sup>64</sup>Cu-labeled NOTA-Bn-NCS (<sup>64</sup>Cu-<b>1</b>), TE2A-Bn-NCS (<sup>64</sup>Cu-<b>2</b>), PCB-TE2A-Bn-NCS (<sup>64</sup>Cu-<b>3</b>), ECB-TE2A (<sup>64</sup>Cu-<b>4</b>), and PCB-TE2A (<sup>64</sup>Cu-<b>5</b>) bioconjugates after HPLC purification were 99%, 96%, 99%, 99%, and 95%, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A–C, Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figure S7">Figure S7</a>). The chemical purities for the same samples based on UV-HPLC chromatograms were 98.3%, 96.5%, 96.9%, 98.1%, and 97.7%, respectively.</div><div class="NLM_p last">Cold Cu(II)-BFCs-c(RGDyK) complexes were prepared by the reaction of BFCs-c(RGDyK) conjugates with 5 equiv CuCl<sub>2</sub> in 0.1 M NH<sub>4</sub>OAc (pH 8.0) buffer at 80 °C for 1 h and used as internal standard for HPLC characterization without further purification. HRMS (FAB) for Cu-ECB-TE2A-c(RGDyK) (Cu-<b>4</b>) calcd. for C<sub>43</sub>H<sub>68</sub>CuN<sub>13</sub>O<sub>11</sub> [M]<sup>+</sup> 1005.4457, found 1005.4460. HRMS (FAB) for Cu-PCB-TE2A-c(RGDyK) (Cu-<b>5</b>) calcd for C<sub>44</sub>H<sub>70</sub>CuN<sub>13</sub>O<sub>11</sub> [M]<sup>+</sup> 1019.4614, found 1019.4618.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro Serum Stability</h3><div class="NLM_p last">In vitro serum stability of all five radiotracers was performed by adding the <sup>64</sup>Cu bioconjugate (50 μL, 7.4–13 MBq) to fetal bovine serum (500 μL). The mixture was then incubated in a ThermoMixer (800 rpm) at 37 °C, and demetalation was analyzed by radio-TLC (10% NH<sub>4</sub>OAc:MeOH = 3:7) at 0, 4, and 24 h.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Plasma Protein Binding Assay</h3><div class="NLM_p last">Plasma was prepared by centrifuging (10000 rpm) blood (SD rat, male, 6 weeks) at 4 °C for 10 min just before the experiment. PD-10 columns (GE healthcare) were first preconditioned with 1 mL of 1% bovine serum albumin in 0.1 M DTPA, which was followed by repeated washing with saline (50 mL). <sup>64</sup>Cu-BFC-c(RGDyK) (0.55–0.75 MBq, 50 μL) was then incubated with plasma (1 mL) and PBS (1 mL) separately for 30 min at 37 °C. After the incubation, each sample was loaded on the preconditioned PD-10 column and eluted with saline; 30 fractions (500 μL each) were collected per sample in Eppendorf tubes. Radioactivity of each fraction was measured using a γ-counter (Perkin Elmer, Wellesley, USA), and a graph of radioactivity (CPM) vs saline volume (mL) was plotted.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Specific Activity Measurement</h3><div class="NLM_p last">The specific activities of all the <sup>64</sup>Cu bioconjugates were measured following previous reports.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Briefly, a calibration curve was first prepared by injecting various amounts (0–2 μg) of Cu-BFCs-c(RGDyK) into HPLC (λ<sub>max</sub> = 220 nm). Nonradioactive Cu complexes were prepared by incubating the BFCs-c(RGDyK) conjugates with excess CuCl<sub>2</sub> (10 mol equivalent) at 90 °C for 1 h. The pH of the reaction medium was maintained at 8 by adding NaOH solution (0.1 M). Subsequently, a known amount of activity of the purified <sup>64</sup>Cu-BFCs-c(RGDyK) (7.4–11.1 MBq) was injected into HPLC, and the peak area obtained in the UV chromatogram was used to calculate specific activity (GBq/μmol).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Determination of Partition Coefficient</h3><div class="NLM_p last">Log <i>D</i> values of all <sup>64</sup>Cu bioconjugates were determined by the octanol/PBS method. Briefly, 5 μL of the tracer (1.85 MBq) was added to a mixture of 1-octanol and phosphate buffered saline (pH 7.4) (1:1 v/v, 1 mL), and the resulting mixture was vortexed vigorously for 5 min at room temperature and centrifuged (10000 rpm, 5 min) thereafter to ensure complete separation of both layers. Next, a 100 μL aliquot was taken from each phase and counted separately using a γ-counter. The partition coefficient was calculated as the ratio of counts in 1-octanol to that in PBS. The Log <i>D</i><sub>7.4</sub> values were reported as an average of six measurements.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Integrin Receptor Binding Assay</h3><div class="NLM_p last">The cell-binding assay of the bioconjugates was performed using <sup>125</sup>I-echistatin on U87MG cells (2 × 10<sup>6</sup>/100 μL, resuspended in a binding buffer (20 mM tris, pH 7.4, 150 mM NaCl, 2 mM CaCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, and 0.1% bovine serum albumin), and IC<sub>50</sub> values were compared to that of c(RGDyK). For this assay, equal volumes of all nonradioactive ligands, NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>), ECB-TE2A-c(RGDyK) (<b>4</b>), and PCB-TE2A-c(RGDyK) (<b>5</b>), and radioactive <sup>125</sup>I-echistatin (3.7 kBq, PerkinElmer, Branford, USA) were used. Various concentrations (10<sup>–5</sup> to 10<sup>–14</sup> M) of the ligands were incubated at room temperature for 60 min, which was followed by the removal of the reaction medium. The cells were then washed with PBS (three times), harvested, and the bound <sup>125</sup>I-echistatin was counted in a γ-counter. Data were analyzed with GraphPad Prism 5 (GraphPad software, Inc., San Diego, USA) to calculate corresponding IC<sub>50</sub> values. Each experiment was conducted in triplicate.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo Stability Studies</h3><div class="NLM_p">In a typical experiment, approximately 37 MBq of radiolabeled conjugates was injected intravenously in SD rats (<i>n</i> = 2, male, 210–220 g). At 1 h postinjection, the animals were sacrificed and blood and organs of interest (liver and kidney) were collected. To determine the stability of the bioconjugates in blood, the blood sample was immediately centrifuged (13000 rpm for 10 min). Then, to the supernatant (200 μL), a solution mixture of acetonitrile/water/trifluoroacetic acid (50:45:5, 100 μL) was added. The mixture was then kept at 4 °C for 10 min and centrifuged again for 10 min at 13000 rpm. The supernatant was then filtered through a 0.22 μm filter and injected into HPLC (Grace smart RP C18 column, 5 μm, 4.6 mm × 250 mm). The eluent [0.1% TFA/H<sub>2</sub>O (solvent A) and 0.1% TFA/acetonitrile (solvent B), a gradient of 1% B to 70% B in 20 min at a flow rate of 1 mL/min] was collected with a fraction collector (1.0 min/fraction), and the radioactivity of each fraction was measured using a γ-counter. To determine the stability of <sup>64</sup>Cu bioconjugates in the liver and kidney, the collected organs were first homogenized, which was followed by the addition of PBS (5 mL) and vigorous vortexing for 5 min. The mixture was then centrifuged for 10 min (13000 rpm). To the supernatant (200 μL), 100 μL of a mixture of acetonitrile:water:trifluoroacetic acid (50:45:5) was added, which was followed by mixing and incubation at 4 °C for 10 min; samples were then centrifuged for 10 min at 13000 rpm. The supernatant was then filtered through a 0.22 μm filter, and the filtrate was injected to reverse-phase HPLC; the activities of collected fractions were measured with a γ-counter. The in vivo stability of <sup>64</sup>Cu-NOTA-Bn-NCS-RGD (<sup>64</sup>Cu-<b>1</b>), <sup>64</sup>Cu-TE2A-Bn-NCS-RGD (<sup>64</sup>Cu-<b>2</b>), and <sup>64</sup>Cu-PCB-TE2A-RGD (<sup>64</sup>Cu-<b>5</b>) were measured for the first time in the current manuscript, and the data were compared to that of <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-RGD (<sup>64</sup>Cu-<b>3</b>), and <sup>64</sup>Cu-ECB-TE2A-RGD (<sup>64</sup>Cu-<b>4</b>), which were reported by us previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">The activities found in the precipitate from blood, liver, and kidneys were less than 10%, and more than 90% of total tissue activities were used for the analysis.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Animal Models</h3><div class="NLM_p last">All the animal experiments were conducted in compliance with the guidelines set by the Institutional Animal Care and Use Committee requirements of Kyungpook National University. The procedures were reviewed and approved by the animal ethics committee of Kyungpook National University (approval no. 2016-0024). Specifically, 6-week old BALB/c female nude mice were used to prepare xenograft tumor models using U87MG cell lines. A total of 5 × 10<sup>6</sup> cells was inoculated subcutaneously into the right flank of the mice, and tumors of the appropriate size required approximately 15 days to develop.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Animal PET Imaging</h3><div class="NLM_p last">Small animal PET images were obtained using an Inveon PET-computed tomography (PET/CT) scanner (Siemens, Knoxville, USA). All radiolabeled tracers (18.5–22.2 MBq, 200 μL of 10% DMSO/saline) were injected via the tail vein into female nude mice bearing xenograft U87MG tumors on their right flank. At 1, 4, and 24 h postinjection, the mice were anesthetized with isoflurane (1–2% in oxygen), positioned prone, and imaged using a PET scanner. CT images were acquired successively immediately after PET imaging without adding any additional contrast agent. All images were reconstructed using the two-dimensional ordered-subsets expectation maximum (OSEM) algorithm. Regions of interest (ROIs) were manually drawn around the perimeters of the organs over 5–7 consecutive slices on transverse PET images entirely covering the most intense areas of <sup>64</sup>Cu-labeled BFC-c(RGDyK) uptake in the tumor, liver, kidney, and muscle while avoiding nearby tissues. Activity counts in the ROIs were calculated as the percentage of the injected dose per gram (%ID/g), and no corrections for attenuation were necessary. Because the location of ROIs on the PET images could not be accurately defined, we used the corresponding transverse CT images as a reference. The PET and CT volumes were manually coregistered for each of the scans (Inveon Research Workplace 4.0).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Biodistribution Study</h3><div class="NLM_p last">Under anesthesia using 1–2% isoflurane in O<sub>2</sub>, tumor-bearing female BALB/c nude mice (<i>n</i> = 3 per group) were subjected to intravenous injection of the purified <sup>64</sup>Cu bioconjugates (0.74 MBq, 200 μL of saline) via tail vein. The animals were sacrificed at 1, 4, and 24 h postinjection and tissues of interest were explanted, weighted, and counted using a γ-counter. Uptake in each tissue was expressed as percent of injected dose per gram (%ID/g) and was calculated by comparing the samples with a standard solution derived from the injected solution. For the blocking study, nonradioactive c(RGDyK) was coinjected (5 mg/kg) with <sup>64</sup>Cu-labeled tracers in tumor models and biodistribution was conducted 1 h postinjection.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01671">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01671" class="ext-link">10.1021/acs.jmedchem.7b01671</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Serum stability studies of <sup>64</sup>Cu-BFCs-c(RGDyK), plasma protein binding studies of <sup>64</sup>Cu-BFCs-c(RGDyK), in vivo stability studies of <sup>64</sup>Cu-BFCs-c(RGDyK), mass spectra of BFCs-c(RGDyK) conjugates, UV HPLC profiles of BFCs-c(RGDyK) conjugates, UV/radio-HPLC chromatogram of <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK), and <sup>64</sup>Cu-ECB-TE2A-c(RGDyK), mass spectra of Cu-ECB-TE2A-c(RGDyK) and Cu-PCB-TE2A-c(RGDyK) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_001.pdf">jm7b01671_si_001.pdf (2.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_002.csv">jm7b01671_si_002.csv (2.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01671" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeongsoo Yoo</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0752-5745" title="Orcid link">http://orcid.org/0000-0002-0752-5745</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e39a8c8c89a3888d96cd8280cd8891"><span class="__cf_email__" data-cfemail="38415757527853564d16595b16534a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swarbhanu Sarkar</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikunj Bhatt</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yeong Su Ha</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuong Tu Huynh</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nisarg Soni</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Woonghee Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Jin Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of RI-Convergence Research, Korea Institute
of Radiological and Medical Sciences, Seoul 139-706, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jung Young Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of RI-Convergence Research, Korea Institute
of Radiological and Medical Sciences, Seoul 139-706, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darpan N. Pandya</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gwang Il An</span> - <span class="hlFld-Affiliation affiliation">Department
of RI-Convergence Research, Korea Institute
of Radiological and Medical Sciences, Seoul 139-706, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyo Chul Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of RI-Convergence Research, Korea Institute
of Radiological and Medical Sciences, Seoul 139-706, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongmin Chang</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu 41944, South
Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0585-8714" title="Orcid link">http://orcid.org/0000-0002-0585-8714</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.S., N.B., and Y.S.H. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d125e2639-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by an R&D program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (nos. 2016R1A2B4011546, 2013R1A4A1069507, 2017M2C2A1014006, 2017M2A2A6A02018506, and 2016H1D3A1907667) and supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI17C0221). Cu-64 production was supported by RI research program in KIRAMS.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">BFCs</td><td class="NLM_def"><p class="first last">bifunctional chelators</p></td></tr><tr><td class="NLM_term">RGD</td><td class="NLM_def"><p class="first last">arginylglycylaspartic acid</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron-emission tomography</p></td></tr><tr><td class="NLM_term">ATSM</td><td class="NLM_def"><p class="first last">diacetyl-bis(<i>N</i>4-methylthiosemicarbazone)</p></td></tr><tr><td class="NLM_term">PTSM</td><td class="NLM_def"><p class="first last">pyruvaldehyde bis(<i>N</i>4-methylthiosemicarbazone)</p></td></tr><tr><td class="NLM_term">DOTA</td><td class="NLM_def"><p class="first last">1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</p></td></tr><tr><td class="NLM_term">ECB-TE2A</td><td class="NLM_def"><p class="first last">ethylene cross-bridged 1,8-<i>N</i>,<i>N</i>′-bis(carboxymethyl)-1,4,8,11-tetraazacyclotetradecane</p></td></tr><tr><td class="NLM_term">PCB-TE2A</td><td class="NLM_def"><p class="first last">propylene cross-bridged 1,8-<i>N</i>,<i>N</i>′-bis(carboxymethyl)-1,4,8,11-tetraazacyclotetradecane</p></td></tr><tr><td class="NLM_term">TETA</td><td class="NLM_def"><p class="first last">1,4,8,11-tetraazacyclotetradecane-<i>N</i>,<i>N</i>′,<i>N</i>″,<i>N</i>‴-tetraacetic acid</p></td></tr><tr><td class="NLM_term">DTPA</td><td class="NLM_def"><p class="first last">diethylenetriaminepentaacetic acid</p></td></tr><tr><td class="NLM_term">PCB-TE2A-Bn-NCS</td><td class="NLM_def"><p class="first last">4,11-<i>N</i>,<i>N</i>′-bis(carboxymethyl)-16-(4-isothiocyanatobenzyl)-1,4,8,11-tetraazabicyclo[6.6.3]heptadecane</p></td></tr><tr><td class="NLM_term">TE2A-Bn-NCS</td><td class="NLM_def"><p class="first last">1,8-<i>N</i>,<i>N</i>′-bis(carboxymethyl)-4-<i>N</i>″-(4′-isothiocyanatophenethyl)-1,4,8,11-tetraazacyclotetradecane</p></td></tr><tr><td class="NLM_term">NOTA</td><td class="NLM_def"><p class="first last">1,4,7-triazacyclododecane-<i>N</i>,<i>N</i>′,<i>N</i>″-triacetic acid)</p></td></tr><tr><td class="NLM_term">NOTA-Bn-NCS</td><td class="NLM_def"><p class="first last">2-<i>S</i>-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">FAB</td><td class="NLM_def"><p class="first last">fast atom bombardment</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dicyclohexylcarbodiimides</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">inhibitory concentrations</p></td></tr><tr><td class="NLM_term">SD rat</td><td class="NLM_def"><p class="first last">Sprague–Dawley rat</p></td></tr><tr><td class="NLM_term">MIP</td><td class="NLM_def"><p class="first last">maximum intensity projection</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">rpm</td><td class="NLM_def"><p class="first last">revolutions per minute</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">%ID/g</td><td class="NLM_def"><p class="first last">percent injected dose per gram</p></td></tr><tr><td class="NLM_term">CPM</td><td class="NLM_def"><p class="first last">counts per minute</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">ROI</td><td class="NLM_def"><p class="first last">region of interest</p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Blower, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweit, J.</span><span> </span><span class="NLM_article-title">Copper radionuclides and radiopharmaceuticals in nuclear medicine</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1016/S0969-8051(96)00130-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2FS0969-8051%2896%2900130-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=9004284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADyaK2sXkslOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=957-980&author=P.+J.+Blowerauthor=J.+S.+Lewisauthor=J.+Zweit&title=Copper+radionuclides+and+radiopharmaceuticals+in+nuclear+medicine&doi=10.1016%2FS0969-8051%2896%2900130-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Copper radionuclides and radiopharmaceuticals in nuclear medicine</span></div><div class="casAuthors">Blower, Philip J.; Lewis, Jason S.; Zweit, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">957-980</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The chem., radiochem., radiobiol., and radiopharmacol. of radiopharmaceuticals contg. copper radionuclides are reviewed, with 210 refs.  Copper radionuclides offer application in positron emission tomog., targeted radiotherapy, and single photon imaging.  The chem. of copper is relatively simple and well-suited to radiopharmaceutical application.  Current radiopharmaceuticals include biomols. labeled via bifunctional chelators primarily based on cyclic polyaminocarboxylates and polyamines, and pyruvaldehyde-bis(N4-methylthiosemicarbazone) (PTSM) and its analogs.  The chem. of copper, of which only a fraction has yet been exploited, is likely to be applied more fully in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjGxleCOHP3LVg90H21EOLACvtfcHk0lgJY1RQl6Y0ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslOqsQ%253D%253D&md5=39b9b14d56995b81d7c57f35e2fcdd82</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2896%2900130-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252896%252900130-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DZweit%26aufirst%3DJ.%26atitle%3DCopper%2520radionuclides%2520and%2520radiopharmaceuticals%2520in%2520nuclear%2520medicine%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D957%26epage%3D980%26doi%3D10.1016%2FS0969-8051%2896%2900130-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Donnelly, P. S.</span><span> </span><span class="NLM_article-title">The role of coordination chemistry in the development of target-specific radiopharmaceuticals</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1039/c0dt01075h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fc0dt01075h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=999-1010&author=P.+S.+Donnelly&title=The+role+of+coordination+chemistry+in+the+development+of+target-specific+radiopharmaceuticals&doi=10.1039%2Fc0dt01075h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2Fc0dt01075h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt01075h%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26atitle%3DThe%2520role%2520of%2520coordination%2520chemistry%2520in%2520the%2520development%2520of%2520target-specific%2520radiopharmaceuticals%26jtitle%3DDalton%2520Trans.%26date%3D2011%26volume%3D40%26spage%3D999%26epage%3D1010%26doi%3D10.1039%2Fc0dt01075h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaehle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margenau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapi, S. E.</span><span> </span><span class="NLM_article-title">A semi-automated system for the routine production of copper-64</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1803</span><span class="NLM_x">–</span> <span class="NLM_lpage">1806</span><span class="refDoi"> DOI: 10.1016/j.apradiso.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.apradiso.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=22516717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2012&pages=1803-1806&author=M.+Kumeauthor=P.+C.+Careyauthor=G.+Gaehleauthor=E.+Madridauthor=T.+Vollerauthor=W.+Margenauauthor=M.+J.+Welchauthor=S.+E.+Lapi&title=A+semi-automated+system+for+the+routine+production+of+copper-64&doi=10.1016%2Fj.apradiso.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A semi-automated system for the routine production of copper-64</span></div><div class="casAuthors">Kume, Maiko; Carey, Paul C.; Gaehle, Gregory; Madrid, Evelyn; Voller, Thomas; Margenau, William; Welch, Michael J.; Lapi, Suzanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An automated system for the prodn. of high specific activity 64Cu via the irradn. of electroplated enriched 64Ni targets has been developed.  We have been operating this system continually on a biweekly or weekly basis for more than two years.  Since the inception of this automated prodn. system, (Oct. 1, 2008), we have had 145 productions, produced 53562 mCi and shipped out 25629 mCi of this isotope to external users.  We routinely produce over 400 mCi of this isotope per batch with a specific activity of 14,000±7600 mCi/μmol for distribution to some 12-15 centers each prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7wqLT8eVV7Vg90H21EOLACvtfcHk0liHfQEi1_VPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslymsL4%253D&md5=b2b7d18dd7b98a6f969cd1779619bfc7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DKume%26aufirst%3DM.%26aulast%3DCarey%26aufirst%3DP.%2BC.%26aulast%3DGaehle%26aufirst%3DG.%26aulast%3DMadrid%26aufirst%3DE.%26aulast%3DVoller%26aufirst%3DT.%26aulast%3DMargenau%26aufirst%3DW.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DLapi%26aufirst%3DS.%2BE.%26atitle%3DA%2520semi-automated%2520system%2520for%2520the%2520routine%2520production%2520of%2520copper-64%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2012%26volume%3D70%26spage%3D1803%26epage%3D1806%26doi%3D10.1016%2Fj.apradiso.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Shokeen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET)</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span><span class="refDoi"> DOI: 10.1021/ar800255q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar800255q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=832-841&author=M.+Shokeenauthor=C.+J.+Anderson&title=Molecular+imaging+of+cancer+with+copper-64+radiopharmaceuticals+and+positron+emission+tomography+%28PET%29&doi=10.1021%2Far800255q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)</span></div><div class="casAuthors">Shokeen, Monica; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">832-841</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mol. imaging has evolved over the past several years into an important tool for diagnosing, understanding, and monitoring disease.  Mol. imaging has distinguished itself as an interdisciplinary field, with contributions from chem., biol., physics, and medicine.  The cross-disciplinary impetus has led to significant achievements, such as the development of more sensitive imaging instruments and robust, safer radiopharmaceuticals, thereby providing more choices to fit personalized medical needs.  Mol. imaging is making steadfast progress in the field of cancer research among others.  Cancer is a challenging disease, characterized by heterogeneity, uncontrolled cell division, and the ability of cancer cells to invade other tissues.  Researchers are addressing these challenges by aggressively identifying and studying key cancer-specific biomarkers such as growth factor receptors, protein kinases, cell adhesion mols., and proteases, as well as cancer-related biol. processes such as hypoxia, apoptosis, and angiogenesis.  Positron emission tomog. (PET) is widely used by clinicians in the United States as a diagnostic mol. imaging tool.  Small-animal PET systems that can image rodents and generate reconstructed images in a noninvasive manner (with a resoln. as low as 1 mm) have been developed and are used frequently, facilitating radiopharmaceutical development and drug discovery.  Currently, [18F]-labeled 2-fluorodeoxyglucose (FDG) is the only PET radiotracer used for routine clin. evaluation (primarily for oncol. imaging).  There is now increasing interest in nontraditional positron-emitting radionuclides, particularly those of the transition metals, for imaging with PET because of increased prodn. and availability.  Copper-based radionuclides are currently being extensively evaluated because they offer a varying range of half-lives and positron energies.  For example, the half-life (12.7 h) and decay properties (β+, 0.653 MeV, 17.8%; β-, 0.579 MeV, 38.4 %; the remainder is electron capture) of 64Cu make it an ideal radioisotope for PET imaging and radiotherapy.  In addn., the well-established coordination chem. of copper allows for its reaction with a wide variety of chelator systems that can potentially be linked to antibodies, proteins, peptides, and other biol. relevant mols.  New chelators with greater in vivo stability, such as the cross-bridged (CB) versions of tetraazamacrocyclic 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), are now available.  Finally, one of the major aspects of successful imaging is the identification and characterization of a relevant disease biomarker at the cellular and subcellular level and the ensuing development of a highly specific targeting moiety.  In this Account, we discuss specific examples of PET imaging with new and improved 64Cu-based radiopharmaceuticals, highlighting the study of some of the key cancer biomarkers, such as epidermal growth-factor receptor (EGFR), somatostatin receptors (SSRs), and integrin αvβ3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSr7XcICUmKbVg90H21EOLACvtfcHk0liHfQEi1_VPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmu7w%253D&md5=3cff4a2250ef2d284b06301c4abfe93f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Far800255q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800255q%26sid%3Dliteratum%253Aachs%26aulast%3DShokeen%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DMolecular%2520imaging%2520of%2520cancer%2520with%2520copper-64%2520radiopharmaceuticals%2520and%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26spage%3D832%26epage%3D841%26doi%3D10.1021%2Far800255q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferdani, R.</span><span> </span><span class="NLM_article-title">Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research</span> <span class="citation_source-journal">Cancer Biother.Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1089/cbr.2009.0674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1089%2Fcbr.2009.0674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19694573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGjurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=379-393&author=C.+J.+Andersonauthor=R.+Ferdani&title=Copper-64+radiopharmaceuticals+for+PET+imaging+of+cancer%3A+advances+in+preclinical+and+clinical+research&doi=10.1089%2Fcbr.2009.0674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research</span></div><div class="casAuthors">Anderson, Carolyn J.; Ferdani, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Copper-64 (T1/2 = 12.7 h; β+, 0.653 MeV [17.8 %]; β-, 0.579 MeV [38.4 %]) has decay characteristics that allow for positron emission tomog. (PET) imaging and targeted radiotherapy of cancer.  The well-established coordination chem. of copper allows for its reaction with a wide variety of chelator systems that can potentially be linked to peptides and other biol. relevant small mols., antibodies, proteins, and nanoparticles.  The 12.7-h half-life of 64Cu provides the flexibility to image both smaller mols. and larger, slower clearing proteins and nanoparticles.  In a practical sense, the radionuclide or the 64Cu-radiopharmaceuticals can be easily shipped for PET imaging studies at sites remote to the prodn. facility.  Due to the versatility of 64Cu, there has been an abundance of novel research in this area over the past 20 years, primarily in the area of PET imaging, but also for the targeted radiotherapy of cancer.  The biol. activity of the hypoxia imaging agent, 60/64Cu-ATSM, has been described in great detail in animal models and in clin. PET studies.  An investigational new drug application for 64Cu-ATSM was recently approved by the U.S.  Food and Drug Administration (FDA) in the United States, paving the way for a multicenter trial to validate the utility of this agent, with the hopeful result being FDA approval for routine clin. use.  This article discusses state-of-the-art cancer imaging with 64Cu radiopharmaceuticals, including 64Cu-ATSM for imaging hypoxia, 64Cu-labeled peptides for tumor-receptor targeting, 64Cu-labeled monoclonal antibodies for targeting tumor antigens, and 64Cu-labeled nanoparticles for cancer targeting.  The emphasis of this article will be on the new scientific discoveries involving 64Cu radiopharmaceuticals, as well as the translation of these into human studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ivKbROZRnLVg90H21EOLACvtfcHk0liHfQEi1_VPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGjurfJ&md5=05c77aece1da552fb15ea19e2385a5cc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2009.0674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2009.0674%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DFerdani%26aufirst%3DR.%26atitle%3DCopper-64%2520radiopharmaceuticals%2520for%2520PET%2520imaging%2520of%2520cancer%253A%2520advances%2520in%2520preclinical%2520and%2520clinical%2520research%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2009%26volume%3D24%26spage%3D379%26epage%3D393%26doi%3D10.1089%2Fcbr.2009.0674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Novak-Hofer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Copper-67 as a therapeutic nuclide for radioimmunotherapy</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1007/s00259-001-0724-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1007%2Fs00259-001-0724-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=12029558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVWms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=821-830&author=I.+Novak-Hoferauthor=P.+A.+Schubiger&title=Copper-67+as+a+therapeutic+nuclide+for+radioimmunotherapy&doi=10.1007%2Fs00259-001-0724-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-67 as a therapeutic nuclide for radioimmunotherapy</span></div><div class="casAuthors">Novak-Hofer, Ilse; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-830</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The application of the beta particle-emitting nuclide 67Cu in radioimmunotherapy is reviewed.  The prodn. of the nuclide is outlined, and different prodn. modes are discussed with an emphasis on cyclotron prodn.  A short survey of copper chelators currently used for antibody labeling and their impact on the pharmacokinetics of 67Cu-labeled immunoconjugates is provided.  Protocols for antibody labeling with 67Cu as well as quality control procedures for 67Cu-labeled antibodies are described.  Preclin. data on the biol. properties of 67Cu-labeled immunoconjugates are reported and discussed.  67Cu-labeled antibodies show higher and more persistent tumor uptake than their radioiodinated counterparts due to accumulation of labeled metabolites in tumor cells.  Biodistribution of 67Cu-labeled antibody fragments has been improved by selection of neg. charged chelators and peptide linkers.  Pharmacokinetic anal. of the accumulated dose in tumor and crit. organs such as the kidney and liver indicates that, despite this improvement, intact 67Cu-labeled antibodies achieve higher tumor uptake and better therapeutic ratios than 67Cu-labeled antibody fragments and that they are at present the logical choice for clin. studies.  Clin. studies using 67Cu-labeled antibodies in lymphoma, colon carcinoma and bladder cancer patients are reviewed.  Some of the advantages over radioiodinated antibodies found in the preclin. work, such as higher tumor uptake and better tumor/blood ratios, have also been found with systemic application in lymphoma and colon carcinoma.  However, in both lymphoma and colon carcinoma patients, the radiation dose to the liver has been found to be higher from 67Cu- than from 131I-labeled antibodies.  The intravesical application of 67Cu-labeled antibody has been shown to be a promising approach for targetting cytotoxic radiation to superficial bladder tumors, without detectable systemic absorption.  Given the favorable properties of 67Cu-labeled antibodies, it is the reliable availability of the 67Cu nuclide which is the limiting factor for their more widespread evaluation in radioimmunotherapy trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowQ_R2l7eBsrVg90H21EOLACvtfcHk0lhBfvChDffTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVWms7k%253D&md5=ca43f817976afb92f37981c7aaef3c80</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00259-001-0724-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-001-0724-y%26sid%3Dliteratum%253Aachs%26aulast%3DNovak-Hofer%26aufirst%3DI.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DCopper-67%2520as%2520a%2520therapeutic%2520nuclide%2520for%2520radioimmunotherapy%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26spage%3D821%26epage%3D830%26doi%3D10.1007%2Fs00259-001-0724-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigsby, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Assessing tumor hypoxia in cervical cancer by positron emission tomography with <sup>60</sup>Cu-ATSM: relationship to therapeutic response-a preliminary report</span> <span class="citation_source-journal">Int. J. Radiat. Oncol., Biol., Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span><span class="refDoi"> DOI: 10.1016/S0360-3016(02)04477-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2FS0360-3016%2802%2904477-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=12654432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BD3s7jvFOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1233-1238&author=F.+Dehdashtiauthor=P.+W.+Grigsbyauthor=M.+A.+Mintunauthor=J.+S.+Lewisauthor=B.+A.+Siegelauthor=M.+J.+Welch&title=Assessing+tumor+hypoxia+in+cervical+cancer+by+positron+emission+tomography+with+60Cu-ATSM%3A+relationship+to+therapeutic+response-a+preliminary+report&doi=10.1016%2FS0360-3016%2802%2904477-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report</span></div><div class="casAuthors">Dehdashti Farrokh; Grigsby Perry W; Mintun Mark A; Lewis Jason S; Siegel Barry A; Welch Michael J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1233-8</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Tumor hypoxia is associated with poor response to therapy.  We have investigated whether pretreatment tumor hypoxia assessed by positron emission tomography (PET) with Cu-60 diacetyl-bis(N(4)-methylthiosemicarbazone) ((60)Cu-ATSM) predicts responsiveness to subsequent therapy in cervical cancer.  METHODS AND MATERIALS:  Fourteen patients with biopsy-proved cervical cancer were studied by PET with (60)Cu-ATSM before initiation of radiotherapy and chemotherapy. (60)Cu-ATSM uptake was evaluated semiquantitatively by determining the tumor-to-muscle activity ratio (T/M) and peak slope index of tumor tracer uptake.  All patients also underwent clinical PET with F-18 fluorodeoxyglucose (FDG) before institution of therapy.  The PET results were correlated with follow-up evaluation (14-24 months).  RESULTS:  Tumor uptake of (60)Cu-ATSM was inversely related to progression-free survival and overall survival (log-rank p = 0.0005 and p = 0.015, respectively).  An arbitrarily selected T/M threshold of 3.5 discriminated those likely to develop recurrence; 6 of 9 patients with normoxic tumors (T/M < 3.5) are free of disease at last follow-up, whereas all of 5 patients with hypoxic tumors (T/M > 3.5) have already developed recurrence.  Similar discrimination was achieved with the peak slope index.  The frequency of locoregional nodal metastasis was greater in hypoxic tumors (p = 0.03).  Tumor FDG uptake did not correlate with (60)Cu-ATSM uptake (r = 0.04; p = 0.80), and there was no significant difference in tumor FDG uptake between patients with hypoxic tumors and those with normoxic tumors.  CONCLUSION:  (60)Cu-ATSM-PET in patients with cervical cancer revealed clinically relevant information about tumor oxygenation that was predictive of tumor behavior and response to therapy in this small study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lBhgs5EX2BOk4JA3soTqfW6udTcc2ebq7LQFEv9efbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7jvFOqsQ%253D%253D&md5=af38a7d093673cad8c6703bcadb679d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2802%2904477-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252802%252904477-2%26sid%3Dliteratum%253Aachs%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DGrigsby%26aufirst%3DP.%2BW.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSiegel%26aufirst%3DB.%2BA.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DAssessing%2520tumor%2520hypoxia%2520in%2520cervical%2520cancer%2520by%2520positron%2520emission%2520tomography%2520with%252060Cu-ATSM%253A%2520relationship%2520to%2520therapeutic%2520response-a%2520preliminary%2520report%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2003%26volume%3D55%26spage%3D1233%26epage%3D1238%26doi%3D10.1016%2FS0360-3016%2802%2904477-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Colombie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frindel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraeber-Bodere, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, M.</span><span> </span><span class="NLM_article-title">Focus on the controversial aspects of <sup>64</sup>Cu-ATSM in tumoral hypoxia mapping by PET imaging</span> <span class="citation_source-journal">Front. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.3389/fmed.2015.00058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.3389%2Ffmed.2015.00058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BC283js1SntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=58&author=M.+Colombieauthor=S.+Gouardauthor=M.+Frindelauthor=A.+Vidalauthor=M.+Cherelauthor=C.+Rousseauauthor=F.+Kraeber-Bodereauthor=M.+Bourgeois&title=Focus+on+the+controversial+aspects+of+64Cu-ATSM+in+tumoral+hypoxia+mapping+by+PET+imaging&doi=10.3389%2Ffmed.2015.00058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging</span></div><div class="casAuthors">Colombie Mathilde; Gouard Sebastien; Frindel Mathieu; Vidal Aurelien; Cherel Michel; Rousseau Caroline; Kraeber-Bodere Francoise; Bourgeois Mickael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn">2296-858X</span>.
    </div><div class="casAbstract">Mapping tumor hypoxia is a great challenge in positron emission tomography (PET) imaging as the precise functional information of the biological processes is needed for many effective therapeutic strategies.  Tumor hypoxia has been widely reported as a poor prognostic indicator and is often associated with tumor aggressiveness, chemo- and radio-resistance.  An accurate diagnosis of hypoxia is a challenge and is crucial for providing accurate treatment for patients' survival benefits.  This challenge has led to the emergence of new and novel PET tracers for the functional and metabolic characterization of tumor hypoxia non-invasively.  Among these tracers, copper semicarbazone compound [64Cu]-diacetyl-bis(N (4)-methylthiosemicarbazone) (=64Cu-ATSM) has been developed as a tracer for hypoxia imaging.  This review focuses on 64Cu-ATSM PET imaging and the concept is presented in two sections.  The first section describes its in vitro development and pre-clinical testing and particularly its affinity in different cell lines.  The second section describes the controversial reports on its specificity for hypoxia imaging.  The review concludes that 64Cu-ATSM - more than a hypoxic tracer, exhibits tracer accumulation in tumor, which is linked to the redox potential and reactive oxygen species.  The authors concluded that 64Cu-ATSNM is a marker of over-reduced cell state and thus an indirect marker for hypoxia imaging.  The affinity of 64Cu-ATSM for over-reduced cells was observed to be a complex phenomenon.  And to provide a definitive and convincing mechanism, more in vivo studies are needed to prove the diagnostic utility of 64Cu-ATSM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdrHqiOVCAxbjnyZkbE8yXfW6udTcc2ebq7LQFEv9efbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283js1SntA%253D%253D&md5=5b5c86bc4b45450230b6d3f8df4d3b16</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffmed.2015.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmed.2015.00058%26sid%3Dliteratum%253Aachs%26aulast%3DColombie%26aufirst%3DM.%26aulast%3DGouard%26aufirst%3DS.%26aulast%3DFrindel%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DA.%26aulast%3DCherel%26aufirst%3DM.%26aulast%3DRousseau%26aufirst%3DC.%26aulast%3DKraeber-Bodere%26aufirst%3DF.%26aulast%3DBourgeois%26aufirst%3DM.%26atitle%3DFocus%2520on%2520the%2520controversial%2520aspects%2520of%252064Cu-ATSM%2520in%2520tumoral%2520hypoxia%2520mapping%2520by%2520PET%2520imaging%26jtitle%3DFront.%2520Med.%26date%3D2015%26volume%3D2%26spage%3D58%26doi%3D10.3389%2Ffmed.2015.00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozzo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abiraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamma, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">PET of somatostatin receptor-positive tumors using <sup>64</sup>Cu- and <sup>68</sup>Ga-somatostatin antagonists: the chelate makes the difference</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1118</span><span class="refDoi"> DOI: 10.2967/jnumed.111.087999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.111.087999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21680701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1110-1118&author=M.+Faniauthor=L.+Del+Pozzoauthor=K.+Abirajauthor=R.+Mansiauthor=M.+L.+Tammaauthor=R.+Cescatoauthor=B.+Waserauthor=W.+A.+Weberauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=PET+of+somatostatin+receptor-positive+tumors+using+64Cu-+and+68Ga-somatostatin+antagonists%3A+the+chelate+makes+the+difference&doi=10.2967%2Fjnumed.111.087999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference</span></div><div class="casAuthors">Fani, Melpomeni; Del Pozzo, Luigi; Abiraj, Keelara; Mansi, Rosalba; Tamma, Maria Luisa; Cescato, Renzo; Waser, Beatrice; Weber, Wolfgang A.; Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1110-1118</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Somatostatin-based radiolabeled peptides have been successfully introduced into the clinic for targeted imaging and radionuclide therapy of somatostatin receptor (sst)-pos. tumors, esp. of subtype 2 (sst2).  The clin. used peptides are exclusively agonists.  Recently, we showed that radiolabeled antagonists may be preferable to agonists because they showed better pharmacokinetics, including higher tumor uptake.  Factors detg. the performance of radioantagonists have only scarcely been studied.  Here, we report on the development and evaluation of four 64Cu or 68Ga radioantagonists for PET of sst2-pos. tumors.  Methods: The novel antagonist p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 (LM3) was coupled to 3 macrocyclic chelators, namely 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane (CB-TE2A), 1,4,7-triazacyclononane, 1-glutaric acid-4,7-acetic acid (NODAGA), and DOTA.  64/natCu- and 68/natGa-NODAGA-LM3 were prepd. at room temp., and 64/natCu-CB-TE2A-LM3 and 68/natGa-DOTA-LM3 were prepd. at 95°C.  Binding affinity and antagonistic properties were detd. with receptor autoradiog. and immunofluorescence microscopy using human embryonic kidney (HEK)-sst2 cells.  In vitro internalization and dissocn. was evaluated using the same cell line.  Biodistribution and small-animal PET studies were performed with HEK-sst2 xenografts.  Results: All metallopeptides demonstrated antagonistic properties.  The affinities depend on chelator and radiometal and vary about 10-fold; 68/natGa-NODAGA-LM3 has the lowest half maximal inhibitory concn. (1.3 ± 0.3 nmol/L).  The biodistribution studies show impressive tumor uptake at 1 h after injection, particularly of 64Cu- and 68Ga-NODAGA-LM3 (∼40 percentage injected dose per g of tissue [%ID/g]), which were proven to be specific.  Background clearance was fast and the tumor washout relatively slow for 64Cu-NODAGA-LM3 (∼15 %ID/g, 24 h after injection) and almost negligible for 64Cu-CB-TE2A-LM3 (26.9 ± 3.3 %ID/g and 21.6 ± 2.1 %ID/g, 4 and 24 h after injection, resp.).  Tumor-to-normal-tissue ratios were significantly higher for 64Cu-NODAGA-LM3 than for 64Cu-CB-TE2A-LM3 (tumor-to-kidney, 12.8 ± 3.6 and 1.7 ± 0.3, resp.; tumor-to-muscle, 1,342 ± 115 and 75.2 ± 8.5, resp., at 24 h, P < 0.001).  Small-animal PET shows clear tumor localization and high image contrast, esp. for 64Cu- and 68Ga-NODAGA-LM3.  Conclusion: This article demonstrates the strong dependence of the affinity and pharmacokinetics of the somatostatin-based radioantagonists on the chelator and radiometal.  64Cu- and 68Ga-NODAGA-LM3 and 64Cu-CB-TE2A-LM3 are promising candidates for clin. translation because of their favorable pharmacokinetics and the high image contrast on PET scans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3cE0MTdcebVg90H21EOLACvtfcHk0liMKhq_9IxpmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVKltro%253D&md5=3225eb0d38a7e33658a8a5168e914497</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.087999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.087999%26sid%3Dliteratum%253Aachs%26aulast%3DFani%26aufirst%3DM.%26aulast%3DDel%2BPozzo%26aufirst%3DL.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DPET%2520of%2520somatostatin%2520receptor-positive%2520tumors%2520using%252064Cu-%2520and%252068Ga-somatostatin%2520antagonists%253A%2520the%2520chelate%2520makes%2520the%2520difference%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1110%26epage%3D1118%26doi%3D10.2967%2Fjnumed.111.087999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cooper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunassee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blower, P. J.</span><span> </span><span class="NLM_article-title">Comparison of <sup>64</sup>Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span><span class="refDoi"> DOI: 10.1021/bc300037w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc300037w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVyqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1029-1039&author=M.+S.+Cooperauthor=M.+T.+Maauthor=K.+Sunasseeauthor=K.+P.+Shawauthor=J.+D.+Williamsauthor=R.+L.+Paulauthor=P.+S.+Donnellyauthor=P.+J.+Blower&title=Comparison+of+64Cu-complexing+bifunctional+chelators+for+radioimmunoconjugation%3A+labeling+efficiency%2C+specific+activity%2C+and+in+vitro%2Fin+vivo+stability&doi=10.1021%2Fbc300037w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability</span></div><div class="casAuthors">Cooper, Maggie S.; Ma, Michelle T.; Sunassee, Kavitha; Shaw, Karen P.; Williams, Jennifer D.; Paul, Rowena L.; Donnelly, Paul S.; Blower, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1029-1039</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High radiolabeling efficiency, preferably to high specific activity, and good stability of the radioimmunoconjugate are essential features for a successful immunoconjugate for imaging or therapy.  In this study, the radiolabeling efficiency, in vitro stability, and biodistribution of immunoconjugates with eight different bifunctional chelators labeled with 64Cu were compared.  The anti-CD20 antibody, rituximab, was conjugated to four macrocyclic bifunctional chelators (p-SCN-Bn-DOTA, p-SCN-Bn-Oxo-DO3A, p-SCN-NOTA, and p-SCN-PCTA), three DTPA derivs. (p-SCN-Bn-DTPA, p-SCN-CHX-A''-DTPA, and ITC-2B3M-DTPA), and a macrobicyclic hexamine (sarcophagine) chelator (sar-CO2H) = (1-NH2-8-NHCO(CH2)3CO2H)sar where sar = sarcophagine = 3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane.  Radiolabeling efficiency under various conditions, in vitro stability in serum at 37 °C, and in vivo biodistribution and imaging in normal mice over 48 h were studied.  All chelators except sar-CO2H were conjugated to rituximab by thiourea bond formation with an av. of 4.9 ± 0.9 chelators per antibody mol.  Sar-CO2H was conjugated to rituximab by amide bond formation with 0.5 chelators per antibody mol.  Efficiencies of 64Cu radiolabeling were dependent on the concn. of immunoconjugate.  Notably, the 64Cu-NOTA-rituximab conjugate demonstrated the highest radiochem. yield (95%) under very dil. conditions (31 nM NOTA-rituximab conjugate).  Similarly, sar-CO-rituximab, contg. 1/10th the no. of chelators per antibody compared to that of other conjugates, retained high labeling efficiency (98%) at an antibody concn. of 250 nM.  In contrast to the radioimmunoconjugates contg. DTPA derivs., which demonstrated poor serum stability, all macrocyclic radioimmunoconjugates were very stable in serum with <6% dissocn. of 64Cu over 48 h.  In vivo biodistribution profiles in normal female Balb/C mice were similar for all the macrocyclic radioimmunoconjugates with most of the activity remaining in the blood pool up to 48 h.  While all the macrocyclic bifunctional chelators are suitable for mol. imaging using 64Cu-labeled antibody conjugates, NOTA and sar-CO2H show significant advantages over the others in that they can be radiolabeled rapidly at room temp., under dil. conditions, resulting in high specific activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIRxZd_GKqI7Vg90H21EOLACvtfcHk0liMKhq_9IxpmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVyqurg%253D&md5=649071237104b7aaffb6d032acce51da</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbc300037w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc300037w%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DM.%2BT.%26aulast%3DSunassee%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DK.%2BP.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPaul%26aufirst%3DR.%2BL.%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26aulast%3DBlower%26aufirst%3DP.%2BJ.%26atitle%3DComparison%2520of%252064Cu-complexing%2520bifunctional%2520chelators%2520for%2520radioimmunoconjugation%253A%2520labeling%2520efficiency%252C%2520specific%2520activity%252C%2520and%2520in%2520vitro%252Fin%2520vivo%2520stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D1029%26epage%3D1039%26doi%3D10.1021%2Fbc300037w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bartholomä, M. D.</span><span> </span><span class="NLM_article-title">Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in positron emission tomography</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.ica.2012.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.ica.2012.01.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2012&pages=36-51&author=M.+D.+Bartholom%C3%A4&title=Recent+developments+in+the+design+of+bifunctional+chelators+for+metal-based+radiopharmaceuticals+used+in+positron+emission+tomography&doi=10.1016%2Fj.ica.2012.01.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2012.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2012.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DBartholom%25C3%25A4%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520bifunctional%2520chelators%2520for%2520metal-based%2520radiopharmaceuticals%2520used%2520in%2520positron%2520emission%2520tomography%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2012%26volume%3D389%26spage%3D36%26epage%3D51%26doi%3D10.1016%2Fj.ica.2012.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zeglis, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span> </span><span class="NLM_article-title">A practical guide to the construction of radiometallated bioconjugates for positron emission tomography</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">6168</span><span class="NLM_x">–</span> <span class="NLM_lpage">6195</span><span class="refDoi"> DOI: 10.1039/c0dt01595d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fc0dt01595d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21442098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvF2qtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=6168-6195&author=B.+M.+Zeglisauthor=J.+S.+Lewis&title=A+practical+guide+to+the+construction+of+radiometallated+bioconjugates+for+positron+emission+tomography&doi=10.1039%2Fc0dt01595d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A practical guide to the construction of radiometallated bioconjugates for positron emission tomography</span></div><div class="casAuthors">Zeglis, Brian M.; Lewis, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6168-6195</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) has become a vital imaging modality in the diagnosis and treatment of disease, most notably cancer.  A wide array of small mol. PET radiotracers have been developed that employ the short half-life radionuclides 11C, 13N, 15O, and 18F.  However, PET radiopharmaceuticals based on biomol. targeting vectors have been the subject of dramatically increased research in both the lab. and the clinic.  Typically based on antibodies, oligopeptides, or oligonucleotides, these tracers have longer biol. half-lives than their small mol. counterparts and thus require labeling with radionuclides with longer, complementary radioactive half-lives, such as the metallic isotopes 64Cu, 68Ga, 86Y, and 89Zr.  Each bioconjugate radiopharmaceutical has four component parts: biomol. vector, radiometal, chelator, and covalent link between chelator and biomol.  With the exception of the radiometal, a tremendous variety of choices exists for each of these pieces, and a plethora of different chelation, conjugation, and radiometallation strategies have been utilized to create agents ranging from 68Ga-labeled pentapeptides to 89Zr-labeled monoclonal antibodies.  Herein, the authors present a practical guide to the construction of radiometal-based PET bioconjugates, in which the design choices and synthetic details of a wide range of biomol. tracers from the literature are collected in a single ref.  In assembling this information, the authors hope both to illuminate the diverse methods employed in the synthesis of these agents and also to create a useful ref. for mol. imaging researchers both experienced and new to the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwQWOZx3f1_7Vg90H21EOLACvtfcHk0liMKhq_9IxpmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvF2qtbc%253D&md5=b8a2d89b48d24ca03115350dc37ff2e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1039%2Fc0dt01595d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt01595d%26sid%3Dliteratum%253Aachs%26aulast%3DZeglis%26aufirst%3DB.%2BM.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26atitle%3DA%2520practical%2520guide%2520to%2520the%2520construction%2520of%2520radiometallated%2520bioconjugates%2520for%2520positron%2520emission%2520tomography%26jtitle%3DDalton%2520Trans.%26date%3D2011%26volume%3D40%26spage%3D6168%26epage%3D6195%26doi%3D10.1039%2Fc0dt01595d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Liu, S.</span><span> </span><span class="NLM_article-title">Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delevery of metallic radionuclides</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.addr.2008.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1347-1370&author=S.+Liu&title=Bifunctional+coupling+agents+for+radiolabeling+of+biomolecules+and+target-specific+delevery+of+metallic+radionuclides&doi=10.1016%2Fj.addr.2008.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DBifunctional%2520coupling%2520agents%2520for%2520radiolabeling%2520of%2520biomolecules%2520and%2520target-specific%2520delevery%2520of%2520metallic%2520radionuclides%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1347%26epage%3D1370%26doi%3D10.1016%2Fj.addr.2008.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span> </span><span class="NLM_article-title">New Bifunctional chelator p-SCN-PhPr-NE3TA for copper-64: synthesis, peptidomimetic conjugation, radiolabeling, and evaluation for PET imaging</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6892</span><span class="NLM_x">–</span> <span class="NLM_lpage">6901</span><span class="refDoi"> DOI: 10.1021/acs.inorgchem.6b00395</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.6b00395" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6892-6901&author=Y.+Gaiauthor=L.+Sunauthor=W.+Huiauthor=Q.+Ouyangauthor=C.+J.+Andersonauthor=G.+Xiangauthor=X.+Maauthor=D.+Zeng&title=New+Bifunctional+chelator+p-SCN-PhPr-NE3TA+for+copper-64%3A+synthesis%2C+peptidomimetic+conjugation%2C+radiolabeling%2C+and+evaluation+for+PET+imaging&doi=10.1021%2Facs.inorgchem.6b00395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging</span></div><div class="casAuthors">Gai, Yongkang; Sun, Lingyi; Hui, Wenqi; Ouyang, Qin; Anderson, Carolyn J.; Xiang, Guangya; Ma, Xiang; Zeng, Dexing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6892-6901</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional chelators play an important role in developing metallic radionuclide-based radiopharmaceuticals.  In this study, a new bifunctional ligand, p-SCN-PhPr-NE3TA, was synthesized and conjugated to a very late antigen-4 targeting peptidomimetic, LLP2A, for evaluating its application in 64Cu-based positron emission tomog. (PET) imaging.  The new ligand exhibited strong selective coordination of Cu(II), leading to a robust Cu complex, even in the presence of 10-fold Fe(III).  The LLP2A conjugate of p-SCN-PhPr-NE3TA was prepd. and successfully labeled with 64Cu under mild conditions.  The conjugate 64Cu-NE3TA-PEG4-LLP2A showed significantly higher specific activity, compared with 64Cu-NOTA-PEG4-LLP2A, while maintaining comparable serum stability.  Subsequent biodistribution studies and PET imaging in mice bearing B16F10 xenografts confirmed its favorable in vivo performance and high tumor uptake with low background, rendering p-SCN-PhPr-NE3TA a promising bifunctional chelator for 64Cu-based radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGDhBmWZMe2bVg90H21EOLACvtfcHk0lhOyZ8usoy99w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrsr7I&md5=135aafec41d1f1ad93a2b45d50d3607f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.6b00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.6b00395%26sid%3Dliteratum%253Aachs%26aulast%3DGai%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHui%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DQ.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DXiang%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DNew%2520Bifunctional%2520chelator%2520p-SCN-PhPr-NE3TA%2520for%2520copper-64%253A%2520synthesis%252C%2520peptidomimetic%2520conjugation%252C%2520radiolabeling%252C%2520and%2520evaluation%2520for%2520PET%2520imaging%26jtitle%3DInorg.%2520Chem.%26date%3D2016%26volume%3D55%26spage%3D6892%26epage%3D6901%26doi%3D10.1021%2Facs.inorgchem.6b00395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pandya, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phapale, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Revival of TE2A; a better chelate for Cu(II) ions than TETA?</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3519</span><span class="refDoi"> DOI: 10.1039/b925703a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fb925703a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=3517-3519&author=D.+N.+Pandyaauthor=J.+Y.+Kimauthor=J.+C.+Parkauthor=H.+Leeauthor=P.+B.+Phapaleauthor=W.+Kwakauthor=T.+H.+Choiauthor=G.+J.+Cheonauthor=Y.-R.+Yoonauthor=J.+Yoo&title=Revival+of+TE2A%3B+a+better+chelate+for+Cu%28II%29+ions+than+TETA%3F&doi=10.1039%2Fb925703a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fb925703a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb925703a%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DD.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPhapale%26aufirst%3DP.%2BB.%26aulast%3DKwak%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DT.%2BH.%26aulast%3DCheon%26aufirst%3DG.%2BJ.%26aulast%3DYoon%26aufirst%3DY.-R.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DRevival%2520of%2520TE2A%253B%2520a%2520better%2520chelate%2520for%2520Cu%2528II%2529%2520ions%2520than%2520TETA%253F%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D3517%26epage%3D3519%26doi%3D10.1039%2Fb925703a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">8674</span><span class="NLM_x">–</span> <span class="NLM_lpage">8682</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1158%2F1078-0432.CCR-04-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=15623652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=8674-8682&author=J.+E.+Spragueauthor=Y.+Pengauthor=X.+Sunauthor=G.+R.+Weismanauthor=E.+H.+Wongauthor=S.+Achilefuauthor=C.+J.+Anderson&title=Preparation+and+biological+evaluation+of+copper-64-labeled+tyr3-octreotate+using+a+cross-bridged+macrocyclic+chelator&doi=10.1158%2F1078-0432.CCR-04-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and biological evaluation of copper-64-labeled Tyr3-octreotate using a cross-bridged macrocyclic chelator</span></div><div class="casAuthors">Sprague, Jennifer E.; Peng, Yijie; Sun, Xiankai; Weisman, Gary R.; Wong, Edward H.; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8674-8682</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatostatin receptors (SSTr) are expressed on many neuroendocrine tumors, and several radiotracers have been developed for imaging these types of tumors.  For this reason, peptide analogs of somatostatin have been well characterized.  Copper-64 (t1/2 = 12.7 h), a positron emitter suitable for positron emission tomog. (PET) imaging, was shown recently to have improved in vivo clearance properties when chelated by the cross-bridged tetraazamacrocycle 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo(6.6.2)hexadecane (CB-TE2A) compared with 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA).  CB-TE2A and TETA were conjugated to the somatostatin analog tyrosine-3-octreotate (Y3-TATE) for evaluation of CB-TE2A as a bifunctional chelator of 64Cu.  The in vitro affinity of each compd. for SSTr was detd. using a homologous competitive binding assay.  In vivo characteristics of both radiolabeled compds. were examd. in biodistribution and microPET studies of AR42J tumor-bearing rats.  Cu-CB-TE2A-Y3-TATE (Kd = 1.7 nmol/L) and Cu-TETA-Y3-TATE (Kd = 0.7 nmol/L) showed similar affinities for AR42J derived SSTr.  In biodistribution studies, nonspecific uptake in blood and liver was lower for 64Cu-CB-TE2A-Y3-TATE.  Differences increased with time such that, at 4 h, blood uptake was 4.3-fold higher and liver uptake was 2.4-fold higher for 64Cu-TETA-Y3-TATE than for 64Cu-CB-TE2A-Y3-TATE.  In addn., 4.4-times greater tumor uptake was detected with 64Cu-CB-TE2A-Y3-TATE than with 64Cu-TETA-Y3-TATE at 4 h postinjection.  MicroPET imaging yielded similar results.  CB-TE2A appears to be a superior in vivo bifunctional chelator of 64Cu for use in mol. imaging by PET or targeted radiotherapy due to both improved nontarget organ clearance and higher target organ uptake of 64Cu-CB-TE2A-Y3-TATE compared with 64Cu-TETA-Y3-TATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8F6EJwbpAbVg90H21EOLACvtfcHk0lhOyZ8usoy99w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsL7F&md5=645d85d633c7cc512392f9ec2c33d68d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1084%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%2520copper-64-labeled%2520tyr3-octreotate%2520using%2520a%2520cross-bridged%2520macrocyclic%2520chelator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D8674%26epage%3D8682%26doi%3D10.1158%2F1078-0432.CCR-04-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Singh, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakanali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramezani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span> </span><span class="NLM_article-title">Enantiopure bifunctional chelators for copper radiopharmaceuticals - does chirality matter in radiotracer design?</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.ejmech.2014.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=24793881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovValtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=308-315&author=A.+N.+Singhauthor=M.+Dakanaliauthor=G.+Haoauthor=S.+Ramezaniauthor=A.+Kumarauthor=X.+Sun&title=Enantiopure+bifunctional+chelators+for+copper+radiopharmaceuticals+-+does+chirality+matter+in+radiotracer+design%3F&doi=10.1016%2Fj.ejmech.2014.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiopure bifunctional chelators for copper radiopharmaceuticals - Does chirality matter in radiotracer design?</span></div><div class="casAuthors">Singh, Ajay N.; Dakanali, Marianna; Hao, Guiyang; Ramezani, Saleh; Kumar, Amit; Sun, Xiankai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">It is well recognized that carbon chirality plays a crit. role in the design of drug mols.  However, very little information is available regarding the effect of stereoisomerism of macrocyclic bifunctional chelators (BFC) on biol. behaviors of the corresponding radiopharmaceuticals.  To evaluate such effects, three enantiopure stereoisomers of a copper radiopharmaceutical BFC bearing two chiral carbon atoms were synthesized in forms of R,R-, S,S-, and R,S-.  Their corresponding peptide conjugates were prepd. by coupling with a model peptide sequence, c(RGDyK), which targets the αvβ3 integrin for in vitro and in vivo evaluation of their biol. behaviors as compared to the racemic conjugate.  Despite the chirality differences, all the conjugates showed a similar in vitro binding affinity profile to the αvβ3 integrin (106, 108, 85 and 100 nM for rac-H2-1, RR-H2-1, SS-H2-1, and RS-H2-1 resp. with all p values > 0.05) and a similar level of in vivo tumor uptake (2.72 ± 0.45, 2.60 ± 0.52, 2.45 ± 0.48 and 2.88 ± 0.59 for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 at 1 h p.i. resp.).  Furthermore, they demonstrated a nearly identical biodistribution pattern in major organs (e.g. 2.07 ± 0.21, 2.13 ± 0.58, 1.70 ± 0.20 and 1.90 ± 0.46 %ID/g at 24 h p.i. in liver for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 resp.; 1.80 ± 0.46, 2.30 ± 1.49, 1.73 ± 0.31 and 2.23 ± 0.71 at 24 h p.i. in kidneys for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 resp.).  Therefore we conclude that the chirality of BFC plays a negligible role in αvβ3-targeted copper radiopharmaceuticals.  However, we believe it is still worthwhile to consider the chirality effects of BFCs on other targeted imaging or therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7eBxXpReeKLVg90H21EOLACvtfcHk0liiEmRQMUA9PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovValtbg%253D&md5=2e522d5d36a4a954a7cc4dea4efa931f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%2BN.%26aulast%3DDakanali%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DRamezani%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DEnantiopure%2520bifunctional%2520chelators%2520for%2520copper%2520radiopharmaceuticals%2520-%2520does%2520chirality%2520matter%2520in%2520radiotracer%2520design%253F%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D308%26epage%3D315%26doi%3D10.1016%2Fj.ejmech.2014.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chong, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwamena, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milenic, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M. W.</span><span> </span><span class="NLM_article-title">Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1021/jm070401q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070401q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=118-125&author=H.-S.+Chongauthor=X.+Maauthor=T.+Leauthor=B.+Kwamenaauthor=D.+E.+Milenicauthor=E.+D.+Bradyauthor=H.+A.+Songauthor=M.+W.+Brechbiel&title=Rational+design+and+generation+of+a+bimodal+bifunctional+ligand+for+antibody-targeted+radiation+cancer+therapy&doi=10.1021%2Fjm070401q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm070401q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070401q%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DH.-S.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DKwamena%26aufirst%3DB.%26aulast%3DMilenic%26aufirst%3DD.%2BE.%26aulast%3DBrady%26aufirst%3DE.%2BD.%26aulast%3DSong%26aufirst%3DH.%2BA.%26aulast%3DBrechbiel%26aufirst%3DM.%2BW.%26atitle%3DRational%2520design%2520and%2520generation%2520of%2520a%2520bimodal%2520bifunctional%2520ligand%2520for%2520antibody-targeted%2520radiation%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D118%26epage%3D125%26doi%3D10.1021%2Fjm070401q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzei, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheingold, A. L.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">10561</span><span class="NLM_x">–</span> <span class="NLM_lpage">10572</span><span class="refDoi"> DOI: 10.1021/ja001295j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja001295j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlektb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=10561-10572&author=E.+H.+Wongauthor=G.+R.+Weismanauthor=D.+C.+Hillauthor=D.+P.+Reedauthor=M.+E.+Rogersauthor=J.+S.+Condonauthor=M.+A.+Faganauthor=J.+C.+Calabreseauthor=K.-C.+Lamauthor=I.+A.+Guzeiauthor=A.+L.+Rheingold&title=Synthesis+and+characterization+of+cross-bridged+cyclams+and+pendant-armed+derivatives+and+structural+studies+of+their+copper%28II%29+complexes&doi=10.1021%2Fja001295j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Cross-Bridged Cyclams and Pendant-Armed Derivatives and Structural Studies of Their Copper(II) Complexes</span></div><div class="casAuthors">Wong, Edward H.; Weisman, Gary R.; Hill, Daniel C.; Reed, David P.; Rogers, Mark E.; Condon, Jeffrey S.; Fagan, Maureen A.; Calabrese, Joseph C.; Lam, Kin-Chung; Guzei, Ilia A.; Rheingold, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10561-10572</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4,8,11-Tetraazabicyclo[6.6.2]hexadecane ligands, including the parent compd., N,N'-dialkyl variants, and the 1st N,N'-di-pendant-arm derivs. were synthesized by a short, efficient, and conceptually novel approach.  Their Cu(II) complexes were prepd., and four of these were structurally characterized by x-ray diffraction.  In all four complexes, the cross-bridged tetraamine ligand is cis-folded, coordinating the metal cation within its mol. cleft using all four N lone pairs.  Geometries intermediate between idealized square pyramidal and trigonal bipyramidal coordination were found for three of the complexes, whereas a distorted octahedral Cu coordination was found for the complex of a di-pendant-arm cross-bridged cyclam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn1D2clrDYp7Vg90H21EOLACvtfcHk0liiEmRQMUA9PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlektb8%253D&md5=775e07e05132769aa54f7d81ba6c83d5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja001295j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001295j%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BC.%26aulast%3DReed%26aufirst%3DD.%2BP.%26aulast%3DRogers%26aufirst%3DM.%2BE.%26aulast%3DCondon%26aufirst%3DJ.%2BS.%26aulast%3DFagan%26aufirst%3DM.%2BA.%26aulast%3DCalabrese%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DK.-C.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520cross-bridged%2520cyclams%2520and%2520pendant-armed%2520derivatives%2520and%2520structural%2520studies%2520of%2520their%2520copper%2528II%2529%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D10561%26epage%3D10572%26doi%3D10.1021%2Fja001295j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pandya, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Propylene cross-bridged macrocyclic bifunctional chelator: a new design for facile bioconjugation and robust <sup>64</sup>Cu complex stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7234</span><span class="NLM_x">–</span> <span class="NLM_lpage">7243</span><span class="refDoi"> DOI: 10.1021/jm500348z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500348z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlynurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7234-7243&author=D.+N.+Pandyaauthor=N.+Bhattauthor=G.+I.+Anauthor=Y.+S.+Haauthor=N.+Soniauthor=H.+Leeauthor=Y.+J.+Leeauthor=J.+Y.+Kimauthor=W.+Leeauthor=H.+Ahnauthor=J.+Yoo&title=Propylene+cross-bridged+macrocyclic+bifunctional+chelator%3A+a+new+design+for+facile+bioconjugation+and+robust+64Cu+complex+stability&doi=10.1021%2Fjm500348z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Propylene Cross-Bridged Macrocyclic Bifunctional Chelator: A New Design for Facile Bioconjugation and Robust 64Cu Complex Stability</span></div><div class="casAuthors">Pandya, Darpan N.; Bhatt, Nikunj; An, Gwang Il; Ha, Yeong Su; Soni, Nisarg; Lee, Hochun; Lee, Yong Jin; Kim, Jung Young; Lee, Woonghee; Ahn, Heesu; Yoo, Jeongsoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7234-7243</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first macrocyclic bifunctional chelator incorporating propylene cross-bridge was efficiently synthesized from cyclam in seven steps.  After the introduction of an extra functional group for facile conjugation onto the propylene cross-bridge, the two carboxylic acid pendants could contribute to strong coordination of Cu(II) ions, leading to a robust Cu complex.  The cyclic RGD peptide conjugate of PCB-TE2A-NCS was prepd. and successfully radiolabeled with 64Cu ion.  The radiolabeled peptide conjugate was evaluated in vivo through a biodistribution study and animal PET imaging to demonstrate high tumor uptake with low background.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3oPJ6cdJ1P7Vg90H21EOLACvtfcHk0liiEmRQMUA9PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlynurjF&md5=12cea84ece6de1385c445fdaa79d19d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm500348z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500348z%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DD.%2BN.%26aulast%3DBhatt%26aufirst%3DN.%26aulast%3DAn%26aufirst%3DG.%2BI.%26aulast%3DHa%26aufirst%3DY.%2BS.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DAhn%26aufirst%3DH.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DPropylene%2520cross-bridged%2520macrocyclic%2520bifunctional%2520chelator%253A%2520a%2520new%2520design%2520for%2520facile%2520bioconjugation%2520and%2520robust%252064Cu%2520complex%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7234%26epage%3D7243%26doi%3D10.1021%2Fjm500348z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boswell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of <sup>64</sup>Cu-TETA-1A3 with <sup>64</sup>Cu-BAT-2IT-1A3</span> <span class="citation_source-journal">Cancer Biother.Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1089/10849780152752083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1089%2F10849780152752083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=11789025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=483-494&author=M.+R.+Lewisauthor=C.+A.+Boswellauthor=R.+Laforestauthor=T.+L.+Buettnerauthor=D.+Yeauthor=J.+M.+Connettauthor=C.+J.+Anderson&title=Conjugation+of+monoclonal+antibodies+with+TETA+using+activated+esters%3A+biological+comparison+of+64Cu-TETA-1A3+with+64Cu-BAT-2IT-1A3&doi=10.1089%2F10849780152752083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of monoclonal antibodies with TETA using activated esters: Biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3</span></div><div class="casAuthors">Lewis, Michael R.; Boswell, C. Andrew; Laforest, Richard; Buettner, Thomas L.; Ye, Dan; Connett, Judith M.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-494</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A simple method for conjugation of monoclonal antibodies (mAbs) with the chelating agent 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), has been developed using com. available reagents.  This method involved activation of a single carboxyl group of TETA with N-hydroxysulfo-succinimide and 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide.  The resulting activated ester of TETA was reacted with the anti-colorectal carcinoma mAb 1A3 at molar ratios ranging from 10:1 to 100:1 to give immunoconjugates modified with an av. of 0.4 to 2.0 functional chelators per antibody mol.  The TETA-1A3 conjugate was labeled with 64Cu at specific activities as high as 15.4 μCi/μg, and the radiolabeled mAb exhibited high in vitro serum stability and minimal loss of immunoreactivity.  The biodistribution of 64Cu-labeled TETA-1A3 in hamsters bearing GW39 human colon carcinoma xenografts was compared to that of 64Cu-BAT-2IT-1A3 (BAT = 6-(p-bromoacetamidobenzyl)-1,4,8,11-tetraazacy- clotetradecane-1,4,8,11-tetraacetic acid; 2IT = 2-iminothiolane).  Both conjugates showed high tumor uptake (6.60-9.05% injected dose/g) from 24 to 48 h post-injection and generally similar blood clearance and non-target organ uptakes.  Human absorbed dose ests. derived from the hamster biodistribution data showed the crit. organs for both conjugates to be the large intenstine and the red marrow.  Our results suggest that the in vitro and in vivo performance characteristics of 64Cu-TETA-1A3 compare favorably with those of 64Cu-BAT-2IT-1A3 and that further evaluation of the diagnostic and therapeutic efficacy of 64Cu-TETA-1A3 is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrEeHOLjrJP7Vg90H21EOLACvtfcHk0ljxbi0SIscFjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFeguw%253D%253D&md5=09b5a01678a8d3d18d78eca55ce9cc9f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1089%2F10849780152752083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F10849780152752083%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DT.%2BL.%26aulast%3DYe%26aufirst%3DD.%26aulast%3DConnett%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DConjugation%2520of%2520monoclonal%2520antibodies%2520with%2520TETA%2520using%2520activated%2520esters%253A%2520biological%2520comparison%2520of%252064Cu-TETA-1A3%2520with%252064Cu-BAT-2IT-1A3%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2001%26volume%3D16%26spage%3D483%26epage%3D494%26doi%3D10.1089%2F10849780152752083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shively, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raubitschek, A.</span><span> </span><span class="NLM_article-title">An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1021/bc0000886</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc0000886" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=320-324&author=M.+R.+Lewisauthor=J.+Y.+Kaoauthor=A.+L.+Andersonauthor=J.+E.+Shivelyauthor=A.+Raubitschek&title=An+improved+method+for+conjugating+monoclonal+antibodies+with+N-hydroxysulfosuccinimidyl+DOTA&doi=10.1021%2Fbc0000886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for conjugating monoclonal antibodies with N-Hydroxysulfosuccinimidyl DOTA</span></div><div class="casAuthors">Lewis, Michael R.; Kao, Jim Y.; Anderson, Anne-Line J.; Shively, John E.; Raubitschek, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-324</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple, water-sol. procedure for conjugation of monoclonal antibodies to 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) has been improved by optimizing pH, buffer, and temp. conditions for the prepn. of N-hydroxysulfosuccinimidyl DOTA and its conjugation to the human/murine chimeric anti-carcinoembryonic antigen antibody cT84.66.  This improved method results in a 6-fold increase in conjugation efficiency, a 3-7-fold decrease in antibody crosslinking, a more homogeneous population of conjugate species, and a 5-fold decrease in the quantities of reagents needed for conjugation.  The cT84.66-DOTA conjugate was labeled to high specific activity with 111In, 90Y, 88Y, 64Cu, and 67Cu, affording near-quant. incorporation of the majority of these radiometals.  This improved conjugation procedure facilitates large-scale prodn. and radiometal labeling of cT84.66-DOTA for clin. radioimmunotherapy trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlh2xDQwZWrVg90H21EOLACvtfcHk0ljxbi0SIscFjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsrk%253D&md5=eb05ee3c229d397826dabdb3089c6e9b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbc0000886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0000886%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DKao%26aufirst%3DJ.%2BY.%26aulast%3DAnderson%26aufirst%3DA.%2BL.%26aulast%3DShively%26aufirst%3DJ.%2BE.%26aulast%3DRaubitschek%26aufirst%3DA.%26atitle%3DAn%2520improved%2520method%2520for%2520conjugating%2520monoclonal%2520antibodies%2520with%2520N-hydroxysulfosuccinimidyl%2520DOTA%26jtitle%3DBioconjugate%2520Chem.%26date%3D2001%26volume%3D12%26spage%3D320%26epage%3D324%26doi%3D10.1021%2Fbc0000886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Litau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibold, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vall-Sagarra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span> </span><span class="NLM_article-title">Comparative assessment of complex stabilities of radiocopper chelating agents by a combination of complex challenge and in vivo experiments</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1002/cmdc.201500132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1002%2Fcmdc.201500132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1200-1208&author=S.+Litauauthor=U.+Seiboldauthor=A.+Vall-Sagarraauthor=G.+Frickerauthor=B.+W%C3%A4nglerauthor=C.+W%C3%A4ngler&title=Comparative+assessment+of+complex+stabilities+of+radiocopper+chelating+agents+by+a+combination+of+complex+challenge+and+in+vivo+experiments&doi=10.1002%2Fcmdc.201500132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500132%26sid%3Dliteratum%253Aachs%26aulast%3DLitau%26aufirst%3DS.%26aulast%3DSeibold%26aufirst%3DU.%26aulast%3DVall-Sagarra%26aufirst%3DA.%26aulast%3DFricker%26aufirst%3DG.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26atitle%3DComparative%2520assessment%2520of%2520complex%2520stabilities%2520of%2520radiocopper%2520chelating%2520agents%2520by%2520a%2520combination%2520of%2520complex%2520challenge%2520and%2520in%2520vivo%2520experiments%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1200%26epage%3D1208%26doi%3D10.1002%2Fcmdc.201500132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Small-animal PET of tumors with <sup>64</sup>Cu-labeled RGD-bombesin heterodimer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.2967/jnumed.108.061739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.108.061739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19525469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2gsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1168-1177&author=Z.+Liuauthor=Z.-B.+Liauthor=Q.+Caoauthor=S.+Liuauthor=F.+Wangauthor=X.+Chen&title=Small-animal+PET+of+tumors+with+64Cu-labeled+RGD-bombesin+heterodimer&doi=10.2967%2Fjnumed.108.061739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-animal PET of tumors with 64Cu-labeled RGD-bombesin heterodimer</span></div><div class="casAuthors">Liu, Zhaofei; Li, Zi-Bo; Cao, Qizhen; Liu, Shuanglong; Wang, Fan; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1168-1177</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The overexpression of gastrin-releasing peptide receptor (GRPR) in various tumor types suggests that GRPR is an attractive target for cancer imaging and therapy with radiolabeled bombesin analogs.  We recently reported the ability of 18F-labeled RGD-bombesin heterodimer to be used for dual integrin αvβ3- and GRPR-targeted imaging.  To further investigate the synergistic effect of the dual-receptor targeting of peptide heterodimers, we evaluated 64Cu-labeled RGD-bombesin for PET imaging of tumors.  Methods: RGD-bombesin was coupled with 1,4,7,10-tetraazacyclododecane-N, N', N'', N'''-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), and the conjugates were labeled with 64Cu.  The in vitro and in vivo characteristics of 64Cu-NOTA-RGD-bombesin were compared with those of 64Cu-NOTA-RGD, 64Cu-NOTA-bombesin, and 64Cu-DOTA-RGD-bombesin.  Results: 64Cu-NOTA-RGD-bombesin and 64Cu-DOTA-RGD-bombesin had comparable dual integrin αvβ3- and GRPR-binding affinities in vitro, both of which were slightly lower than RGD for integrin binding and bombesin for GRPR binding.  64Cu-NOTA-RGD-bombesin possessed significantly higher tumor uptake than did 64Cu-NOTA-RGD, 64Cu-NOTA-bombesin, the mixt. of 64Cu-NOTA-RGD and 64Cu-NOTA-bombesin, or 64Cu-DOTA-RGD-bombesin in PC-3 prostate cancer.  64Cu-NOTA-RGD-bombesin also showed improved in vivo kinetics such as lower liver and intestinal activity accumulation than did the bombesin tracers.  64Cu-NOTA-RGD-bombesin also outperformed 64Cu-NOTA-RGD in a 4T1 murine mammary carcinoma model that expresses integrin on tumor vasculature but no GRPR in tumor tissue, which had no uptake of 64Cu-NOTA-bombesin.  Conclusion: Compared with other tracers, 64Cu-NOTA-RGD-bombesin showed favorable in vivo kinetics and enhanced tumor uptake, which warrants its further investigation for targeting tumors that express integrin or GRPR or that coexpress integrin and GRPR for imaging and therapeutic applications.  The synergistic effect of RGD-bombesin heterodimers obsd. in this study also encourages further investigations of novel heterodimers recognizing other cell surface receptors for tumor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCpydvyLFVQLVg90H21EOLACvtfcHk0ljxbi0SIscFjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2gsbY%253D&md5=896e276601fd8c9bf0edf677b09a7094</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.061739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.061739%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.-B.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSmall-animal%2520PET%2520of%2520tumors%2520with%252064Cu-labeled%2520RGD-bombesin%2520heterodimer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D1168%26epage%3D1177%26doi%3D10.2967%2Fjnumed.108.061739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.nucmedbio.2008.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19324273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVOrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=277-285&author=L.+Weiauthor=Y.+Yeauthor=T.+J.+Wadasauthor=J.+S.+Lewisauthor=M.+J.+Welchauthor=S.+Achilefuauthor=C.+J.+Anderson&title=64Cu-Labeled+CB-TE2A+and+diamsar-conjugated+RGD+peptide+analogs+for+targeting+angiogenesis%3A+comparison+of+their+biological+activity&doi=10.1016%2Fj.nucmedbio.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity</span></div><div class="casAuthors">Wei, Lihui; Ye, Yunpeng; Wadas, Thaddeus J.; Lewis, Jason S.; Welch, Michael J.; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The αvβ3 integrin is a cell adhesion mol. known to be involved in stages of angiogenesis and metastasis.  In this study, the chelators CB-TE2A and diamsar were conjugated to cyclic RGDyK and RGDfD and the biol. properties of 64Cu-labeled peptides were compared.  CB-TE2A-c(RGDyK) and diamsar-c(RGDfD) were labeled with 64Cu in 0.1 M NH4OAc (pH = 8) at 95° and 25°, resp.  PET and biodistribution studies were carried out on M21 (αvβ3-pos.) and M21L (αv-neg.) melanoma-bearing mice.  Binding affinity of the Cu-chelator-RGD peptides to αvβ3 integrins was detd. by a competitive binding affinity assay.  Biol. studies showed higher concn. of 64Cu-CB-TE2A-c(RGDyK) in M21 tumor compared to M21L tumor at 1 and 4 h pi.  Tumor concn. of 64Cu-CB-TE2A-c(RGDyK) was higher than that of 64Cu-diamsar-c(RGDfD).  The difference is not due to differing binding affinities, since similar values were obtained for the agents.  Compared to 64Cu-diamsar-c(RGDfD), there is more rapid liver and blood clearance of 64Cu-CB-TE2A-c(RGDyK), resulting in a lower liver and blood concn. at 24 h pi.  Both 64Cu-labeled RGD peptides show similar binding affinities to αvβ3.  The differences in their biodistribution properties are likely related to different linkers, charges and lipophilicities.  The M21 tumor is clearly visualized with 64Cu-CB-TE2A-c(RGDyK) by microPET imaging.  Administration of c(RGDyK) as a block significantly reduced the tumor concn.; however, the radioactivity background was also decreased by the blocking dose.  Both 64Cu-CB-TE2A-c(RGDyK) and 64Cu-diamsar-c(RGDfD) are potential candidates for imaging tumor angiogenesis.  For diamsar-c(RGDfD), a linker may be needed between the Cu-chelator moiety and the RGD peptide to achieve optimal in vivo tumor concn. and clearance from nontarget organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rKsKYK5XNbVg90H21EOLACvtfcHk0lhgw5kHGlYc-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVOrs7Y%253D&md5=1cc7db355bafa66036a018a65978dd4e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DWadas%26aufirst%3DT.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3D64Cu-Labeled%2520CB-TE2A%2520and%2520diamsar-conjugated%2520RGD%2520peptide%2520analogs%2520for%2520targeting%2520angiogenesis%253A%2520comparison%2520of%2520their%2520biological%2520activity%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.nucmedbio.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weilbaecher, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a <sup>64</sup>Cu-labeled RGD peptide</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=311-318&author=J.+E.+Spragueauthor=H.+Kitauraauthor=W.+Zouauthor=Y.+Yeauthor=S.+Achilefuauthor=K.+N.+Weilbaecherauthor=S.+L.+Teitelbaumauthor=C.+J.+Anderson&title=Noninvasive+imaging+of+osteoclasts+in+parathyroid+hormone-induced+osteolysis+using+a+64Cu-labeled+RGD+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DWeilbaecher%26aufirst%3DK.%2BN.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DNoninvasive%2520imaging%2520of%2520osteoclasts%2520in%2520parathyroid%2520hormone-induced%2520osteolysis%2520using%2520a%252064Cu-labeled%2520RGD%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Tayar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Pattern recognition study of QSAR substituent descriptors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1007/BF01557723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1007%2FBF01557723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=111-132&author=H.+Van+de+Waterbeemdauthor=N.+El+Tayarauthor=P.+A.+Carruptauthor=B.+Testa&title=Pattern+recognition+study+of+QSAR+substituent+descriptors&doi=10.1007%2FBF01557723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FBF01557723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01557723%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DEl%2BTayar%26aufirst%3DN.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPattern%2520recognition%2520study%2520of%2520QSAR%2520substituent%2520descriptors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1989%26volume%3D3%26spage%3D111%26epage%3D132%26doi%3D10.1007%2FBF01557723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">microPET Imaging of glioma integrin α<sub>v</sub>β<sub>3</sub> expression using <sup>64</sup>Cu-labeled tetrameric RGD peptide</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1707-1718&author=Y.+Wuauthor=X.+Zhangauthor=Z.+Xiongauthor=Z.+Chengauthor=D.+R.+Fisherauthor=S.+Liuauthor=S.+S.+Gambhirauthor=X.+Chen&title=microPET+Imaging+of+glioma+integrin+%CE%B1v%CE%B23+expression+using+64Cu-labeled+tetrameric+RGD+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DFisher%26aufirst%3DD.%2BR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DmicroPET%2520Imaging%2520of%2520glioma%2520integrin%2520%25CE%25B1v%25CE%25B23%2520expression%2520using%252064Cu-labeled%2520tetrameric%2520RGD%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1707%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yoo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span> </span><span class="NLM_article-title">SPECT/CT imaging of high-risk atherosclerotic plaques using integrin-binding RGD dimer peptides</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">11752</span><span class="NLM_x">–</span> <span class="NLM_lpage">11763</span><span class="refDoi"> DOI: 10.1038/srep11752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1038%2Fsrep11752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=26123253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BC2MbosV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11752-11763&author=J.+S.+Yooauthor=J.+Leeauthor=J.+H.+Jungauthor=B.+S.+Moonauthor=S.+Kimauthor=B.+C.+Leeauthor=S.+E.+Kim&title=SPECT%2FCT+imaging+of+high-risk+atherosclerotic+plaques+using+integrin-binding+RGD+dimer+peptides&doi=10.1038%2Fsrep11752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides</span></div><div class="casAuthors">Yoo Jung Sun; Lee Jonghwan; Kim Soonhag; Jung Jae Ho; Moon Byung Seok; Lee Byung Chul; Kim Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11752</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vulnerable atherosclerotic plaques with unique biological signatures are responsible for most major cardiovascular events including acute myocardial infarction and stroke.  However, current clinical diagnostic approaches for atherosclerosis focus on anatomical measurements such as the degree of luminal stenosis and wall thickness.  An abundance of neovessels with elevated expression of integrin αvβ3 is closely associated with an increased risk of plaque rupture.  Herein we evaluated the potential of an αvβ3 integrin-targeting radiotracer, (99m)Tc-IDA-D-[c(RGDfK)]2, for SPECT/CT imaging of high-risk plaque in murine atherosclerosis models.  In vivo uptake of (99m)Tc-IDA-D-[c(RGDfK)]2 was significantly higher in atherosclerotic aortas than in relatively normal aortas.  Comparison with the negative-control peptide, (99m)Tc-IDA-D-[c(RADfK)]2, proved specific binding of (99m)Tc-IDA-D-[c(RGDfK)]2 for plaque lesions in in vivo SPECT/CT and ex vivo autoradiographic imaging.  Histopathological characterization revealed that a prominent SPECT signal of (99m)Tc-IDA-D-[c(RGDfK)]2 corresponded to the presence of high-risk plaques with a large necrotic core, a thin fibrous cap, and vibrant neoangiogenic events.  Notably, the RGD dimer based (99m)Tc-IDA-D-[c(RGDfK)]2 showed better imaging performance in comparison with the common monomeric RGD peptide probe (123)I-c(RGDyV) and fluorescence tissue assay corroborated this.  Our preclinical data demonstrated that (99m)Tc-IDA-D-[c(RGDfK)]2 SPECT/CT is a sensitive tool to noninvasively gauge atherosclerosis beyond vascular anatomy by assessing culprit plaque neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7W6al4e03HjQLBVDQn4bCfW6udTcc2eaphF0-wkqST7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbosV2rsg%253D%253D&md5=45460f525f7f897be74d9e026ca1f536</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep11752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11752%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3DSPECT%252FCT%2520imaging%2520of%2520high-risk%2520atherosclerotic%2520plaques%2520using%2520integrin-binding%2520RGD%2520dimer%2520peptides%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11752%26epage%3D11763%26doi%3D10.1038%2Fsrep11752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&issue=12&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lgdL5St5HsDLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D12%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Banerjee, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferdani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2669</span><span class="refDoi"> DOI: 10.1021/jm401921j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401921j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2657-2669&issue=6&author=S.+R.+Banerjeeauthor=M.+Pullambhatlaauthor=C.+A.+Fossauthor=S.+Nimmagaddaauthor=R.+Ferdaniauthor=C.+J.+Andersonauthor=R.+C.+Measeauthor=M.+G.+Pomper&title=64Cu-Labeled+inhibitors+of+prostate-specific+membrane+antigen+for+PET+imaging+of+prostate+cancer&doi=10.1021%2Fjm401921j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer</span></div><div class="casAuthors">Banerjee, Sangeeta Ray; Pullambhatla, Mrudula; Foss, Catherine A.; Nimmagadda, Sridhar; Ferdani, Riccardo; Anderson, Carolyn J.; Mease, Ronnie C.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2657-2669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) is a well-recognized target for identification and therapy of a variety of cancers.  Here we report five 64Cu-labeled inhibitors of PSMA, [64Cu]3-7, which are based on the lysine-glutamate urea scaffold and utilize a variety of macrocyclic chelators, namely NOTA(3), PCTA(4), Oxo-DO3A(5), CB-TE2A(6), and DOTA(7), in an effort to det. which provides the most suitable pharmacokinetics for in vivo PET imaging. [64Cu]3-7 were prepd. in high radiochem. yield (60-90%) and purity (>95%).  Positron emission tomog. (PET) imaging studies of [64Cu]3-7 revealed specific accumulation in PSMA-expressing xenografts (PSMA+ PC3 PIP) relative to isogenic control tumor (PSMA- PC3 flu) and background tissue.  The favorable kinetics and high image contrast provided by CB-TE2A chelated [64Cu]6 suggest it as the most promising among the candidates tested.  That could be due to the higher stability of [64Cu]CB-TE2A as compared with [64Cu]NOTA, [64Cu]PCTA, [64Cu]Oxo-DO3A, and [64Cu]DOTA chelates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgcn3xPOl6rVg90H21EOLACvtfcHk0lgdL5St5HsDLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKitb8%253D&md5=511ffeb4ceb22ac99f7b21d0a5591efa</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm401921j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401921j%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DFoss%26aufirst%3DC.%2BA.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DFerdani%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3D64Cu-Labeled%2520inhibitors%2520of%2520prostate-specific%2520membrane%2520antigen%2520for%2520PET%2520imaging%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D6%26spage%3D2657%26epage%3D2669%26doi%3D10.1021%2Fjm401921j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dumont, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fani, M.</span><span> </span><span class="NLM_article-title">Novel <sup>64</sup>Cu-and <sup>68</sup>Ga-labeled RGD conjugates show improved PET imaging of α<sub>ν</sub>β<sub>3</sub> integrin expression and facile radiosynthesis</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.2967/jnumed.111.087700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.111.087700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1276-1284&author=R.+A.+Dumontauthor=F.+Deiningerauthor=R.+Haubnerauthor=H.+R.+Maeckeauthor=W.+A.+Weberauthor=M.+Fani&title=Novel+64Cu-and+68Ga-labeled+RGD+conjugates+show+improved+PET+imaging+of+%CE%B1%CE%BD%CE%B23+integrin+expression+and+facile+radiosynthesis&doi=10.2967%2Fjnumed.111.087700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.087700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.087700%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DR.%2BA.%26aulast%3DDeininger%26aufirst%3DF.%26aulast%3DHaubner%26aufirst%3DR.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DFani%26aufirst%3DM.%26atitle%3DNovel%252064Cu-and%252068Ga-labeled%2520RGD%2520conjugates%2520show%2520improved%2520PET%2520imaging%2520of%2520%25CE%25B1%25CE%25BD%25CE%25B23%2520integrin%2520expression%2520and%2520facile%2520radiosynthesis%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1276%26epage%3D1284%26doi%3D10.2967%2Fjnumed.111.087700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lhI9bfxhBINvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Boswell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheingold, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span><span class="refDoi"> DOI: 10.1021/jm030383m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030383m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1465-1474&author=C.+A.+Boswellauthor=X.+Sunauthor=W.+Niuauthor=G.+R.+Weismanauthor=E.+H.+Wongauthor=A.+L.+Rheingoldauthor=C.+J.+Anderson&title=Comparative+in+vivo+stability+of+copper-64-labeled+cross-bridged+and+conventional+tetraazamacrocyclic+complexes&doi=10.1021%2Fjm030383m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes</span></div><div class="casAuthors">Boswell, C. Andrew; Sun, Xiankai; Niu, Weijun; Weisman, Gary R.; Wong, Edward H.; Rheingold, Arnold L.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1465-1474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increased use of copper radioisotopes in radiopharmaceutical applications has created a need for bifunctional chelators (BFCs) that form stable radiocopper complexes and allow covalent attachment to biol. mols.  The chelators most commonly utilized for labeling copper radionuclides to biomols. are analogs of 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA); however, recent reports have communicated the instability of the radio-Cu(II)-TETA complexes in vivo.  A class of bicyclic tetraazamacrocycles, the ethylene "cross-bridged" cyclam (CB-cyclam) derivs., form highly kinetically stable complexes with Cu(II) and therefore may be less susceptible to transchelation than their nonbridged analogs in vivo.  Herein we report results on the relative biol. stabilities and identification of the resulting radiolabeled metabolites of a series of 64Cu-labeled macrocyclic complexes.  Metab. studies in normal rat liver have revealed that the 64Cu complex of 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane (64Cu-CB-TE2A) resulted in significantly lower values of protein-assocd. 64Cu than 64Cu-TETA [13 ± 6% vs 75 ± 9% at 4 h].  A similar trend was obsd. for the corresponding cyclen derivs., with the 64Cu complex of 4,10-bis(carboxymethyl)-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane (64Cu-CB-DO2A) undergoing less transchelation than the 64Cu complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (64Cu-DOTA) [61 ± 14% vs 90.3 ± 0.5% protein assocd. 64Cu at 4 h].  These data indicate that the structurally reinforcing cross-bridge enhances in vivo stability by reducing metal loss to protein in both the cyclam and cyclen cross-bridged 64Cu complexes and that 64Cu-CB-TE2A is superior to 64Cu-CB-DO2A in that regard.  These findings further suggest that a bifunctional chelator deriv. of CB-TE2A is a highly desirable alternative for labeling copper radionuclides to biol. mols. for diagnostic imaging and targeted radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0FGtigmddbVg90H21EOLACvtfcHk0lhI9bfxhBINvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagtLw%253D&md5=542e8b853716a629b641740f102a48db</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm030383m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030383m%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DW.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DComparative%2520in%2520vivo%2520stability%2520of%2520copper-64-labeled%2520cross-bridged%2520and%2520conventional%2520tetraazamacrocyclic%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1465%26epage%3D1474%26doi%3D10.1021%2Fjm030383m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreerama, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5057</span><span class="NLM_x">–</span> <span class="NLM_lpage">5069</span><span class="refDoi"> DOI: 10.1021/jm0704088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0704088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVens7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5057-5069&author=J.+Wangauthor=C.-T.+Yangauthor=Y.-S.+Kimauthor=S.+G.+Sreeramaauthor=Q.+Caoauthor=Z.-B.+Liauthor=Z.+Heauthor=X.+Chenauthor=S.+Liu&title=64Cu-Labeled+triphenylphosphonium+and+triphenylarsonium+cations+as+highly+tumor-selective+imaging+agents&doi=10.1021%2Fjm0704088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents</span></div><div class="casAuthors">Wang, Jianjun; Yang, Chang-Tong; Kim, Young-Seung; Sreerama, Subramanya G.; Cao, Qizhen; Li, Zi-Bo; He, Zhengjie; Chen, Xiaoyuan; Liu, Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5057-5069</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report presents synthesis and evaluation of the 64Cu-labeled triphenylphosphonium (TPP) cations as new radiotracers for imaging tumors by positron emission tomog.  Biodistribution properties of 64Cu-L1, 64Cu-L2, 64Cu-L3, and 99mTc-Sestamibi were evaluated in athymic nude mice bearing U87MG human glioma xenografts.  The most striking difference is that 64Cu-L1, 64Cu-L2, and 64Cu-L3 have much lower heart uptake (<0.6% ID/g) than 99mTc-Sestamibi (∼18% ID/g) at >30 min p.i.  Their tumor/heart ratios increase steadily from ∼1 at 5 min p.i. to ∼5 at 120 min p.i.  The tumor/heart ratio of 64Cu-L3 is ∼40 times better than that of 99mTc-Sestamibi at 120 min postinjection.  Results from in vitro assays show that 64Cu-L1 is able to localize in tumor mitochondria.  The tumor is clearly visualized in the tumor-bearing mice administered with 64Cu-L1 as 30 min postinjection.  The 64Cu-labeled TPP/TPA cations are very selective radiotracers that are able to provide the information of mitochondrial bioenergetic function in tumors by monitoring mitochondrial potential in a noninvasive fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK5KYmQOI0H7Vg90H21EOLACvtfcHk0lhI9bfxhBINvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVens7vK&md5=f38aacf5ab06845d569dfe89ed2ec58f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0704088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704088%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.-T.%26aulast%3DKim%26aufirst%3DY.-S.%26aulast%3DSreerama%26aufirst%3DS.%2BG.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.-B.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D64Cu-Labeled%2520triphenylphosphonium%2520and%2520triphenylarsonium%2520cations%2520as%2520highly%2520tumor-selective%2520imaging%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5057%26epage%3D5069%26doi%3D10.1021%2Fjm0704088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rogers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1021/bc9600372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9600372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADyaK28XjvFequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=511-522&author=B.+E.+Rogersauthor=C.+J.+Andersonauthor=J.+M.+Connettauthor=L.+W.+Guoauthor=W.+B.+Edwardsauthor=E.+L.+Shermanauthor=K.+R.+Zinnauthor=M.+J.+Welch&title=Comparison+of+four+bifunctional+chelates+for+radiolabeling+monoclonal+antibodies+with+copper+radioisotopes%3A+biodistribution+and+metabolism&doi=10.1021%2Fbc9600372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution and Metabolism</span></div><div class="casAuthors">Rogers, Buck E.; Anderson, Carolyn J.; Connett, Judith M.; Guo, Li Wu; Edwards, W. Barry; Sherman, Elizabeth L. C.; Zinn, Kurt R.; Welch, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bifunctional chelating agents (BFCs), 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (BAT), 6-[p-(isothiocyanato)benzyl]-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (SCN-TETA), 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid (CPTA), and 1-[(1,4,7,10,13-pentaazacyclopentadec-1-yl)methyl]benzoic acid (PCBA), were synthesized and conjugated to the anti-colorectal monoclonal antibody (mAb), 1A3, and antibody fragments, 1A3-F(ab')2, for radiolabeling with 64,67Cu and comparison in animal models.  In vivo metab. studies were carried out in liver and kidneys to correlate the nature of the metabolites formed to the uptake and retention of the radiolabel in each organ.  Animal biodistribution studies were performed in Golden Syrian hamsters bearing the GW39 human colon cancer tumors and in normal Sprague-Dawley rats.  All conjugates showed good tumor uptake in hamsters.  Biodistribution in rats showed that 64Cu-BAT-2IT-1A3 had the lowest liver and kidney uptake of the intact 1A3 conjugates (p < 0.03), whereas in hamsters, there were no significant differences in liver and kidney uptake between the four intact BFC-1A3 conjugates.  Tumor-bearing hamsters injected with 64Cu-CPTA-1A3-F(ab')2 and 64Cu-PCBA-1A3-F(ab')2 had from 3 to 7 times greater uptake in the kidneys than hamsters given 64Cu-labeled BAT and SCN-TETA 1A3-F(ab')2 conjugates, while rats injected with 64Cu-CPTA-1A3-F(ab')2 and 64Cu-PCBA-1A3-F(ab')2 had nearly twice the uptake.  The in vivo metab. of the mAbs 1A3 and 1A3-F(ab')2 radiolabeled with 67Cu through the SCN-TETA, CPTA, and PCBA BFCs was investigated by excising the livers and kidneys of normal rats from 1-5 days postinjection of the radiolabeled conjugates.  Liver and kidney homogenates were analyzed by size exclusion chromatog. and thin layer chromatog. (TLC).  The size exclusion chromatog. data showed that all of the 67Cu-labeled 1A3-F(ab')2 conjugates were >85% degraded in the kidneys to small mol. wt. metabolites by 1 day postinjection.  In contrast, in the liver at 1 day post-injection, greater than 70% of the 67Cu-labeled 1A3 conjugates were unmetabolized.  By day 5, a 35 kDa peak appeared in the liver of rats injected with the 67Cu-labeled 1A3 conjugates, possibly due to transchelation of the 67Cu to proteins.  Superoxide dismutase chromatog. elutes at the same retention time as this 67Cu-labeled metabolite.  The TLC data indicate that the low mol. wt. metabolite (<5 kDa) of both 67Cu-CPTA-1A3 and 67Cu-CPTA-1A3-F(ab')2 conjugates cochromatographed with a 67Cu-CPTA-ε-lysine std.  Our data suggest that chelate charge and lipophilicity play a large role in kidney retention of 64/67Cu-labeled BFC-1A3-F(ab')2 conjugates, while transchelation of the copper label appears to be the major factor for liver accumulation of 64/67Cu-labeled BFC-1A3 conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_M4QJlxIFbbVg90H21EOLACvtfcHk0lg7lvm02Bl4LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFequrY%253D&md5=759c3d215a1ea49f0dd7a08c2ccbdc55</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbc9600372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9600372%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DB.%2BE.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DConnett%26aufirst%3DJ.%2BM.%26aulast%3DGuo%26aufirst%3DL.%2BW.%26aulast%3DEdwards%26aufirst%3DW.%2BB.%26aulast%3DSherman%26aufirst%3DE.%2BL.%26aulast%3DZinn%26aufirst%3DK.%2BR.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DComparison%2520of%2520four%2520bifunctional%2520chelates%2520for%2520radiolabeling%2520monoclonal%2520antibodies%2520with%2520copper%2520radioisotopes%253A%2520biodistribution%2520and%2520metabolism%26jtitle%3DBioconjugate%2520Chem.%26date%3D1996%26volume%3D7%26spage%3D511%26epage%3D522%26doi%3D10.1021%2Fbc9600372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6625</span><span class="NLM_x">–</span> <span class="NLM_lpage">6637</span><span class="refDoi"> DOI: 10.1021/jm0496990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0496990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6625-6637&author=J.+Yooauthor=D.+E.+Reichertauthor=M.+J.+Welch&title=Comparative+in+vivo+behavior+studies+of+cyclen-based+copper-64+complexes%3A+regioselective+synthesis%2C+X-ray+structure%2C+radiochemistry%2C+log+P%2C+and+biodistribution&doi=10.1021%2Fjm0496990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm0496990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0496990%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520in%2520vivo%2520behavior%2520studies%2520of%2520cyclen-based%2520copper-64%2520complexes%253A%2520regioselective%2520synthesis%252C%2520X-ray%2520structure%252C%2520radiochemistry%252C%2520log%2520P%252C%2520and%2520biodistribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6625%26epage%3D6637%26doi%3D10.1021%2Fjm0496990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Woonghee Lee, Swarbhanu Sarkar, Rammyani Pal, Jung Young Kim, Hyun Park, Phuong Tu Huynh, Abhinav Bhise, Kondapa Naidu Bobba, Kwang Il Kim, Yeong Su Ha, Nisarg Soni, Wanook Kim, Kiwoong Lee, Jung-Min Jung, Subramani Rajkumar, Kyo Chul Lee, <span class="NLM_string-name hlFld-ContribAuthor">Jeongsoo Yoo</span>. </span><span class="cited-content_cbyCitation_article-title">Successful Application of CuAAC Click Reaction in Constructing 64Cu-Labeled Antibody Conjugates for Immuno-PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2021,</strong> <em>4 </em>
                                    (3)
                                     , 2544-2557. <a href="https://doi.org/10.1021/acsabm.0c01555" title="DOI URL">https://doi.org/10.1021/acsabm.0c01555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c01555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c01555%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DSuccessful%252BApplication%252Bof%252BCuAAC%252BClick%252BReaction%252Bin%252BConstructing%252B64Cu-Labeled%252BAntibody%252BConjugates%252Bfor%252BImmuno-PET%252BImaging%26aulast%3DLee%26aufirst%3DWoonghee%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01122020%26date%3D25012021%26date%3D18022021%26volume%3D4%26issue%3D3%26spage%3D2544%26epage%3D2557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Neha Choudhary, Alexander Dimmling, Xiaozhu Wang, Lily Southcott, Valery Radchenko, Brian O. Patrick, Peter Comba, <span class="NLM_string-name hlFld-ContribAuthor">Chris Orvig</span>. </span><span class="cited-content_cbyCitation_article-title">Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (13)
                                     , 8685-8693. <a href="https://doi.org/10.1021/acs.inorgchem.9b01016" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b01016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b01016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b01016%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DOctadentate%252BOxine-Armed%252BBispidine%252BLigand%252Bfor%252BRadiopharmaceutical%252BChemistry%26aulast%3DChoudhary%26aufirst%3DNeha%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09042019%26date%3D18062019%26volume%3D58%26issue%3D13%26spage%3D8685%26epage%3D8693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaozhu Wang, María de Guadalupe Jaraquemada-Peláez, Yang Cao, Jinhe Pan, Kuo-Shyan Lin, Brian O. Patrick, <span class="NLM_string-name hlFld-ContribAuthor">Chris Orvig</span>. </span><span class="cited-content_cbyCitation_article-title">H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 2275-2285. <a href="https://doi.org/10.1021/acs.inorgchem.8b01208" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b01208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b01208%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DH2hox%25253A%252BDual-Channel%252BOxine-Derived%252BAcyclic%252BChelating%252BLigand%252Bfor%252B68Ga%252BRadiopharmaceuticals%26aulast%3DWang%26aufirst%3DXiaozhu%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D03052018%26date%3D10072018%26volume%3D58%26issue%3D4%26spage%3D2275%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eszter Boros, <span class="NLM_string-name hlFld-ContribAuthor">Alan B. Packard</span>. </span><span class="cited-content_cbyCitation_article-title">Radioactive Transition Metals for Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 870-901. <a href="https://doi.org/10.1021/acs.chemrev.8b00281" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00281%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRadioactive%252BTransition%252BMetals%252Bfor%252BImaging%252Band%252BTherapy%26aulast%3DBoros%26aufirst%3DEszter%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D08052018%26date%3D09102018%26volume%3D119%26issue%3D2%26spage%3D870%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaozhu Wang, María de
Guadalupe Jaraquemada-Peláez, Cristina Rodríguez-Rodríguez, Yang Cao, Christian Buchwalder, Neha Choudhary, Una Jermilova, Caterina F. Ramogida, Katayoun Saatchi, Urs O. Häfeli, Brian O. Patrick, <span class="NLM_string-name hlFld-ContribAuthor">Chris Orvig</span>. </span><span class="cited-content_cbyCitation_article-title">H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (45)
                                     , 15487-15500. <a href="https://doi.org/10.1021/jacs.8b09964" title="DOI URL">https://doi.org/10.1021/jacs.8b09964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b09964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b09964%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DH4octox%25253A%252BVersatile%252BBimodal%252BOctadentate%252BAcyclic%252BChelating%252BLigand%252Bfor%252BMedicinal%252BInorganic%252BChemistry%26aulast%3DWang%26aufirst%3DXiaozhu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13092018%26date%3D05112018%26date%3D16102018%26volume%3D140%26issue%3D45%26spage%3D15487%26epage%3D15500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tomáš David, Veronika Hlinová, Vojtěch Kubíček, Ralf Bergmann, Franziska Striese, Nicole Berndt, Dávid Szöllősi, Tibor Kovács, Domokos Máthé, Michael Bachmann, Hans-Jürgen Pietzsch, <span class="NLM_string-name hlFld-ContribAuthor">Petr Hermann</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8774-8796. <a href="https://doi.org/10.1021/acs.jmedchem.8b00932" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00932%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImproved%252BConjugation%25252C%252B64-Cu%252BRadiolabeling%25252C%252Bin%252BVivo%252BStability%25252C%252Band%252BImaging%252BUsing%252BNonprotected%252BBifunctional%252BMacrocyclic%252BLigands%25253A%252BBis%252528Phosphinate%252529%252BCyclam%252B%252528BPC%252529%252BChelators%26aulast%3DDavid%26aufirst%3DTom%25C3%25A1%25C5%25A1%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11062018%26date%3D24092018%26date%3D05092018%26volume%3D61%26issue%3D19%26spage%3D8774%26epage%3D8796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Choudhary</span>, <span class="hlFld-ContribAuthor ">Kendall E.  Barrett</span>, <span class="hlFld-ContribAuthor ">Manja  Kubeil</span>, <span class="hlFld-ContribAuthor ">Valery  Radchenko</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Engle</span>, <span class="hlFld-ContribAuthor ">Holger  Stephan</span>, <span class="hlFld-ContribAuthor ">María  de Guadalupe Jaraquemada-Peláez</span>, <span class="hlFld-ContribAuthor ">Chris  Orvig</span>. </span><span class="cited-content_cbyCitation_article-title">Metal ion size profoundly affects H
              3
              glyox chelate chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (26)
                                     , 15663-15674. <a href="https://doi.org/10.1039/D1RA01793D" title="DOI URL">https://doi.org/10.1039/D1RA01793D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA01793D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA01793D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMetal%252Bion%252Bsize%252Bprofoundly%252Baffects%252BH%252B3%252Bglyox%252Bchelate%252Bchemistry%26aulast%3DChoudhary%26aufirst%3DNeha%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D26%26spage%3D15663%26epage%3D15674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Martin</span>, <span class="hlFld-ContribAuthor ">Stephan  Maus</span>, <span class="hlFld-ContribAuthor ">Tobias  Stemler</span>, <span class="hlFld-ContribAuthor ">Florian  Rosar</span>, <span class="hlFld-ContribAuthor ">Fadi  Khreish</span>, <span class="hlFld-ContribAuthor ">Jason P.  Holland</span>, <span class="hlFld-ContribAuthor ">Samer  Ezziddin</span>, <span class="hlFld-ContribAuthor ">Mark D.  Bartholomä</span>. </span><span class="cited-content_cbyCitation_article-title">Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 95-108. <a href="https://doi.org/10.1007/s11307-020-01530-8" title="DOI URL">https://doi.org/10.1007/s11307-020-01530-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-020-01530-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-020-01530-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DProof-of-Concept%252BStudy%252Bof%252Bthe%252BNOTI%252BChelating%252BPlatform%25253A%252BPreclinical%252BEvaluation%252Bof%252B64Cu-Labeled%252BMono-%252Band%252BTrimeric%252Bc%252528RGDfK%252529%252BConjugates%26aulast%3DMartin%26aufirst%3DSebastian%26date%3D2021%26date%3D2020%26volume%3D23%26issue%3D1%26spage%3D95%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaozhong  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Tian</span>, <span class="hlFld-ContribAuthor ">Dongliang  Guan</span>, <span class="hlFld-ContribAuthor ">Jiwei  Ao</span>, <span class="hlFld-ContribAuthor ">Zhimeng  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiping  Le</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (7)
                                     , 896-900. <a href="https://doi.org/10.1016/j.bmcl.2019.01.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bdual-cyclic%252BRGD%252Bpeptides%252Bfor%252B%2525CE%2525B1v%2525CE%2525B23%252Bintegrin%252Btargeting%26aulast%3DLiu%26aufirst%3DJunjie%26date%3D2019%26volume%3D29%26issue%3D7%26spage%3D896%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxi  Ling</span>, <span class="hlFld-ContribAuthor ">Cathy S.  Cutler</span>, <span class="hlFld-ContribAuthor ">Carolyn J.  Anderson</span>. </span><span class="cited-content_cbyCitation_article-title">The Radiopharmaceutical Chemistry of the Radioisotopes of Copper. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 335-358. <a href="https://doi.org/10.1007/978-3-319-98947-1_19" title="DOI URL">https://doi.org/10.1007/978-3-319-98947-1_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-98947-1_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-98947-1_19%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRadiopharmaceutical%252BChemistry%252Bof%252Bthe%252BRadioisotopes%252Bof%252BCopper%26aulast%3DLing%26aufirst%3DXiaoxi%26date%3D2019%26date%3D2019%26spage%3D335%26epage%3D358%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DRadiopharmaceutical%252BChemistry%26aulast%3DLewis%26aufirst%3DJason%2BS.%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeye  Zhou</span>, <span class="hlFld-ContribAuthor ">Jihui  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Man  Zhao</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengming  Deng</span>, <span class="hlFld-ContribAuthor ">Yiwei  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">64
              Cu-based Radiopharmaceuticals in Molecular Imaging. </span><span class="cited-content_cbyCitation_journal-name">Technology in Cancer Research & Treatment</span><span> <strong>2019,</strong> <em>18 </em>, 153303381983075. <a href="https://doi.org/10.1177/1533033819830758" title="DOI URL">https://doi.org/10.1177/1533033819830758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1533033819830758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1533033819830758%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnology%2520in%2520Cancer%2520Research%2520%2526%2520Treatment%26atitle%3D64%252BCu-based%252BRadiopharmaceuticals%252Bin%252BMolecular%252BImaging%26aulast%3DZhou%26aufirst%3DYeye%26date%3D2019%26date%3D2019%26volume%3D18%26spage%3D153303381983075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luise  Fiedler</span>, <span class="hlFld-ContribAuthor ">Markus  Kellner</span>, <span class="hlFld-ContribAuthor ">Rosel  Oos</span>, <span class="hlFld-ContribAuthor ">Guido  Böning</span>, <span class="hlFld-ContribAuthor ">Sibylle  Ziegler</span>, <span class="hlFld-ContribAuthor ">Peter  Bartenstein</span>, <span class="hlFld-ContribAuthor ">Reinhard  Zeidler</span>, <span class="hlFld-ContribAuthor ">Franz Josef  Gildehaus</span>, <span class="hlFld-ContribAuthor ">Simon  Lindner</span>. </span><span class="cited-content_cbyCitation_article-title">Fully Automated Production and Characterization of
              64
              Cu and Proof-of-Principle Small-Animal PET Imaging Using
              64
              Cu-Labelled CA XII Targeting 6A10 Fab. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , 1230-1237. <a href="https://doi.org/10.1002/cmdc.201800130" title="DOI URL">https://doi.org/10.1002/cmdc.201800130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800130%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFully%252BAutomated%252BProduction%252Band%252BCharacterization%252Bof%252B64%252BCu%252Band%252BProof-of-Principle%252BSmall-Animal%252BPET%252BImaging%252BUsing%252B64%252BCu-Labelled%252BCA%252BXII%252BTargeting%252B6A10%252BFab%26aulast%3DFiedler%26aufirst%3DLuise%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D12%26spage%3D1230%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0007.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of BFC-c(RGDyK) conjugates, NOTA-Bn-NCS-c(RGDyK) (<b>1</b>), TE2A-Bn-NCS-c(RGDyK) (<b>2</b>), PCB-TE2A-Bn-NCS-c(RGDyK) (<b>3</b>), ECB-TE2A-c(RGDyK) (<b>4</b>), and PCB-TE2A-c(RGDyK) (<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthetic procedures for the <sup>64</sup>Cu bioconjugates. (A) Conjugation strategies for noncross-bridged chelators, TE2A-Bn-NCS and NOTA-Bn-NCS, to c(RGDyK), and radiolabeling with Cu-64. (B) Conjugation of PCB-TE2A to c(RGDyK) and radiolabeling with Cu-64. Reaction conditions: (i) diisopropylethylamine (DIEA), dimethylformamide (DMF), room temperature, 16 h; (ii) <sup>64</sup>CuCl<sub>2</sub>, water, 50 °C, 15 min; (iii) dicyclohexylcarbodiimide (DCC), DIEA, DMSO, room temperature, 16 h; (iv) <sup>64</sup>CuCl<sub>2</sub>, 0.1 M NH<sub>4</sub>OAc buffer (pH 8), 80 °C, 60 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–C) UV-HPLC (230 nm, black) and radio-HPLC (red) chromatogram of bioconjugates. (A) UV/radio HPLC chromatogram of <sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>1</b>). (B) UV/radio HPLC chromatogram of <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>). (C) UV/radio HPLC chromatogram of <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>). (D) Measurement of the biophysical properties of the bioconjugates. (E) In vitro inhibition of <sup>125</sup>I-echistain binding to integrin on U87MG cells by c(RGDyK) and bioconjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo stability of radiotracers in rat tissues at 1 h postinjection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative PET (A–J) and PET/CT (K–O) images of bioconjugates in U87MG tumor-bearing mice at 1, 4, and 24 h postinjection (<i>n</i> = 3 for each group). PET images are shown in maximum intensity projection mode. All images are decay-corrected and adjusted to the same maximum value. (A,F,K) <sup>64</sup>Cu-NOTA-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>1</b>), (B,G,L) <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>), (C,H,M) <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>3</b>), (D,I,N) <sup>64</sup>Cu-ECB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>4</b>), and (E,J,O) <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>). White arrowhead indicates tumor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/medium/jm-2017-016718_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Biodistribution data of (A) <sup>64</sup>Cu-TE2A-Bn-NCS-c(RGDyK) (<sup>64</sup>Cu-<b>2</b>) and (B) <sup>64</sup>Cu-PCB-TE2A-c(RGDyK) (<sup>64</sup>Cu-<b>5</b>) at 1 h, 1 h with blocking, and 4 and 24 h postinjection in U87MG tumor-bearing nude mice (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01671/20180110/images/large/jm-2017-016718_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01671&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Blower, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweit, J.</span><span> </span><span class="NLM_article-title">Copper radionuclides and radiopharmaceuticals in nuclear medicine</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1016/S0969-8051(96)00130-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2FS0969-8051%2896%2900130-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=9004284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADyaK2sXkslOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=957-980&author=P.+J.+Blowerauthor=J.+S.+Lewisauthor=J.+Zweit&title=Copper+radionuclides+and+radiopharmaceuticals+in+nuclear+medicine&doi=10.1016%2FS0969-8051%2896%2900130-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Copper radionuclides and radiopharmaceuticals in nuclear medicine</span></div><div class="casAuthors">Blower, Philip J.; Lewis, Jason S.; Zweit, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">957-980</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The chem., radiochem., radiobiol., and radiopharmacol. of radiopharmaceuticals contg. copper radionuclides are reviewed, with 210 refs.  Copper radionuclides offer application in positron emission tomog., targeted radiotherapy, and single photon imaging.  The chem. of copper is relatively simple and well-suited to radiopharmaceutical application.  Current radiopharmaceuticals include biomols. labeled via bifunctional chelators primarily based on cyclic polyaminocarboxylates and polyamines, and pyruvaldehyde-bis(N4-methylthiosemicarbazone) (PTSM) and its analogs.  The chem. of copper, of which only a fraction has yet been exploited, is likely to be applied more fully in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjGxleCOHP3LVg90H21EOLACvtfcHk0lgsKGH72iSaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslOqsQ%253D%253D&md5=39b9b14d56995b81d7c57f35e2fcdd82</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2896%2900130-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252896%252900130-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DZweit%26aufirst%3DJ.%26atitle%3DCopper%2520radionuclides%2520and%2520radiopharmaceuticals%2520in%2520nuclear%2520medicine%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D957%26epage%3D980%26doi%3D10.1016%2FS0969-8051%2896%2900130-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Donnelly, P. S.</span><span> </span><span class="NLM_article-title">The role of coordination chemistry in the development of target-specific radiopharmaceuticals</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1039/c0dt01075h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fc0dt01075h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=999-1010&author=P.+S.+Donnelly&title=The+role+of+coordination+chemistry+in+the+development+of+target-specific+radiopharmaceuticals&doi=10.1039%2Fc0dt01075h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2Fc0dt01075h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt01075h%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26atitle%3DThe%2520role%2520of%2520coordination%2520chemistry%2520in%2520the%2520development%2520of%2520target-specific%2520radiopharmaceuticals%26jtitle%3DDalton%2520Trans.%26date%3D2011%26volume%3D40%26spage%3D999%26epage%3D1010%26doi%3D10.1039%2Fc0dt01075h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaehle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margenau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapi, S. E.</span><span> </span><span class="NLM_article-title">A semi-automated system for the routine production of copper-64</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1803</span><span class="NLM_x">–</span> <span class="NLM_lpage">1806</span><span class="refDoi"> DOI: 10.1016/j.apradiso.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.apradiso.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=22516717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2012&pages=1803-1806&author=M.+Kumeauthor=P.+C.+Careyauthor=G.+Gaehleauthor=E.+Madridauthor=T.+Vollerauthor=W.+Margenauauthor=M.+J.+Welchauthor=S.+E.+Lapi&title=A+semi-automated+system+for+the+routine+production+of+copper-64&doi=10.1016%2Fj.apradiso.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A semi-automated system for the routine production of copper-64</span></div><div class="casAuthors">Kume, Maiko; Carey, Paul C.; Gaehle, Gregory; Madrid, Evelyn; Voller, Thomas; Margenau, William; Welch, Michael J.; Lapi, Suzanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An automated system for the prodn. of high specific activity 64Cu via the irradn. of electroplated enriched 64Ni targets has been developed.  We have been operating this system continually on a biweekly or weekly basis for more than two years.  Since the inception of this automated prodn. system, (Oct. 1, 2008), we have had 145 productions, produced 53562 mCi and shipped out 25629 mCi of this isotope to external users.  We routinely produce over 400 mCi of this isotope per batch with a specific activity of 14,000±7600 mCi/μmol for distribution to some 12-15 centers each prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7wqLT8eVV7Vg90H21EOLACvtfcHk0liUR-DN0Vb8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslymsL4%253D&md5=b2b7d18dd7b98a6f969cd1779619bfc7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DKume%26aufirst%3DM.%26aulast%3DCarey%26aufirst%3DP.%2BC.%26aulast%3DGaehle%26aufirst%3DG.%26aulast%3DMadrid%26aufirst%3DE.%26aulast%3DVoller%26aufirst%3DT.%26aulast%3DMargenau%26aufirst%3DW.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DLapi%26aufirst%3DS.%2BE.%26atitle%3DA%2520semi-automated%2520system%2520for%2520the%2520routine%2520production%2520of%2520copper-64%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2012%26volume%3D70%26spage%3D1803%26epage%3D1806%26doi%3D10.1016%2Fj.apradiso.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Shokeen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET)</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span><span class="refDoi"> DOI: 10.1021/ar800255q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar800255q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=832-841&author=M.+Shokeenauthor=C.+J.+Anderson&title=Molecular+imaging+of+cancer+with+copper-64+radiopharmaceuticals+and+positron+emission+tomography+%28PET%29&doi=10.1021%2Far800255q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)</span></div><div class="casAuthors">Shokeen, Monica; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">832-841</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mol. imaging has evolved over the past several years into an important tool for diagnosing, understanding, and monitoring disease.  Mol. imaging has distinguished itself as an interdisciplinary field, with contributions from chem., biol., physics, and medicine.  The cross-disciplinary impetus has led to significant achievements, such as the development of more sensitive imaging instruments and robust, safer radiopharmaceuticals, thereby providing more choices to fit personalized medical needs.  Mol. imaging is making steadfast progress in the field of cancer research among others.  Cancer is a challenging disease, characterized by heterogeneity, uncontrolled cell division, and the ability of cancer cells to invade other tissues.  Researchers are addressing these challenges by aggressively identifying and studying key cancer-specific biomarkers such as growth factor receptors, protein kinases, cell adhesion mols., and proteases, as well as cancer-related biol. processes such as hypoxia, apoptosis, and angiogenesis.  Positron emission tomog. (PET) is widely used by clinicians in the United States as a diagnostic mol. imaging tool.  Small-animal PET systems that can image rodents and generate reconstructed images in a noninvasive manner (with a resoln. as low as 1 mm) have been developed and are used frequently, facilitating radiopharmaceutical development and drug discovery.  Currently, [18F]-labeled 2-fluorodeoxyglucose (FDG) is the only PET radiotracer used for routine clin. evaluation (primarily for oncol. imaging).  There is now increasing interest in nontraditional positron-emitting radionuclides, particularly those of the transition metals, for imaging with PET because of increased prodn. and availability.  Copper-based radionuclides are currently being extensively evaluated because they offer a varying range of half-lives and positron energies.  For example, the half-life (12.7 h) and decay properties (β+, 0.653 MeV, 17.8%; β-, 0.579 MeV, 38.4 %; the remainder is electron capture) of 64Cu make it an ideal radioisotope for PET imaging and radiotherapy.  In addn., the well-established coordination chem. of copper allows for its reaction with a wide variety of chelator systems that can potentially be linked to antibodies, proteins, peptides, and other biol. relevant mols.  New chelators with greater in vivo stability, such as the cross-bridged (CB) versions of tetraazamacrocyclic 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), are now available.  Finally, one of the major aspects of successful imaging is the identification and characterization of a relevant disease biomarker at the cellular and subcellular level and the ensuing development of a highly specific targeting moiety.  In this Account, we discuss specific examples of PET imaging with new and improved 64Cu-based radiopharmaceuticals, highlighting the study of some of the key cancer biomarkers, such as epidermal growth-factor receptor (EGFR), somatostatin receptors (SSRs), and integrin αvβ3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSr7XcICUmKbVg90H21EOLACvtfcHk0liUR-DN0Vb8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmu7w%253D&md5=3cff4a2250ef2d284b06301c4abfe93f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Far800255q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800255q%26sid%3Dliteratum%253Aachs%26aulast%3DShokeen%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DMolecular%2520imaging%2520of%2520cancer%2520with%2520copper-64%2520radiopharmaceuticals%2520and%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26spage%3D832%26epage%3D841%26doi%3D10.1021%2Far800255q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferdani, R.</span><span> </span><span class="NLM_article-title">Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research</span> <span class="citation_source-journal">Cancer Biother.Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1089/cbr.2009.0674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1089%2Fcbr.2009.0674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19694573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGjurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=379-393&author=C.+J.+Andersonauthor=R.+Ferdani&title=Copper-64+radiopharmaceuticals+for+PET+imaging+of+cancer%3A+advances+in+preclinical+and+clinical+research&doi=10.1089%2Fcbr.2009.0674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research</span></div><div class="casAuthors">Anderson, Carolyn J.; Ferdani, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Copper-64 (T1/2 = 12.7 h; β+, 0.653 MeV [17.8 %]; β-, 0.579 MeV [38.4 %]) has decay characteristics that allow for positron emission tomog. (PET) imaging and targeted radiotherapy of cancer.  The well-established coordination chem. of copper allows for its reaction with a wide variety of chelator systems that can potentially be linked to peptides and other biol. relevant small mols., antibodies, proteins, and nanoparticles.  The 12.7-h half-life of 64Cu provides the flexibility to image both smaller mols. and larger, slower clearing proteins and nanoparticles.  In a practical sense, the radionuclide or the 64Cu-radiopharmaceuticals can be easily shipped for PET imaging studies at sites remote to the prodn. facility.  Due to the versatility of 64Cu, there has been an abundance of novel research in this area over the past 20 years, primarily in the area of PET imaging, but also for the targeted radiotherapy of cancer.  The biol. activity of the hypoxia imaging agent, 60/64Cu-ATSM, has been described in great detail in animal models and in clin. PET studies.  An investigational new drug application for 64Cu-ATSM was recently approved by the U.S.  Food and Drug Administration (FDA) in the United States, paving the way for a multicenter trial to validate the utility of this agent, with the hopeful result being FDA approval for routine clin. use.  This article discusses state-of-the-art cancer imaging with 64Cu radiopharmaceuticals, including 64Cu-ATSM for imaging hypoxia, 64Cu-labeled peptides for tumor-receptor targeting, 64Cu-labeled monoclonal antibodies for targeting tumor antigens, and 64Cu-labeled nanoparticles for cancer targeting.  The emphasis of this article will be on the new scientific discoveries involving 64Cu radiopharmaceuticals, as well as the translation of these into human studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ivKbROZRnLVg90H21EOLACvtfcHk0ljK2uFDYtqOPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGjurfJ&md5=05c77aece1da552fb15ea19e2385a5cc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2009.0674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2009.0674%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DFerdani%26aufirst%3DR.%26atitle%3DCopper-64%2520radiopharmaceuticals%2520for%2520PET%2520imaging%2520of%2520cancer%253A%2520advances%2520in%2520preclinical%2520and%2520clinical%2520research%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2009%26volume%3D24%26spage%3D379%26epage%3D393%26doi%3D10.1089%2Fcbr.2009.0674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Novak-Hofer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Copper-67 as a therapeutic nuclide for radioimmunotherapy</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1007/s00259-001-0724-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1007%2Fs00259-001-0724-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=12029558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVWms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=821-830&author=I.+Novak-Hoferauthor=P.+A.+Schubiger&title=Copper-67+as+a+therapeutic+nuclide+for+radioimmunotherapy&doi=10.1007%2Fs00259-001-0724-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-67 as a therapeutic nuclide for radioimmunotherapy</span></div><div class="casAuthors">Novak-Hofer, Ilse; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-830</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The application of the beta particle-emitting nuclide 67Cu in radioimmunotherapy is reviewed.  The prodn. of the nuclide is outlined, and different prodn. modes are discussed with an emphasis on cyclotron prodn.  A short survey of copper chelators currently used for antibody labeling and their impact on the pharmacokinetics of 67Cu-labeled immunoconjugates is provided.  Protocols for antibody labeling with 67Cu as well as quality control procedures for 67Cu-labeled antibodies are described.  Preclin. data on the biol. properties of 67Cu-labeled immunoconjugates are reported and discussed.  67Cu-labeled antibodies show higher and more persistent tumor uptake than their radioiodinated counterparts due to accumulation of labeled metabolites in tumor cells.  Biodistribution of 67Cu-labeled antibody fragments has been improved by selection of neg. charged chelators and peptide linkers.  Pharmacokinetic anal. of the accumulated dose in tumor and crit. organs such as the kidney and liver indicates that, despite this improvement, intact 67Cu-labeled antibodies achieve higher tumor uptake and better therapeutic ratios than 67Cu-labeled antibody fragments and that they are at present the logical choice for clin. studies.  Clin. studies using 67Cu-labeled antibodies in lymphoma, colon carcinoma and bladder cancer patients are reviewed.  Some of the advantages over radioiodinated antibodies found in the preclin. work, such as higher tumor uptake and better tumor/blood ratios, have also been found with systemic application in lymphoma and colon carcinoma.  However, in both lymphoma and colon carcinoma patients, the radiation dose to the liver has been found to be higher from 67Cu- than from 131I-labeled antibodies.  The intravesical application of 67Cu-labeled antibody has been shown to be a promising approach for targetting cytotoxic radiation to superficial bladder tumors, without detectable systemic absorption.  Given the favorable properties of 67Cu-labeled antibodies, it is the reliable availability of the 67Cu nuclide which is the limiting factor for their more widespread evaluation in radioimmunotherapy trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowQ_R2l7eBsrVg90H21EOLACvtfcHk0ljK2uFDYtqOPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVWms7k%253D&md5=ca43f817976afb92f37981c7aaef3c80</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00259-001-0724-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-001-0724-y%26sid%3Dliteratum%253Aachs%26aulast%3DNovak-Hofer%26aufirst%3DI.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DCopper-67%2520as%2520a%2520therapeutic%2520nuclide%2520for%2520radioimmunotherapy%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26spage%3D821%26epage%3D830%26doi%3D10.1007%2Fs00259-001-0724-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigsby, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Assessing tumor hypoxia in cervical cancer by positron emission tomography with <sup>60</sup>Cu-ATSM: relationship to therapeutic response-a preliminary report</span> <span class="citation_source-journal">Int. J. Radiat. Oncol., Biol., Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span><span class="refDoi"> DOI: 10.1016/S0360-3016(02)04477-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2FS0360-3016%2802%2904477-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=12654432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BD3s7jvFOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1233-1238&author=F.+Dehdashtiauthor=P.+W.+Grigsbyauthor=M.+A.+Mintunauthor=J.+S.+Lewisauthor=B.+A.+Siegelauthor=M.+J.+Welch&title=Assessing+tumor+hypoxia+in+cervical+cancer+by+positron+emission+tomography+with+60Cu-ATSM%3A+relationship+to+therapeutic+response-a+preliminary+report&doi=10.1016%2FS0360-3016%2802%2904477-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report</span></div><div class="casAuthors">Dehdashti Farrokh; Grigsby Perry W; Mintun Mark A; Lewis Jason S; Siegel Barry A; Welch Michael J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1233-8</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Tumor hypoxia is associated with poor response to therapy.  We have investigated whether pretreatment tumor hypoxia assessed by positron emission tomography (PET) with Cu-60 diacetyl-bis(N(4)-methylthiosemicarbazone) ((60)Cu-ATSM) predicts responsiveness to subsequent therapy in cervical cancer.  METHODS AND MATERIALS:  Fourteen patients with biopsy-proved cervical cancer were studied by PET with (60)Cu-ATSM before initiation of radiotherapy and chemotherapy. (60)Cu-ATSM uptake was evaluated semiquantitatively by determining the tumor-to-muscle activity ratio (T/M) and peak slope index of tumor tracer uptake.  All patients also underwent clinical PET with F-18 fluorodeoxyglucose (FDG) before institution of therapy.  The PET results were correlated with follow-up evaluation (14-24 months).  RESULTS:  Tumor uptake of (60)Cu-ATSM was inversely related to progression-free survival and overall survival (log-rank p = 0.0005 and p = 0.015, respectively).  An arbitrarily selected T/M threshold of 3.5 discriminated those likely to develop recurrence; 6 of 9 patients with normoxic tumors (T/M < 3.5) are free of disease at last follow-up, whereas all of 5 patients with hypoxic tumors (T/M > 3.5) have already developed recurrence.  Similar discrimination was achieved with the peak slope index.  The frequency of locoregional nodal metastasis was greater in hypoxic tumors (p = 0.03).  Tumor FDG uptake did not correlate with (60)Cu-ATSM uptake (r = 0.04; p = 0.80), and there was no significant difference in tumor FDG uptake between patients with hypoxic tumors and those with normoxic tumors.  CONCLUSION:  (60)Cu-ATSM-PET in patients with cervical cancer revealed clinically relevant information about tumor oxygenation that was predictive of tumor behavior and response to therapy in this small study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lBhgs5EX2BOk4JA3soTqfW6udTcc2eYEGTW-4WBG-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7jvFOqsQ%253D%253D&md5=af38a7d093673cad8c6703bcadb679d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2802%2904477-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252802%252904477-2%26sid%3Dliteratum%253Aachs%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DGrigsby%26aufirst%3DP.%2BW.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSiegel%26aufirst%3DB.%2BA.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DAssessing%2520tumor%2520hypoxia%2520in%2520cervical%2520cancer%2520by%2520positron%2520emission%2520tomography%2520with%252060Cu-ATSM%253A%2520relationship%2520to%2520therapeutic%2520response-a%2520preliminary%2520report%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2003%26volume%3D55%26spage%3D1233%26epage%3D1238%26doi%3D10.1016%2FS0360-3016%2802%2904477-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Colombie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frindel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraeber-Bodere, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, M.</span><span> </span><span class="NLM_article-title">Focus on the controversial aspects of <sup>64</sup>Cu-ATSM in tumoral hypoxia mapping by PET imaging</span> <span class="citation_source-journal">Front. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.3389/fmed.2015.00058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.3389%2Ffmed.2015.00058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BC283js1SntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=58&author=M.+Colombieauthor=S.+Gouardauthor=M.+Frindelauthor=A.+Vidalauthor=M.+Cherelauthor=C.+Rousseauauthor=F.+Kraeber-Bodereauthor=M.+Bourgeois&title=Focus+on+the+controversial+aspects+of+64Cu-ATSM+in+tumoral+hypoxia+mapping+by+PET+imaging&doi=10.3389%2Ffmed.2015.00058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging</span></div><div class="casAuthors">Colombie Mathilde; Gouard Sebastien; Frindel Mathieu; Vidal Aurelien; Cherel Michel; Rousseau Caroline; Kraeber-Bodere Francoise; Bourgeois Mickael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn">2296-858X</span>.
    </div><div class="casAbstract">Mapping tumor hypoxia is a great challenge in positron emission tomography (PET) imaging as the precise functional information of the biological processes is needed for many effective therapeutic strategies.  Tumor hypoxia has been widely reported as a poor prognostic indicator and is often associated with tumor aggressiveness, chemo- and radio-resistance.  An accurate diagnosis of hypoxia is a challenge and is crucial for providing accurate treatment for patients' survival benefits.  This challenge has led to the emergence of new and novel PET tracers for the functional and metabolic characterization of tumor hypoxia non-invasively.  Among these tracers, copper semicarbazone compound [64Cu]-diacetyl-bis(N (4)-methylthiosemicarbazone) (=64Cu-ATSM) has been developed as a tracer for hypoxia imaging.  This review focuses on 64Cu-ATSM PET imaging and the concept is presented in two sections.  The first section describes its in vitro development and pre-clinical testing and particularly its affinity in different cell lines.  The second section describes the controversial reports on its specificity for hypoxia imaging.  The review concludes that 64Cu-ATSM - more than a hypoxic tracer, exhibits tracer accumulation in tumor, which is linked to the redox potential and reactive oxygen species.  The authors concluded that 64Cu-ATSNM is a marker of over-reduced cell state and thus an indirect marker for hypoxia imaging.  The affinity of 64Cu-ATSM for over-reduced cells was observed to be a complex phenomenon.  And to provide a definitive and convincing mechanism, more in vivo studies are needed to prove the diagnostic utility of 64Cu-ATSM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdrHqiOVCAxbjnyZkbE8yXfW6udTcc2eakxZpI4H2LrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283js1SntA%253D%253D&md5=5b5c86bc4b45450230b6d3f8df4d3b16</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffmed.2015.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmed.2015.00058%26sid%3Dliteratum%253Aachs%26aulast%3DColombie%26aufirst%3DM.%26aulast%3DGouard%26aufirst%3DS.%26aulast%3DFrindel%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DA.%26aulast%3DCherel%26aufirst%3DM.%26aulast%3DRousseau%26aufirst%3DC.%26aulast%3DKraeber-Bodere%26aufirst%3DF.%26aulast%3DBourgeois%26aufirst%3DM.%26atitle%3DFocus%2520on%2520the%2520controversial%2520aspects%2520of%252064Cu-ATSM%2520in%2520tumoral%2520hypoxia%2520mapping%2520by%2520PET%2520imaging%26jtitle%3DFront.%2520Med.%26date%3D2015%26volume%3D2%26spage%3D58%26doi%3D10.3389%2Ffmed.2015.00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozzo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abiraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamma, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">PET of somatostatin receptor-positive tumors using <sup>64</sup>Cu- and <sup>68</sup>Ga-somatostatin antagonists: the chelate makes the difference</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1118</span><span class="refDoi"> DOI: 10.2967/jnumed.111.087999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.111.087999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21680701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1110-1118&author=M.+Faniauthor=L.+Del+Pozzoauthor=K.+Abirajauthor=R.+Mansiauthor=M.+L.+Tammaauthor=R.+Cescatoauthor=B.+Waserauthor=W.+A.+Weberauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=PET+of+somatostatin+receptor-positive+tumors+using+64Cu-+and+68Ga-somatostatin+antagonists%3A+the+chelate+makes+the+difference&doi=10.2967%2Fjnumed.111.087999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference</span></div><div class="casAuthors">Fani, Melpomeni; Del Pozzo, Luigi; Abiraj, Keelara; Mansi, Rosalba; Tamma, Maria Luisa; Cescato, Renzo; Waser, Beatrice; Weber, Wolfgang A.; Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1110-1118</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Somatostatin-based radiolabeled peptides have been successfully introduced into the clinic for targeted imaging and radionuclide therapy of somatostatin receptor (sst)-pos. tumors, esp. of subtype 2 (sst2).  The clin. used peptides are exclusively agonists.  Recently, we showed that radiolabeled antagonists may be preferable to agonists because they showed better pharmacokinetics, including higher tumor uptake.  Factors detg. the performance of radioantagonists have only scarcely been studied.  Here, we report on the development and evaluation of four 64Cu or 68Ga radioantagonists for PET of sst2-pos. tumors.  Methods: The novel antagonist p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 (LM3) was coupled to 3 macrocyclic chelators, namely 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane (CB-TE2A), 1,4,7-triazacyclononane, 1-glutaric acid-4,7-acetic acid (NODAGA), and DOTA.  64/natCu- and 68/natGa-NODAGA-LM3 were prepd. at room temp., and 64/natCu-CB-TE2A-LM3 and 68/natGa-DOTA-LM3 were prepd. at 95°C.  Binding affinity and antagonistic properties were detd. with receptor autoradiog. and immunofluorescence microscopy using human embryonic kidney (HEK)-sst2 cells.  In vitro internalization and dissocn. was evaluated using the same cell line.  Biodistribution and small-animal PET studies were performed with HEK-sst2 xenografts.  Results: All metallopeptides demonstrated antagonistic properties.  The affinities depend on chelator and radiometal and vary about 10-fold; 68/natGa-NODAGA-LM3 has the lowest half maximal inhibitory concn. (1.3 ± 0.3 nmol/L).  The biodistribution studies show impressive tumor uptake at 1 h after injection, particularly of 64Cu- and 68Ga-NODAGA-LM3 (∼40 percentage injected dose per g of tissue [%ID/g]), which were proven to be specific.  Background clearance was fast and the tumor washout relatively slow for 64Cu-NODAGA-LM3 (∼15 %ID/g, 24 h after injection) and almost negligible for 64Cu-CB-TE2A-LM3 (26.9 ± 3.3 %ID/g and 21.6 ± 2.1 %ID/g, 4 and 24 h after injection, resp.).  Tumor-to-normal-tissue ratios were significantly higher for 64Cu-NODAGA-LM3 than for 64Cu-CB-TE2A-LM3 (tumor-to-kidney, 12.8 ± 3.6 and 1.7 ± 0.3, resp.; tumor-to-muscle, 1,342 ± 115 and 75.2 ± 8.5, resp., at 24 h, P < 0.001).  Small-animal PET shows clear tumor localization and high image contrast, esp. for 64Cu- and 68Ga-NODAGA-LM3.  Conclusion: This article demonstrates the strong dependence of the affinity and pharmacokinetics of the somatostatin-based radioantagonists on the chelator and radiometal.  64Cu- and 68Ga-NODAGA-LM3 and 64Cu-CB-TE2A-LM3 are promising candidates for clin. translation because of their favorable pharmacokinetics and the high image contrast on PET scans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3cE0MTdcebVg90H21EOLACvtfcHk0lg78ZhzfL59Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVKltro%253D&md5=3225eb0d38a7e33658a8a5168e914497</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.087999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.087999%26sid%3Dliteratum%253Aachs%26aulast%3DFani%26aufirst%3DM.%26aulast%3DDel%2BPozzo%26aufirst%3DL.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DPET%2520of%2520somatostatin%2520receptor-positive%2520tumors%2520using%252064Cu-%2520and%252068Ga-somatostatin%2520antagonists%253A%2520the%2520chelate%2520makes%2520the%2520difference%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1110%26epage%3D1118%26doi%3D10.2967%2Fjnumed.111.087999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cooper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunassee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blower, P. J.</span><span> </span><span class="NLM_article-title">Comparison of <sup>64</sup>Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span><span class="refDoi"> DOI: 10.1021/bc300037w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc300037w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVyqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1029-1039&author=M.+S.+Cooperauthor=M.+T.+Maauthor=K.+Sunasseeauthor=K.+P.+Shawauthor=J.+D.+Williamsauthor=R.+L.+Paulauthor=P.+S.+Donnellyauthor=P.+J.+Blower&title=Comparison+of+64Cu-complexing+bifunctional+chelators+for+radioimmunoconjugation%3A+labeling+efficiency%2C+specific+activity%2C+and+in+vitro%2Fin+vivo+stability&doi=10.1021%2Fbc300037w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability</span></div><div class="casAuthors">Cooper, Maggie S.; Ma, Michelle T.; Sunassee, Kavitha; Shaw, Karen P.; Williams, Jennifer D.; Paul, Rowena L.; Donnelly, Paul S.; Blower, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1029-1039</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High radiolabeling efficiency, preferably to high specific activity, and good stability of the radioimmunoconjugate are essential features for a successful immunoconjugate for imaging or therapy.  In this study, the radiolabeling efficiency, in vitro stability, and biodistribution of immunoconjugates with eight different bifunctional chelators labeled with 64Cu were compared.  The anti-CD20 antibody, rituximab, was conjugated to four macrocyclic bifunctional chelators (p-SCN-Bn-DOTA, p-SCN-Bn-Oxo-DO3A, p-SCN-NOTA, and p-SCN-PCTA), three DTPA derivs. (p-SCN-Bn-DTPA, p-SCN-CHX-A''-DTPA, and ITC-2B3M-DTPA), and a macrobicyclic hexamine (sarcophagine) chelator (sar-CO2H) = (1-NH2-8-NHCO(CH2)3CO2H)sar where sar = sarcophagine = 3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane.  Radiolabeling efficiency under various conditions, in vitro stability in serum at 37 °C, and in vivo biodistribution and imaging in normal mice over 48 h were studied.  All chelators except sar-CO2H were conjugated to rituximab by thiourea bond formation with an av. of 4.9 ± 0.9 chelators per antibody mol.  Sar-CO2H was conjugated to rituximab by amide bond formation with 0.5 chelators per antibody mol.  Efficiencies of 64Cu radiolabeling were dependent on the concn. of immunoconjugate.  Notably, the 64Cu-NOTA-rituximab conjugate demonstrated the highest radiochem. yield (95%) under very dil. conditions (31 nM NOTA-rituximab conjugate).  Similarly, sar-CO-rituximab, contg. 1/10th the no. of chelators per antibody compared to that of other conjugates, retained high labeling efficiency (98%) at an antibody concn. of 250 nM.  In contrast to the radioimmunoconjugates contg. DTPA derivs., which demonstrated poor serum stability, all macrocyclic radioimmunoconjugates were very stable in serum with <6% dissocn. of 64Cu over 48 h.  In vivo biodistribution profiles in normal female Balb/C mice were similar for all the macrocyclic radioimmunoconjugates with most of the activity remaining in the blood pool up to 48 h.  While all the macrocyclic bifunctional chelators are suitable for mol. imaging using 64Cu-labeled antibody conjugates, NOTA and sar-CO2H show significant advantages over the others in that they can be radiolabeled rapidly at room temp., under dil. conditions, resulting in high specific activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIRxZd_GKqI7Vg90H21EOLACvtfcHk0lgvxuPmooZF3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVyqurg%253D&md5=649071237104b7aaffb6d032acce51da</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbc300037w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc300037w%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DM.%2BT.%26aulast%3DSunassee%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DK.%2BP.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPaul%26aufirst%3DR.%2BL.%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26aulast%3DBlower%26aufirst%3DP.%2BJ.%26atitle%3DComparison%2520of%252064Cu-complexing%2520bifunctional%2520chelators%2520for%2520radioimmunoconjugation%253A%2520labeling%2520efficiency%252C%2520specific%2520activity%252C%2520and%2520in%2520vitro%252Fin%2520vivo%2520stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D1029%26epage%3D1039%26doi%3D10.1021%2Fbc300037w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bartholomä, M. D.</span><span> </span><span class="NLM_article-title">Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in positron emission tomography</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.ica.2012.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.ica.2012.01.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2012&pages=36-51&author=M.+D.+Bartholom%C3%A4&title=Recent+developments+in+the+design+of+bifunctional+chelators+for+metal-based+radiopharmaceuticals+used+in+positron+emission+tomography&doi=10.1016%2Fj.ica.2012.01.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2012.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2012.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DBartholom%25C3%25A4%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520bifunctional%2520chelators%2520for%2520metal-based%2520radiopharmaceuticals%2520used%2520in%2520positron%2520emission%2520tomography%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2012%26volume%3D389%26spage%3D36%26epage%3D51%26doi%3D10.1016%2Fj.ica.2012.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zeglis, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span> </span><span class="NLM_article-title">A practical guide to the construction of radiometallated bioconjugates for positron emission tomography</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">6168</span><span class="NLM_x">–</span> <span class="NLM_lpage">6195</span><span class="refDoi"> DOI: 10.1039/c0dt01595d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fc0dt01595d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21442098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvF2qtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=6168-6195&author=B.+M.+Zeglisauthor=J.+S.+Lewis&title=A+practical+guide+to+the+construction+of+radiometallated+bioconjugates+for+positron+emission+tomography&doi=10.1039%2Fc0dt01595d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A practical guide to the construction of radiometallated bioconjugates for positron emission tomography</span></div><div class="casAuthors">Zeglis, Brian M.; Lewis, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6168-6195</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) has become a vital imaging modality in the diagnosis and treatment of disease, most notably cancer.  A wide array of small mol. PET radiotracers have been developed that employ the short half-life radionuclides 11C, 13N, 15O, and 18F.  However, PET radiopharmaceuticals based on biomol. targeting vectors have been the subject of dramatically increased research in both the lab. and the clinic.  Typically based on antibodies, oligopeptides, or oligonucleotides, these tracers have longer biol. half-lives than their small mol. counterparts and thus require labeling with radionuclides with longer, complementary radioactive half-lives, such as the metallic isotopes 64Cu, 68Ga, 86Y, and 89Zr.  Each bioconjugate radiopharmaceutical has four component parts: biomol. vector, radiometal, chelator, and covalent link between chelator and biomol.  With the exception of the radiometal, a tremendous variety of choices exists for each of these pieces, and a plethora of different chelation, conjugation, and radiometallation strategies have been utilized to create agents ranging from 68Ga-labeled pentapeptides to 89Zr-labeled monoclonal antibodies.  Herein, the authors present a practical guide to the construction of radiometal-based PET bioconjugates, in which the design choices and synthetic details of a wide range of biomol. tracers from the literature are collected in a single ref.  In assembling this information, the authors hope both to illuminate the diverse methods employed in the synthesis of these agents and also to create a useful ref. for mol. imaging researchers both experienced and new to the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwQWOZx3f1_7Vg90H21EOLACvtfcHk0lj7LKTJg2Lrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvF2qtbc%253D&md5=b8a2d89b48d24ca03115350dc37ff2e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1039%2Fc0dt01595d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt01595d%26sid%3Dliteratum%253Aachs%26aulast%3DZeglis%26aufirst%3DB.%2BM.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26atitle%3DA%2520practical%2520guide%2520to%2520the%2520construction%2520of%2520radiometallated%2520bioconjugates%2520for%2520positron%2520emission%2520tomography%26jtitle%3DDalton%2520Trans.%26date%3D2011%26volume%3D40%26spage%3D6168%26epage%3D6195%26doi%3D10.1039%2Fc0dt01595d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Liu, S.</span><span> </span><span class="NLM_article-title">Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delevery of metallic radionuclides</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.addr.2008.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1347-1370&author=S.+Liu&title=Bifunctional+coupling+agents+for+radiolabeling+of+biomolecules+and+target-specific+delevery+of+metallic+radionuclides&doi=10.1016%2Fj.addr.2008.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DBifunctional%2520coupling%2520agents%2520for%2520radiolabeling%2520of%2520biomolecules%2520and%2520target-specific%2520delevery%2520of%2520metallic%2520radionuclides%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1347%26epage%3D1370%26doi%3D10.1016%2Fj.addr.2008.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span> </span><span class="NLM_article-title">New Bifunctional chelator p-SCN-PhPr-NE3TA for copper-64: synthesis, peptidomimetic conjugation, radiolabeling, and evaluation for PET imaging</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6892</span><span class="NLM_x">–</span> <span class="NLM_lpage">6901</span><span class="refDoi"> DOI: 10.1021/acs.inorgchem.6b00395</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.6b00395" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6892-6901&author=Y.+Gaiauthor=L.+Sunauthor=W.+Huiauthor=Q.+Ouyangauthor=C.+J.+Andersonauthor=G.+Xiangauthor=X.+Maauthor=D.+Zeng&title=New+Bifunctional+chelator+p-SCN-PhPr-NE3TA+for+copper-64%3A+synthesis%2C+peptidomimetic+conjugation%2C+radiolabeling%2C+and+evaluation+for+PET+imaging&doi=10.1021%2Facs.inorgchem.6b00395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging</span></div><div class="casAuthors">Gai, Yongkang; Sun, Lingyi; Hui, Wenqi; Ouyang, Qin; Anderson, Carolyn J.; Xiang, Guangya; Ma, Xiang; Zeng, Dexing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6892-6901</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional chelators play an important role in developing metallic radionuclide-based radiopharmaceuticals.  In this study, a new bifunctional ligand, p-SCN-PhPr-NE3TA, was synthesized and conjugated to a very late antigen-4 targeting peptidomimetic, LLP2A, for evaluating its application in 64Cu-based positron emission tomog. (PET) imaging.  The new ligand exhibited strong selective coordination of Cu(II), leading to a robust Cu complex, even in the presence of 10-fold Fe(III).  The LLP2A conjugate of p-SCN-PhPr-NE3TA was prepd. and successfully labeled with 64Cu under mild conditions.  The conjugate 64Cu-NE3TA-PEG4-LLP2A showed significantly higher specific activity, compared with 64Cu-NOTA-PEG4-LLP2A, while maintaining comparable serum stability.  Subsequent biodistribution studies and PET imaging in mice bearing B16F10 xenografts confirmed its favorable in vivo performance and high tumor uptake with low background, rendering p-SCN-PhPr-NE3TA a promising bifunctional chelator for 64Cu-based radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGDhBmWZMe2bVg90H21EOLACvtfcHk0lj7LKTJg2Lrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrsr7I&md5=135aafec41d1f1ad93a2b45d50d3607f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.6b00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.6b00395%26sid%3Dliteratum%253Aachs%26aulast%3DGai%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHui%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DQ.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DXiang%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DNew%2520Bifunctional%2520chelator%2520p-SCN-PhPr-NE3TA%2520for%2520copper-64%253A%2520synthesis%252C%2520peptidomimetic%2520conjugation%252C%2520radiolabeling%252C%2520and%2520evaluation%2520for%2520PET%2520imaging%26jtitle%3DInorg.%2520Chem.%26date%3D2016%26volume%3D55%26spage%3D6892%26epage%3D6901%26doi%3D10.1021%2Facs.inorgchem.6b00395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pandya, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phapale, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Revival of TE2A; a better chelate for Cu(II) ions than TETA?</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3519</span><span class="refDoi"> DOI: 10.1039/b925703a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1039%2Fb925703a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=3517-3519&author=D.+N.+Pandyaauthor=J.+Y.+Kimauthor=J.+C.+Parkauthor=H.+Leeauthor=P.+B.+Phapaleauthor=W.+Kwakauthor=T.+H.+Choiauthor=G.+J.+Cheonauthor=Y.-R.+Yoonauthor=J.+Yoo&title=Revival+of+TE2A%3B+a+better+chelate+for+Cu%28II%29+ions+than+TETA%3F&doi=10.1039%2Fb925703a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fb925703a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb925703a%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DD.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPhapale%26aufirst%3DP.%2BB.%26aulast%3DKwak%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DT.%2BH.%26aulast%3DCheon%26aufirst%3DG.%2BJ.%26aulast%3DYoon%26aufirst%3DY.-R.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DRevival%2520of%2520TE2A%253B%2520a%2520better%2520chelate%2520for%2520Cu%2528II%2529%2520ions%2520than%2520TETA%253F%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D3517%26epage%3D3519%26doi%3D10.1039%2Fb925703a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">8674</span><span class="NLM_x">–</span> <span class="NLM_lpage">8682</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1158%2F1078-0432.CCR-04-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=15623652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=8674-8682&author=J.+E.+Spragueauthor=Y.+Pengauthor=X.+Sunauthor=G.+R.+Weismanauthor=E.+H.+Wongauthor=S.+Achilefuauthor=C.+J.+Anderson&title=Preparation+and+biological+evaluation+of+copper-64-labeled+tyr3-octreotate+using+a+cross-bridged+macrocyclic+chelator&doi=10.1158%2F1078-0432.CCR-04-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and biological evaluation of copper-64-labeled Tyr3-octreotate using a cross-bridged macrocyclic chelator</span></div><div class="casAuthors">Sprague, Jennifer E.; Peng, Yijie; Sun, Xiankai; Weisman, Gary R.; Wong, Edward H.; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8674-8682</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatostatin receptors (SSTr) are expressed on many neuroendocrine tumors, and several radiotracers have been developed for imaging these types of tumors.  For this reason, peptide analogs of somatostatin have been well characterized.  Copper-64 (t1/2 = 12.7 h), a positron emitter suitable for positron emission tomog. (PET) imaging, was shown recently to have improved in vivo clearance properties when chelated by the cross-bridged tetraazamacrocycle 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo(6.6.2)hexadecane (CB-TE2A) compared with 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA).  CB-TE2A and TETA were conjugated to the somatostatin analog tyrosine-3-octreotate (Y3-TATE) for evaluation of CB-TE2A as a bifunctional chelator of 64Cu.  The in vitro affinity of each compd. for SSTr was detd. using a homologous competitive binding assay.  In vivo characteristics of both radiolabeled compds. were examd. in biodistribution and microPET studies of AR42J tumor-bearing rats.  Cu-CB-TE2A-Y3-TATE (Kd = 1.7 nmol/L) and Cu-TETA-Y3-TATE (Kd = 0.7 nmol/L) showed similar affinities for AR42J derived SSTr.  In biodistribution studies, nonspecific uptake in blood and liver was lower for 64Cu-CB-TE2A-Y3-TATE.  Differences increased with time such that, at 4 h, blood uptake was 4.3-fold higher and liver uptake was 2.4-fold higher for 64Cu-TETA-Y3-TATE than for 64Cu-CB-TE2A-Y3-TATE.  In addn., 4.4-times greater tumor uptake was detected with 64Cu-CB-TE2A-Y3-TATE than with 64Cu-TETA-Y3-TATE at 4 h postinjection.  MicroPET imaging yielded similar results.  CB-TE2A appears to be a superior in vivo bifunctional chelator of 64Cu for use in mol. imaging by PET or targeted radiotherapy due to both improved nontarget organ clearance and higher target organ uptake of 64Cu-CB-TE2A-Y3-TATE compared with 64Cu-TETA-Y3-TATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8F6EJwbpAbVg90H21EOLACvtfcHk0ljlHju_SSQMYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsL7F&md5=645d85d633c7cc512392f9ec2c33d68d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1084%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%2520copper-64-labeled%2520tyr3-octreotate%2520using%2520a%2520cross-bridged%2520macrocyclic%2520chelator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D8674%26epage%3D8682%26doi%3D10.1158%2F1078-0432.CCR-04-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Singh, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakanali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramezani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span> </span><span class="NLM_article-title">Enantiopure bifunctional chelators for copper radiopharmaceuticals - does chirality matter in radiotracer design?</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.ejmech.2014.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=24793881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovValtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=308-315&author=A.+N.+Singhauthor=M.+Dakanaliauthor=G.+Haoauthor=S.+Ramezaniauthor=A.+Kumarauthor=X.+Sun&title=Enantiopure+bifunctional+chelators+for+copper+radiopharmaceuticals+-+does+chirality+matter+in+radiotracer+design%3F&doi=10.1016%2Fj.ejmech.2014.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiopure bifunctional chelators for copper radiopharmaceuticals - Does chirality matter in radiotracer design?</span></div><div class="casAuthors">Singh, Ajay N.; Dakanali, Marianna; Hao, Guiyang; Ramezani, Saleh; Kumar, Amit; Sun, Xiankai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">It is well recognized that carbon chirality plays a crit. role in the design of drug mols.  However, very little information is available regarding the effect of stereoisomerism of macrocyclic bifunctional chelators (BFC) on biol. behaviors of the corresponding radiopharmaceuticals.  To evaluate such effects, three enantiopure stereoisomers of a copper radiopharmaceutical BFC bearing two chiral carbon atoms were synthesized in forms of R,R-, S,S-, and R,S-.  Their corresponding peptide conjugates were prepd. by coupling with a model peptide sequence, c(RGDyK), which targets the αvβ3 integrin for in vitro and in vivo evaluation of their biol. behaviors as compared to the racemic conjugate.  Despite the chirality differences, all the conjugates showed a similar in vitro binding affinity profile to the αvβ3 integrin (106, 108, 85 and 100 nM for rac-H2-1, RR-H2-1, SS-H2-1, and RS-H2-1 resp. with all p values > 0.05) and a similar level of in vivo tumor uptake (2.72 ± 0.45, 2.60 ± 0.52, 2.45 ± 0.48 and 2.88 ± 0.59 for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 at 1 h p.i. resp.).  Furthermore, they demonstrated a nearly identical biodistribution pattern in major organs (e.g. 2.07 ± 0.21, 2.13 ± 0.58, 1.70 ± 0.20 and 1.90 ± 0.46 %ID/g at 24 h p.i. in liver for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 resp.; 1.80 ± 0.46, 2.30 ± 1.49, 1.73 ± 0.31 and 2.23 ± 0.71 at 24 h p.i. in kidneys for rac-64Cu-1, RR-64Cu-1, SS-64Cu-1, and RS-64Cu-1 resp.).  Therefore we conclude that the chirality of BFC plays a negligible role in αvβ3-targeted copper radiopharmaceuticals.  However, we believe it is still worthwhile to consider the chirality effects of BFCs on other targeted imaging or therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7eBxXpReeKLVg90H21EOLACvtfcHk0lgtyV-A3VvNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovValtbg%253D&md5=2e522d5d36a4a954a7cc4dea4efa931f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%2BN.%26aulast%3DDakanali%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DRamezani%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DEnantiopure%2520bifunctional%2520chelators%2520for%2520copper%2520radiopharmaceuticals%2520-%2520does%2520chirality%2520matter%2520in%2520radiotracer%2520design%253F%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D308%26epage%3D315%26doi%3D10.1016%2Fj.ejmech.2014.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chong, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwamena, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milenic, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M. W.</span><span> </span><span class="NLM_article-title">Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1021/jm070401q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070401q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=118-125&author=H.-S.+Chongauthor=X.+Maauthor=T.+Leauthor=B.+Kwamenaauthor=D.+E.+Milenicauthor=E.+D.+Bradyauthor=H.+A.+Songauthor=M.+W.+Brechbiel&title=Rational+design+and+generation+of+a+bimodal+bifunctional+ligand+for+antibody-targeted+radiation+cancer+therapy&doi=10.1021%2Fjm070401q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm070401q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070401q%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DH.-S.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DKwamena%26aufirst%3DB.%26aulast%3DMilenic%26aufirst%3DD.%2BE.%26aulast%3DBrady%26aufirst%3DE.%2BD.%26aulast%3DSong%26aufirst%3DH.%2BA.%26aulast%3DBrechbiel%26aufirst%3DM.%2BW.%26atitle%3DRational%2520design%2520and%2520generation%2520of%2520a%2520bimodal%2520bifunctional%2520ligand%2520for%2520antibody-targeted%2520radiation%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D118%26epage%3D125%26doi%3D10.1021%2Fjm070401q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzei, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheingold, A. L.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">10561</span><span class="NLM_x">–</span> <span class="NLM_lpage">10572</span><span class="refDoi"> DOI: 10.1021/ja001295j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja001295j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlektb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=10561-10572&author=E.+H.+Wongauthor=G.+R.+Weismanauthor=D.+C.+Hillauthor=D.+P.+Reedauthor=M.+E.+Rogersauthor=J.+S.+Condonauthor=M.+A.+Faganauthor=J.+C.+Calabreseauthor=K.-C.+Lamauthor=I.+A.+Guzeiauthor=A.+L.+Rheingold&title=Synthesis+and+characterization+of+cross-bridged+cyclams+and+pendant-armed+derivatives+and+structural+studies+of+their+copper%28II%29+complexes&doi=10.1021%2Fja001295j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Cross-Bridged Cyclams and Pendant-Armed Derivatives and Structural Studies of Their Copper(II) Complexes</span></div><div class="casAuthors">Wong, Edward H.; Weisman, Gary R.; Hill, Daniel C.; Reed, David P.; Rogers, Mark E.; Condon, Jeffrey S.; Fagan, Maureen A.; Calabrese, Joseph C.; Lam, Kin-Chung; Guzei, Ilia A.; Rheingold, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10561-10572</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4,8,11-Tetraazabicyclo[6.6.2]hexadecane ligands, including the parent compd., N,N'-dialkyl variants, and the 1st N,N'-di-pendant-arm derivs. were synthesized by a short, efficient, and conceptually novel approach.  Their Cu(II) complexes were prepd., and four of these were structurally characterized by x-ray diffraction.  In all four complexes, the cross-bridged tetraamine ligand is cis-folded, coordinating the metal cation within its mol. cleft using all four N lone pairs.  Geometries intermediate between idealized square pyramidal and trigonal bipyramidal coordination were found for three of the complexes, whereas a distorted octahedral Cu coordination was found for the complex of a di-pendant-arm cross-bridged cyclam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn1D2clrDYp7Vg90H21EOLACvtfcHk0lgtyV-A3VvNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlektb8%253D&md5=775e07e05132769aa54f7d81ba6c83d5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja001295j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001295j%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BC.%26aulast%3DReed%26aufirst%3DD.%2BP.%26aulast%3DRogers%26aufirst%3DM.%2BE.%26aulast%3DCondon%26aufirst%3DJ.%2BS.%26aulast%3DFagan%26aufirst%3DM.%2BA.%26aulast%3DCalabrese%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DK.-C.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520cross-bridged%2520cyclams%2520and%2520pendant-armed%2520derivatives%2520and%2520structural%2520studies%2520of%2520their%2520copper%2528II%2529%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D10561%26epage%3D10572%26doi%3D10.1021%2Fja001295j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pandya, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Propylene cross-bridged macrocyclic bifunctional chelator: a new design for facile bioconjugation and robust <sup>64</sup>Cu complex stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7234</span><span class="NLM_x">–</span> <span class="NLM_lpage">7243</span><span class="refDoi"> DOI: 10.1021/jm500348z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500348z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlynurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7234-7243&author=D.+N.+Pandyaauthor=N.+Bhattauthor=G.+I.+Anauthor=Y.+S.+Haauthor=N.+Soniauthor=H.+Leeauthor=Y.+J.+Leeauthor=J.+Y.+Kimauthor=W.+Leeauthor=H.+Ahnauthor=J.+Yoo&title=Propylene+cross-bridged+macrocyclic+bifunctional+chelator%3A+a+new+design+for+facile+bioconjugation+and+robust+64Cu+complex+stability&doi=10.1021%2Fjm500348z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Propylene Cross-Bridged Macrocyclic Bifunctional Chelator: A New Design for Facile Bioconjugation and Robust 64Cu Complex Stability</span></div><div class="casAuthors">Pandya, Darpan N.; Bhatt, Nikunj; An, Gwang Il; Ha, Yeong Su; Soni, Nisarg; Lee, Hochun; Lee, Yong Jin; Kim, Jung Young; Lee, Woonghee; Ahn, Heesu; Yoo, Jeongsoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7234-7243</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first macrocyclic bifunctional chelator incorporating propylene cross-bridge was efficiently synthesized from cyclam in seven steps.  After the introduction of an extra functional group for facile conjugation onto the propylene cross-bridge, the two carboxylic acid pendants could contribute to strong coordination of Cu(II) ions, leading to a robust Cu complex.  The cyclic RGD peptide conjugate of PCB-TE2A-NCS was prepd. and successfully radiolabeled with 64Cu ion.  The radiolabeled peptide conjugate was evaluated in vivo through a biodistribution study and animal PET imaging to demonstrate high tumor uptake with low background.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3oPJ6cdJ1P7Vg90H21EOLACvtfcHk0li8akH9M62g6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlynurjF&md5=12cea84ece6de1385c445fdaa79d19d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm500348z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500348z%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DD.%2BN.%26aulast%3DBhatt%26aufirst%3DN.%26aulast%3DAn%26aufirst%3DG.%2BI.%26aulast%3DHa%26aufirst%3DY.%2BS.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DAhn%26aufirst%3DH.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DPropylene%2520cross-bridged%2520macrocyclic%2520bifunctional%2520chelator%253A%2520a%2520new%2520design%2520for%2520facile%2520bioconjugation%2520and%2520robust%252064Cu%2520complex%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7234%26epage%3D7243%26doi%3D10.1021%2Fjm500348z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boswell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of <sup>64</sup>Cu-TETA-1A3 with <sup>64</sup>Cu-BAT-2IT-1A3</span> <span class="citation_source-journal">Cancer Biother.Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1089/10849780152752083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1089%2F10849780152752083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=11789025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=483-494&author=M.+R.+Lewisauthor=C.+A.+Boswellauthor=R.+Laforestauthor=T.+L.+Buettnerauthor=D.+Yeauthor=J.+M.+Connettauthor=C.+J.+Anderson&title=Conjugation+of+monoclonal+antibodies+with+TETA+using+activated+esters%3A+biological+comparison+of+64Cu-TETA-1A3+with+64Cu-BAT-2IT-1A3&doi=10.1089%2F10849780152752083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of monoclonal antibodies with TETA using activated esters: Biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3</span></div><div class="casAuthors">Lewis, Michael R.; Boswell, C. Andrew; Laforest, Richard; Buettner, Thomas L.; Ye, Dan; Connett, Judith M.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-494</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A simple method for conjugation of monoclonal antibodies (mAbs) with the chelating agent 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), has been developed using com. available reagents.  This method involved activation of a single carboxyl group of TETA with N-hydroxysulfo-succinimide and 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide.  The resulting activated ester of TETA was reacted with the anti-colorectal carcinoma mAb 1A3 at molar ratios ranging from 10:1 to 100:1 to give immunoconjugates modified with an av. of 0.4 to 2.0 functional chelators per antibody mol.  The TETA-1A3 conjugate was labeled with 64Cu at specific activities as high as 15.4 μCi/μg, and the radiolabeled mAb exhibited high in vitro serum stability and minimal loss of immunoreactivity.  The biodistribution of 64Cu-labeled TETA-1A3 in hamsters bearing GW39 human colon carcinoma xenografts was compared to that of 64Cu-BAT-2IT-1A3 (BAT = 6-(p-bromoacetamidobenzyl)-1,4,8,11-tetraazacy- clotetradecane-1,4,8,11-tetraacetic acid; 2IT = 2-iminothiolane).  Both conjugates showed high tumor uptake (6.60-9.05% injected dose/g) from 24 to 48 h post-injection and generally similar blood clearance and non-target organ uptakes.  Human absorbed dose ests. derived from the hamster biodistribution data showed the crit. organs for both conjugates to be the large intenstine and the red marrow.  Our results suggest that the in vitro and in vivo performance characteristics of 64Cu-TETA-1A3 compare favorably with those of 64Cu-BAT-2IT-1A3 and that further evaluation of the diagnostic and therapeutic efficacy of 64Cu-TETA-1A3 is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrEeHOLjrJP7Vg90H21EOLACvtfcHk0li8akH9M62g6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFeguw%253D%253D&md5=09b5a01678a8d3d18d78eca55ce9cc9f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1089%2F10849780152752083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F10849780152752083%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DT.%2BL.%26aulast%3DYe%26aufirst%3DD.%26aulast%3DConnett%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DConjugation%2520of%2520monoclonal%2520antibodies%2520with%2520TETA%2520using%2520activated%2520esters%253A%2520biological%2520comparison%2520of%252064Cu-TETA-1A3%2520with%252064Cu-BAT-2IT-1A3%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2001%26volume%3D16%26spage%3D483%26epage%3D494%26doi%3D10.1089%2F10849780152752083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lewis, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shively, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raubitschek, A.</span><span> </span><span class="NLM_article-title">An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1021/bc0000886</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc0000886" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=320-324&author=M.+R.+Lewisauthor=J.+Y.+Kaoauthor=A.+L.+Andersonauthor=J.+E.+Shivelyauthor=A.+Raubitschek&title=An+improved+method+for+conjugating+monoclonal+antibodies+with+N-hydroxysulfosuccinimidyl+DOTA&doi=10.1021%2Fbc0000886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for conjugating monoclonal antibodies with N-Hydroxysulfosuccinimidyl DOTA</span></div><div class="casAuthors">Lewis, Michael R.; Kao, Jim Y.; Anderson, Anne-Line J.; Shively, John E.; Raubitschek, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-324</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple, water-sol. procedure for conjugation of monoclonal antibodies to 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) has been improved by optimizing pH, buffer, and temp. conditions for the prepn. of N-hydroxysulfosuccinimidyl DOTA and its conjugation to the human/murine chimeric anti-carcinoembryonic antigen antibody cT84.66.  This improved method results in a 6-fold increase in conjugation efficiency, a 3-7-fold decrease in antibody crosslinking, a more homogeneous population of conjugate species, and a 5-fold decrease in the quantities of reagents needed for conjugation.  The cT84.66-DOTA conjugate was labeled to high specific activity with 111In, 90Y, 88Y, 64Cu, and 67Cu, affording near-quant. incorporation of the majority of these radiometals.  This improved conjugation procedure facilitates large-scale prodn. and radiometal labeling of cT84.66-DOTA for clin. radioimmunotherapy trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlh2xDQwZWrVg90H21EOLACvtfcHk0lho7ho4PV5YoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsrk%253D&md5=eb05ee3c229d397826dabdb3089c6e9b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbc0000886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0000886%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BR.%26aulast%3DKao%26aufirst%3DJ.%2BY.%26aulast%3DAnderson%26aufirst%3DA.%2BL.%26aulast%3DShively%26aufirst%3DJ.%2BE.%26aulast%3DRaubitschek%26aufirst%3DA.%26atitle%3DAn%2520improved%2520method%2520for%2520conjugating%2520monoclonal%2520antibodies%2520with%2520N-hydroxysulfosuccinimidyl%2520DOTA%26jtitle%3DBioconjugate%2520Chem.%26date%3D2001%26volume%3D12%26spage%3D320%26epage%3D324%26doi%3D10.1021%2Fbc0000886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Litau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibold, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vall-Sagarra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span> </span><span class="NLM_article-title">Comparative assessment of complex stabilities of radiocopper chelating agents by a combination of complex challenge and in vivo experiments</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1002/cmdc.201500132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1002%2Fcmdc.201500132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1200-1208&author=S.+Litauauthor=U.+Seiboldauthor=A.+Vall-Sagarraauthor=G.+Frickerauthor=B.+W%C3%A4nglerauthor=C.+W%C3%A4ngler&title=Comparative+assessment+of+complex+stabilities+of+radiocopper+chelating+agents+by+a+combination+of+complex+challenge+and+in+vivo+experiments&doi=10.1002%2Fcmdc.201500132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500132%26sid%3Dliteratum%253Aachs%26aulast%3DLitau%26aufirst%3DS.%26aulast%3DSeibold%26aufirst%3DU.%26aulast%3DVall-Sagarra%26aufirst%3DA.%26aulast%3DFricker%26aufirst%3DG.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26atitle%3DComparative%2520assessment%2520of%2520complex%2520stabilities%2520of%2520radiocopper%2520chelating%2520agents%2520by%2520a%2520combination%2520of%2520complex%2520challenge%2520and%2520in%2520vivo%2520experiments%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1200%26epage%3D1208%26doi%3D10.1002%2Fcmdc.201500132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Small-animal PET of tumors with <sup>64</sup>Cu-labeled RGD-bombesin heterodimer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.2967/jnumed.108.061739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.108.061739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19525469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2gsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1168-1177&author=Z.+Liuauthor=Z.-B.+Liauthor=Q.+Caoauthor=S.+Liuauthor=F.+Wangauthor=X.+Chen&title=Small-animal+PET+of+tumors+with+64Cu-labeled+RGD-bombesin+heterodimer&doi=10.2967%2Fjnumed.108.061739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-animal PET of tumors with 64Cu-labeled RGD-bombesin heterodimer</span></div><div class="casAuthors">Liu, Zhaofei; Li, Zi-Bo; Cao, Qizhen; Liu, Shuanglong; Wang, Fan; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1168-1177</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The overexpression of gastrin-releasing peptide receptor (GRPR) in various tumor types suggests that GRPR is an attractive target for cancer imaging and therapy with radiolabeled bombesin analogs.  We recently reported the ability of 18F-labeled RGD-bombesin heterodimer to be used for dual integrin αvβ3- and GRPR-targeted imaging.  To further investigate the synergistic effect of the dual-receptor targeting of peptide heterodimers, we evaluated 64Cu-labeled RGD-bombesin for PET imaging of tumors.  Methods: RGD-bombesin was coupled with 1,4,7,10-tetraazacyclododecane-N, N', N'', N'''-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), and the conjugates were labeled with 64Cu.  The in vitro and in vivo characteristics of 64Cu-NOTA-RGD-bombesin were compared with those of 64Cu-NOTA-RGD, 64Cu-NOTA-bombesin, and 64Cu-DOTA-RGD-bombesin.  Results: 64Cu-NOTA-RGD-bombesin and 64Cu-DOTA-RGD-bombesin had comparable dual integrin αvβ3- and GRPR-binding affinities in vitro, both of which were slightly lower than RGD for integrin binding and bombesin for GRPR binding.  64Cu-NOTA-RGD-bombesin possessed significantly higher tumor uptake than did 64Cu-NOTA-RGD, 64Cu-NOTA-bombesin, the mixt. of 64Cu-NOTA-RGD and 64Cu-NOTA-bombesin, or 64Cu-DOTA-RGD-bombesin in PC-3 prostate cancer.  64Cu-NOTA-RGD-bombesin also showed improved in vivo kinetics such as lower liver and intestinal activity accumulation than did the bombesin tracers.  64Cu-NOTA-RGD-bombesin also outperformed 64Cu-NOTA-RGD in a 4T1 murine mammary carcinoma model that expresses integrin on tumor vasculature but no GRPR in tumor tissue, which had no uptake of 64Cu-NOTA-bombesin.  Conclusion: Compared with other tracers, 64Cu-NOTA-RGD-bombesin showed favorable in vivo kinetics and enhanced tumor uptake, which warrants its further investigation for targeting tumors that express integrin or GRPR or that coexpress integrin and GRPR for imaging and therapeutic applications.  The synergistic effect of RGD-bombesin heterodimers obsd. in this study also encourages further investigations of novel heterodimers recognizing other cell surface receptors for tumor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCpydvyLFVQLVg90H21EOLACvtfcHk0lj-cGbVURwESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2gsbY%253D&md5=896e276601fd8c9bf0edf677b09a7094</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.061739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.061739%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.-B.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSmall-animal%2520PET%2520of%2520tumors%2520with%252064Cu-labeled%2520RGD-bombesin%2520heterodimer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D1168%26epage%3D1177%26doi%3D10.2967%2Fjnumed.108.061739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1016%2Fj.nucmedbio.2008.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=19324273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVOrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=277-285&author=L.+Weiauthor=Y.+Yeauthor=T.+J.+Wadasauthor=J.+S.+Lewisauthor=M.+J.+Welchauthor=S.+Achilefuauthor=C.+J.+Anderson&title=64Cu-Labeled+CB-TE2A+and+diamsar-conjugated+RGD+peptide+analogs+for+targeting+angiogenesis%3A+comparison+of+their+biological+activity&doi=10.1016%2Fj.nucmedbio.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity</span></div><div class="casAuthors">Wei, Lihui; Ye, Yunpeng; Wadas, Thaddeus J.; Lewis, Jason S.; Welch, Michael J.; Achilefu, Samuel; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The αvβ3 integrin is a cell adhesion mol. known to be involved in stages of angiogenesis and metastasis.  In this study, the chelators CB-TE2A and diamsar were conjugated to cyclic RGDyK and RGDfD and the biol. properties of 64Cu-labeled peptides were compared.  CB-TE2A-c(RGDyK) and diamsar-c(RGDfD) were labeled with 64Cu in 0.1 M NH4OAc (pH = 8) at 95° and 25°, resp.  PET and biodistribution studies were carried out on M21 (αvβ3-pos.) and M21L (αv-neg.) melanoma-bearing mice.  Binding affinity of the Cu-chelator-RGD peptides to αvβ3 integrins was detd. by a competitive binding affinity assay.  Biol. studies showed higher concn. of 64Cu-CB-TE2A-c(RGDyK) in M21 tumor compared to M21L tumor at 1 and 4 h pi.  Tumor concn. of 64Cu-CB-TE2A-c(RGDyK) was higher than that of 64Cu-diamsar-c(RGDfD).  The difference is not due to differing binding affinities, since similar values were obtained for the agents.  Compared to 64Cu-diamsar-c(RGDfD), there is more rapid liver and blood clearance of 64Cu-CB-TE2A-c(RGDyK), resulting in a lower liver and blood concn. at 24 h pi.  Both 64Cu-labeled RGD peptides show similar binding affinities to αvβ3.  The differences in their biodistribution properties are likely related to different linkers, charges and lipophilicities.  The M21 tumor is clearly visualized with 64Cu-CB-TE2A-c(RGDyK) by microPET imaging.  Administration of c(RGDyK) as a block significantly reduced the tumor concn.; however, the radioactivity background was also decreased by the blocking dose.  Both 64Cu-CB-TE2A-c(RGDyK) and 64Cu-diamsar-c(RGDfD) are potential candidates for imaging tumor angiogenesis.  For diamsar-c(RGDfD), a linker may be needed between the Cu-chelator moiety and the RGD peptide to achieve optimal in vivo tumor concn. and clearance from nontarget organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rKsKYK5XNbVg90H21EOLACvtfcHk0lj-cGbVURwESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVOrs7Y%253D&md5=1cc7db355bafa66036a018a65978dd4e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DWadas%26aufirst%3DT.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3D64Cu-Labeled%2520CB-TE2A%2520and%2520diamsar-conjugated%2520RGD%2520peptide%2520analogs%2520for%2520targeting%2520angiogenesis%253A%2520comparison%2520of%2520their%2520biological%2520activity%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.nucmedbio.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sprague, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achilefu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weilbaecher, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a <sup>64</sup>Cu-labeled RGD peptide</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=311-318&author=J.+E.+Spragueauthor=H.+Kitauraauthor=W.+Zouauthor=Y.+Yeauthor=S.+Achilefuauthor=K.+N.+Weilbaecherauthor=S.+L.+Teitelbaumauthor=C.+J.+Anderson&title=Noninvasive+imaging+of+osteoclasts+in+parathyroid+hormone-induced+osteolysis+using+a+64Cu-labeled+RGD+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSprague%26aufirst%3DJ.%2BE.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DAchilefu%26aufirst%3DS.%26aulast%3DWeilbaecher%26aufirst%3DK.%2BN.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DNoninvasive%2520imaging%2520of%2520osteoclasts%2520in%2520parathyroid%2520hormone-induced%2520osteolysis%2520using%2520a%252064Cu-labeled%2520RGD%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Tayar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Pattern recognition study of QSAR substituent descriptors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1007/BF01557723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1007%2FBF01557723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=111-132&author=H.+Van+de+Waterbeemdauthor=N.+El+Tayarauthor=P.+A.+Carruptauthor=B.+Testa&title=Pattern+recognition+study+of+QSAR+substituent+descriptors&doi=10.1007%2FBF01557723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FBF01557723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01557723%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DEl%2BTayar%26aufirst%3DN.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPattern%2520recognition%2520study%2520of%2520QSAR%2520substituent%2520descriptors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1989%26volume%3D3%26spage%3D111%26epage%3D132%26doi%3D10.1007%2FBF01557723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">microPET Imaging of glioma integrin α<sub>v</sub>β<sub>3</sub> expression using <sup>64</sup>Cu-labeled tetrameric RGD peptide</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1707-1718&author=Y.+Wuauthor=X.+Zhangauthor=Z.+Xiongauthor=Z.+Chengauthor=D.+R.+Fisherauthor=S.+Liuauthor=S.+S.+Gambhirauthor=X.+Chen&title=microPET+Imaging+of+glioma+integrin+%CE%B1v%CE%B23+expression+using+64Cu-labeled+tetrameric+RGD+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DFisher%26aufirst%3DD.%2BR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DmicroPET%2520Imaging%2520of%2520glioma%2520integrin%2520%25CE%25B1v%25CE%25B23%2520expression%2520using%252064Cu-labeled%2520tetrameric%2520RGD%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1707%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yoo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span> </span><span class="NLM_article-title">SPECT/CT imaging of high-risk atherosclerotic plaques using integrin-binding RGD dimer peptides</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">11752</span><span class="NLM_x">–</span> <span class="NLM_lpage">11763</span><span class="refDoi"> DOI: 10.1038/srep11752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1038%2Fsrep11752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=26123253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A280%3ADC%252BC2MbosV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11752-11763&author=J.+S.+Yooauthor=J.+Leeauthor=J.+H.+Jungauthor=B.+S.+Moonauthor=S.+Kimauthor=B.+C.+Leeauthor=S.+E.+Kim&title=SPECT%2FCT+imaging+of+high-risk+atherosclerotic+plaques+using+integrin-binding+RGD+dimer+peptides&doi=10.1038%2Fsrep11752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides</span></div><div class="casAuthors">Yoo Jung Sun; Lee Jonghwan; Kim Soonhag; Jung Jae Ho; Moon Byung Seok; Lee Byung Chul; Kim Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11752</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vulnerable atherosclerotic plaques with unique biological signatures are responsible for most major cardiovascular events including acute myocardial infarction and stroke.  However, current clinical diagnostic approaches for atherosclerosis focus on anatomical measurements such as the degree of luminal stenosis and wall thickness.  An abundance of neovessels with elevated expression of integrin αvβ3 is closely associated with an increased risk of plaque rupture.  Herein we evaluated the potential of an αvβ3 integrin-targeting radiotracer, (99m)Tc-IDA-D-[c(RGDfK)]2, for SPECT/CT imaging of high-risk plaque in murine atherosclerosis models.  In vivo uptake of (99m)Tc-IDA-D-[c(RGDfK)]2 was significantly higher in atherosclerotic aortas than in relatively normal aortas.  Comparison with the negative-control peptide, (99m)Tc-IDA-D-[c(RADfK)]2, proved specific binding of (99m)Tc-IDA-D-[c(RGDfK)]2 for plaque lesions in in vivo SPECT/CT and ex vivo autoradiographic imaging.  Histopathological characterization revealed that a prominent SPECT signal of (99m)Tc-IDA-D-[c(RGDfK)]2 corresponded to the presence of high-risk plaques with a large necrotic core, a thin fibrous cap, and vibrant neoangiogenic events.  Notably, the RGD dimer based (99m)Tc-IDA-D-[c(RGDfK)]2 showed better imaging performance in comparison with the common monomeric RGD peptide probe (123)I-c(RGDyV) and fluorescence tissue assay corroborated this.  Our preclinical data demonstrated that (99m)Tc-IDA-D-[c(RGDfK)]2 SPECT/CT is a sensitive tool to noninvasively gauge atherosclerosis beyond vascular anatomy by assessing culprit plaque neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7W6al4e03HjQLBVDQn4bCfW6udTcc2ebQQtRPo6GmHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbosV2rsg%253D%253D&md5=45460f525f7f897be74d9e026ca1f536</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep11752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11752%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3DSPECT%252FCT%2520imaging%2520of%2520high-risk%2520atherosclerotic%2520plaques%2520using%2520integrin-binding%2520RGD%2520dimer%2520peptides%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11752%26epage%3D11763%26doi%3D10.1038%2Fsrep11752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&issue=12&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0liq9H9iElCslw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D12%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Banerjee, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferdani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2669</span><span class="refDoi"> DOI: 10.1021/jm401921j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401921j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2657-2669&issue=6&author=S.+R.+Banerjeeauthor=M.+Pullambhatlaauthor=C.+A.+Fossauthor=S.+Nimmagaddaauthor=R.+Ferdaniauthor=C.+J.+Andersonauthor=R.+C.+Measeauthor=M.+G.+Pomper&title=64Cu-Labeled+inhibitors+of+prostate-specific+membrane+antigen+for+PET+imaging+of+prostate+cancer&doi=10.1021%2Fjm401921j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer</span></div><div class="casAuthors">Banerjee, Sangeeta Ray; Pullambhatla, Mrudula; Foss, Catherine A.; Nimmagadda, Sridhar; Ferdani, Riccardo; Anderson, Carolyn J.; Mease, Ronnie C.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2657-2669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) is a well-recognized target for identification and therapy of a variety of cancers.  Here we report five 64Cu-labeled inhibitors of PSMA, [64Cu]3-7, which are based on the lysine-glutamate urea scaffold and utilize a variety of macrocyclic chelators, namely NOTA(3), PCTA(4), Oxo-DO3A(5), CB-TE2A(6), and DOTA(7), in an effort to det. which provides the most suitable pharmacokinetics for in vivo PET imaging. [64Cu]3-7 were prepd. in high radiochem. yield (60-90%) and purity (>95%).  Positron emission tomog. (PET) imaging studies of [64Cu]3-7 revealed specific accumulation in PSMA-expressing xenografts (PSMA+ PC3 PIP) relative to isogenic control tumor (PSMA- PC3 flu) and background tissue.  The favorable kinetics and high image contrast provided by CB-TE2A chelated [64Cu]6 suggest it as the most promising among the candidates tested.  That could be due to the higher stability of [64Cu]CB-TE2A as compared with [64Cu]NOTA, [64Cu]PCTA, [64Cu]Oxo-DO3A, and [64Cu]DOTA chelates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgcn3xPOl6rVg90H21EOLACvtfcHk0liq9H9iElCslw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKitb8%253D&md5=511ffeb4ceb22ac99f7b21d0a5591efa</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm401921j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401921j%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DFoss%26aufirst%3DC.%2BA.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DFerdani%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3D64Cu-Labeled%2520inhibitors%2520of%2520prostate-specific%2520membrane%2520antigen%2520for%2520PET%2520imaging%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D6%26spage%3D2657%26epage%3D2669%26doi%3D10.1021%2Fjm401921j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dumont, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fani, M.</span><span> </span><span class="NLM_article-title">Novel <sup>64</sup>Cu-and <sup>68</sup>Ga-labeled RGD conjugates show improved PET imaging of α<sub>ν</sub>β<sub>3</sub> integrin expression and facile radiosynthesis</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.2967/jnumed.111.087700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.2967%2Fjnumed.111.087700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1276-1284&author=R.+A.+Dumontauthor=F.+Deiningerauthor=R.+Haubnerauthor=H.+R.+Maeckeauthor=W.+A.+Weberauthor=M.+Fani&title=Novel+64Cu-and+68Ga-labeled+RGD+conjugates+show+improved+PET+imaging+of+%CE%B1%CE%BD%CE%B23+integrin+expression+and+facile+radiosynthesis&doi=10.2967%2Fjnumed.111.087700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.087700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.087700%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DR.%2BA.%26aulast%3DDeininger%26aufirst%3DF.%26aulast%3DHaubner%26aufirst%3DR.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DFani%26aufirst%3DM.%26atitle%3DNovel%252064Cu-and%252068Ga-labeled%2520RGD%2520conjugates%2520show%2520improved%2520PET%2520imaging%2520of%2520%25CE%25B1%25CE%25BD%25CE%25B23%2520integrin%2520expression%2520and%2520facile%2520radiosynthesis%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1276%26epage%3D1284%26doi%3D10.2967%2Fjnumed.111.087700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lgVPiDJj2MXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Boswell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheingold, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span> </span><span class="NLM_article-title">Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span><span class="refDoi"> DOI: 10.1021/jm030383m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030383m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1465-1474&author=C.+A.+Boswellauthor=X.+Sunauthor=W.+Niuauthor=G.+R.+Weismanauthor=E.+H.+Wongauthor=A.+L.+Rheingoldauthor=C.+J.+Anderson&title=Comparative+in+vivo+stability+of+copper-64-labeled+cross-bridged+and+conventional+tetraazamacrocyclic+complexes&doi=10.1021%2Fjm030383m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes</span></div><div class="casAuthors">Boswell, C. Andrew; Sun, Xiankai; Niu, Weijun; Weisman, Gary R.; Wong, Edward H.; Rheingold, Arnold L.; Anderson, Carolyn J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1465-1474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increased use of copper radioisotopes in radiopharmaceutical applications has created a need for bifunctional chelators (BFCs) that form stable radiocopper complexes and allow covalent attachment to biol. mols.  The chelators most commonly utilized for labeling copper radionuclides to biomols. are analogs of 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA); however, recent reports have communicated the instability of the radio-Cu(II)-TETA complexes in vivo.  A class of bicyclic tetraazamacrocycles, the ethylene "cross-bridged" cyclam (CB-cyclam) derivs., form highly kinetically stable complexes with Cu(II) and therefore may be less susceptible to transchelation than their nonbridged analogs in vivo.  Herein we report results on the relative biol. stabilities and identification of the resulting radiolabeled metabolites of a series of 64Cu-labeled macrocyclic complexes.  Metab. studies in normal rat liver have revealed that the 64Cu complex of 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane (64Cu-CB-TE2A) resulted in significantly lower values of protein-assocd. 64Cu than 64Cu-TETA [13 ± 6% vs 75 ± 9% at 4 h].  A similar trend was obsd. for the corresponding cyclen derivs., with the 64Cu complex of 4,10-bis(carboxymethyl)-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane (64Cu-CB-DO2A) undergoing less transchelation than the 64Cu complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (64Cu-DOTA) [61 ± 14% vs 90.3 ± 0.5% protein assocd. 64Cu at 4 h].  These data indicate that the structurally reinforcing cross-bridge enhances in vivo stability by reducing metal loss to protein in both the cyclam and cyclen cross-bridged 64Cu complexes and that 64Cu-CB-TE2A is superior to 64Cu-CB-DO2A in that regard.  These findings further suggest that a bifunctional chelator deriv. of CB-TE2A is a highly desirable alternative for labeling copper radionuclides to biol. mols. for diagnostic imaging and targeted radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0FGtigmddbVg90H21EOLACvtfcHk0lgVPiDJj2MXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagtLw%253D&md5=542e8b853716a629b641740f102a48db</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm030383m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030383m%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DW.%26aulast%3DWeisman%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DE.%2BH.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26atitle%3DComparative%2520in%2520vivo%2520stability%2520of%2520copper-64-labeled%2520cross-bridged%2520and%2520conventional%2520tetraazamacrocyclic%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1465%26epage%3D1474%26doi%3D10.1021%2Fjm030383m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreerama, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span> </span><span class="NLM_article-title"><sup>64</sup>Cu-Labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5057</span><span class="NLM_x">–</span> <span class="NLM_lpage">5069</span><span class="refDoi"> DOI: 10.1021/jm0704088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0704088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVens7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5057-5069&author=J.+Wangauthor=C.-T.+Yangauthor=Y.-S.+Kimauthor=S.+G.+Sreeramaauthor=Q.+Caoauthor=Z.-B.+Liauthor=Z.+Heauthor=X.+Chenauthor=S.+Liu&title=64Cu-Labeled+triphenylphosphonium+and+triphenylarsonium+cations+as+highly+tumor-selective+imaging+agents&doi=10.1021%2Fjm0704088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents</span></div><div class="casAuthors">Wang, Jianjun; Yang, Chang-Tong; Kim, Young-Seung; Sreerama, Subramanya G.; Cao, Qizhen; Li, Zi-Bo; He, Zhengjie; Chen, Xiaoyuan; Liu, Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5057-5069</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report presents synthesis and evaluation of the 64Cu-labeled triphenylphosphonium (TPP) cations as new radiotracers for imaging tumors by positron emission tomog.  Biodistribution properties of 64Cu-L1, 64Cu-L2, 64Cu-L3, and 99mTc-Sestamibi were evaluated in athymic nude mice bearing U87MG human glioma xenografts.  The most striking difference is that 64Cu-L1, 64Cu-L2, and 64Cu-L3 have much lower heart uptake (<0.6% ID/g) than 99mTc-Sestamibi (∼18% ID/g) at >30 min p.i.  Their tumor/heart ratios increase steadily from ∼1 at 5 min p.i. to ∼5 at 120 min p.i.  The tumor/heart ratio of 64Cu-L3 is ∼40 times better than that of 99mTc-Sestamibi at 120 min postinjection.  Results from in vitro assays show that 64Cu-L1 is able to localize in tumor mitochondria.  The tumor is clearly visualized in the tumor-bearing mice administered with 64Cu-L1 as 30 min postinjection.  The 64Cu-labeled TPP/TPA cations are very selective radiotracers that are able to provide the information of mitochondrial bioenergetic function in tumors by monitoring mitochondrial potential in a noninvasive fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK5KYmQOI0H7Vg90H21EOLACvtfcHk0ljvhZ-FznIiHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVens7vK&md5=f38aacf5ab06845d569dfe89ed2ec58f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0704088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704088%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.-T.%26aulast%3DKim%26aufirst%3DY.-S.%26aulast%3DSreerama%26aufirst%3DS.%2BG.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.-B.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D64Cu-Labeled%2520triphenylphosphonium%2520and%2520triphenylarsonium%2520cations%2520as%2520highly%2520tumor-selective%2520imaging%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5057%26epage%3D5069%26doi%3D10.1021%2Fjm0704088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rogers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1021/bc9600372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9600372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;key=1%3ACAS%3A528%3ADyaK28XjvFequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=511-522&author=B.+E.+Rogersauthor=C.+J.+Andersonauthor=J.+M.+Connettauthor=L.+W.+Guoauthor=W.+B.+Edwardsauthor=E.+L.+Shermanauthor=K.+R.+Zinnauthor=M.+J.+Welch&title=Comparison+of+four+bifunctional+chelates+for+radiolabeling+monoclonal+antibodies+with+copper+radioisotopes%3A+biodistribution+and+metabolism&doi=10.1021%2Fbc9600372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution and Metabolism</span></div><div class="casAuthors">Rogers, Buck E.; Anderson, Carolyn J.; Connett, Judith M.; Guo, Li Wu; Edwards, W. Barry; Sherman, Elizabeth L. C.; Zinn, Kurt R.; Welch, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bifunctional chelating agents (BFCs), 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (BAT), 6-[p-(isothiocyanato)benzyl]-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (SCN-TETA), 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid (CPTA), and 1-[(1,4,7,10,13-pentaazacyclopentadec-1-yl)methyl]benzoic acid (PCBA), were synthesized and conjugated to the anti-colorectal monoclonal antibody (mAb), 1A3, and antibody fragments, 1A3-F(ab')2, for radiolabeling with 64,67Cu and comparison in animal models.  In vivo metab. studies were carried out in liver and kidneys to correlate the nature of the metabolites formed to the uptake and retention of the radiolabel in each organ.  Animal biodistribution studies were performed in Golden Syrian hamsters bearing the GW39 human colon cancer tumors and in normal Sprague-Dawley rats.  All conjugates showed good tumor uptake in hamsters.  Biodistribution in rats showed that 64Cu-BAT-2IT-1A3 had the lowest liver and kidney uptake of the intact 1A3 conjugates (p < 0.03), whereas in hamsters, there were no significant differences in liver and kidney uptake between the four intact BFC-1A3 conjugates.  Tumor-bearing hamsters injected with 64Cu-CPTA-1A3-F(ab')2 and 64Cu-PCBA-1A3-F(ab')2 had from 3 to 7 times greater uptake in the kidneys than hamsters given 64Cu-labeled BAT and SCN-TETA 1A3-F(ab')2 conjugates, while rats injected with 64Cu-CPTA-1A3-F(ab')2 and 64Cu-PCBA-1A3-F(ab')2 had nearly twice the uptake.  The in vivo metab. of the mAbs 1A3 and 1A3-F(ab')2 radiolabeled with 67Cu through the SCN-TETA, CPTA, and PCBA BFCs was investigated by excising the livers and kidneys of normal rats from 1-5 days postinjection of the radiolabeled conjugates.  Liver and kidney homogenates were analyzed by size exclusion chromatog. and thin layer chromatog. (TLC).  The size exclusion chromatog. data showed that all of the 67Cu-labeled 1A3-F(ab')2 conjugates were >85% degraded in the kidneys to small mol. wt. metabolites by 1 day postinjection.  In contrast, in the liver at 1 day post-injection, greater than 70% of the 67Cu-labeled 1A3 conjugates were unmetabolized.  By day 5, a 35 kDa peak appeared in the liver of rats injected with the 67Cu-labeled 1A3 conjugates, possibly due to transchelation of the 67Cu to proteins.  Superoxide dismutase chromatog. elutes at the same retention time as this 67Cu-labeled metabolite.  The TLC data indicate that the low mol. wt. metabolite (<5 kDa) of both 67Cu-CPTA-1A3 and 67Cu-CPTA-1A3-F(ab')2 conjugates cochromatographed with a 67Cu-CPTA-ε-lysine std.  Our data suggest that chelate charge and lipophilicity play a large role in kidney retention of 64/67Cu-labeled BFC-1A3-F(ab')2 conjugates, while transchelation of the copper label appears to be the major factor for liver accumulation of 64/67Cu-labeled BFC-1A3 conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_M4QJlxIFbbVg90H21EOLACvtfcHk0ljvhZ-FznIiHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFequrY%253D&md5=759c3d215a1ea49f0dd7a08c2ccbdc55</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbc9600372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9600372%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DB.%2BE.%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DConnett%26aufirst%3DJ.%2BM.%26aulast%3DGuo%26aufirst%3DL.%2BW.%26aulast%3DEdwards%26aufirst%3DW.%2BB.%26aulast%3DSherman%26aufirst%3DE.%2BL.%26aulast%3DZinn%26aufirst%3DK.%2BR.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DComparison%2520of%2520four%2520bifunctional%2520chelates%2520for%2520radiolabeling%2520monoclonal%2520antibodies%2520with%2520copper%2520radioisotopes%253A%2520biodistribution%2520and%2520metabolism%26jtitle%3DBioconjugate%2520Chem.%26date%3D1996%26volume%3D7%26spage%3D511%26epage%3D522%26doi%3D10.1021%2Fbc9600372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6625</span><span class="NLM_x">–</span> <span class="NLM_lpage">6637</span><span class="refDoi"> DOI: 10.1021/jm0496990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0496990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6625-6637&author=J.+Yooauthor=D.+E.+Reichertauthor=M.+J.+Welch&title=Comparative+in+vivo+behavior+studies+of+cyclen-based+copper-64+complexes%3A+regioselective+synthesis%2C+X-ray+structure%2C+radiochemistry%2C+log+P%2C+and+biodistribution&doi=10.1021%2Fjm0496990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm0496990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0496990%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520in%2520vivo%2520behavior%2520studies%2520of%2520cyclen-based%2520copper-64%2520complexes%253A%2520regioselective%2520synthesis%252C%2520X-ray%2520structure%252C%2520radiochemistry%252C%2520log%2520P%252C%2520and%2520biodistribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6625%26epage%3D6637%26doi%3D10.1021%2Fjm0496990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01671">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72471"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01671">10.1021/acs.jmedchem.7b01671</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Serum stability studies of <sup>64</sup>Cu-BFCs-c(RGDyK), plasma protein binding studies of <sup>64</sup>Cu-BFCs-c(RGDyK), in vivo stability studies of <sup>64</sup>Cu-BFCs-c(RGDyK), mass spectra of BFCs-c(RGDyK) conjugates, UV HPLC profiles of BFCs-c(RGDyK) conjugates, UV/radio-HPLC chromatogram of <sup>64</sup>Cu-PCB-TE2A-Bn-NCS-c(RGDyK), and <sup>64</sup>Cu-ECB-TE2A-c(RGDyK), mass spectra of Cu-ECB-TE2A-c(RGDyK) and Cu-PCB-TE2A-c(RGDyK) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_001.pdf">jm7b01671_si_001.pdf (2.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01671/suppl_file/jm7b01671_si_002.csv">jm7b01671_si_002.csv (2.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01671&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01671%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01671" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679971866a833c9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
